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The RNA binding protein DAZL (Deleted in Azoospermia) is essential for germ cell 
survival and subsequent fertility.  The transgenic mouse DAZL model has confirmed 
that knockout (KO) females are infertile as a direct consequence of complete 
postnatal oocyte ablation.  Interestingly, the heterozygous (Het) DAZL females have 
increased fertility giving rise to significantly more viable offspring, accompanied by 
significantly reduced plasma FSH and increased inhibin B compared to levels 
observed in the wildtype (Wt) females.  Recent studies to identify putative DAZL 
mRNA targets suggest that DAZL may have multiple functions and mRNA targets 
throughout germ cell development.  However, how this protein functions within the 
oocyte and how functional copy number gives rise to increased fertility remains to be 
fully elucidated.   
 
The studies in this thesis sought to identify putative DAZL mRNA targets in addition 
to molecular mechanisms which may be either affected direct or indirectly as a result 
of the functional copy number of DAZL (Wt or Het) within the oocyte or follicular 
unit.  Oocytes from Wt and Het were evaluated for their expression of selected 
oocyte genes and comparative analysis suggests that oocyte gene expression is 
significantly altered between the genotypes.  Genes of interest include Oosp1 and 
H1foo, both of which are down-regulated in mRNA expression in Het d21 oocytes 
and d10 ovaries compared to the Wt.  Furthermore, an in silico bioinformatics 
approach was utilised to identify putative DAZL mRNA targets using a consensus 
DAZL binding sequence.  One candidate target, PDCD4, previously identified as a 
tumour suppressor gene was selected for further investigation.  Despite PDCD4 
mRNA and protein being highly expressed within the ovary, no difference in mRNA 
levels between Het and Wt was observed.  However, although not ruling out the 
possibility of being a DAZL target we now have evidence that PDCD4 can function 
within the steroidogenic cells of the corpus luteum in relation to functional luteolysis.   
 




Indirect actions of DAZL upon local regulation and response of follicle growth in 
culture were evaluated to investigate follicles at the gonadotrophin dependent stage 
of growth.  Individual follicles from Wt and Het d21 mice were cultured in the 
presence of FSH at 1iu, 0.5iu, 0.1iu and 0.01iu for a six day period.  Final follicle 
size/morphology did not differ between genotypes at 1iu, 0.5iu and 0.1iu of FSH, but 
by d3 at 0.01iu FSH growth of Wt follicles was significantly (P<0.001) perturbed 
compared to the Het.  Despite no difference in final size between 1iu, 0.5iu, 0.1iu 
FSH treatments, mRNA analysis of individual follicles demonstrated a significant 
up-regulation of FSH receptor (P<0.05), aromatase (P<0.05) and inhibin βA (P<0.01) 
and a significant down-regulation in inhibin βB (P<0.01) expression in the Het 
follicles compared to the Wt, suggesting an increase in follicle maturity, sensitivity 
and hence suitability for selection as viable pre-ovulatory follicles.  Furthermore, 
atresia rates from cultured follicles were significantly lower (P<0.05 (1iu, 0.1iu 
FSH); P<0.01(0.01iu FSH)) in the Het compared to the Wt. 
 
These studies provide strong evidence that multiple mechanisms within the 
oocyte/follicle are directly and indirectly affected as a result of functional copy 
number of DAZL.  Although direct in vivo targets remain to be identified it is clear 
that DAZL protein potentially targets multiple mRNAs at different stages of 
development, pre-programming the oocyte to increase the sensitivity of follicle 
and/or the functioning within a transcription complex regulating development.  In 
conclusion, the beneficial consequences of increased fertility in the Het females is 
accompanied by a possible acceleration in oocyte and follicle maturation, an 
increased sensitivity to FSH in vitro with evidence of advanced stages of growth and, 
a reduction in follicle atresia.  These differences support the suggestion that DAZL is 
having systemic effects on the paracrine communication within the follicle unit 
between the oocyte and somatic cells altering regulation and subsequent selection, 
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Chapter 1: Literature review 
Regulation of normal female reproductive function is principally governed by the 
finely coordinated actions of the gonadotrophin hormones which systemically 
regulate folliculogenesis.  In turn folliculogenesis is a process which encompasses 
local steroidogenesis, gene regulation, cell cycle progression, cytodifferentiation and 
apoptosis (Richards et al., 1995).  Oocyte expressed genes notably play an important 
role in producing vital regulatory molecules that directly affect fundamental 
physiological processes during folliculogenesis (Erickson and Shimasaki, 2000).  
Acknowledging the importance of these oocytes factors implies that any alterations 
or disruptions of these specific genes may lead to infertility and ovarian pathology 
(Erickson and Shimasaki, 2000).  However, the oocyte does not function alone and it 
has long been established that the communication between it and the surrounding 
somatic cells of the ovarian follicle are necessary for appropriate functionality.  From 
a historic perspective the identification of the physiological importance of somatic 
cell-oocyte interactions dates back to 1959, whereby it was reported that the after 
ovectomy spontaneous transformation of the large Graafian follicle into a corpus 
luteum occurred (Falck, 1959).  From these observations, which have subsequently 
been confirmed by others (El-Fouly et al., 1970; Channing 1970; Hubbard and 
Erickson 1988; Vanderhyden et al., 1993), it can be concluded that the oocyte 
produces essential signals which subsequently suppress luteinisation and, upon 
removal, these signals cease to operate, hence onset of luteinisation.  Moreover, it 
has now been acknowledged that this communication is a two-way mechanism 
requiring a plethora of essential mediators with alterations in control being 
responsible for many underlying disorders of female reproductive health.  To 
understand and appreciate the complexity of this bi-directional control of the 
follicular unit we have to acknowledge the sophistication of the developmental 
systems involved, starting from embryonic development and ending with ovarian 
quiescence, whereby the oocytes pool is essentially depleted. 
 
A finite, non-renewable pool of primordial follicles is believed to be present at the 
time of birth and if correct the supply of primordial follicles in postnatal life should 
Chapter 1                                                                                            Literature review 
 2
be depleted during follicle development, either by undergoing atresia or surviving to 
ovulation (Kerr et al., 2006).  As a result of this predetermined supply of oocytes it is 
fundamentally important to ensure that the supply of oocytes is not wasted and that 
follicle development occurs efficiently.  The cessation of the ovarian function occurs 
when the ovary becomes exhausted of germ cells, which is classified as menopause 
in human females. However recent evidence suggested that this may not be the case 
and oocyte renewability has been a target of biological investigation and subjected to 
recent debate.  This original dogma, has been  recently challenged by Tilly and 
colleagues (Johnson et al., 2004; 2005), who suggest that intra- and extra-ovarian 
germline stem cells can replenish oocytes and form new primordial follicles in adult 
life.  However, this new concept has been hotly disputed between Tilly’s laboratory 
and others within the ovarian field (Telfer et al., 2005; Powell, 2006; Faddy and 
Gosden, 2007; Tilly and Johnson, 2007).  In support, a further study in mice shows 
that despite continued activation of follicles throughout ovarian cycles, there was 
little reduction in the overall number of follicles from birth up to 140 days of ages 
suggesting that follicle replenishment may be occurring in these mice (Kerr et al., 
2006).  However the authors do not propose the presence of germline stem cells as 
suggested by Tilly, and with no clear explanations of their result the debate 
continues. 
 
Indisputably, reproducing is fundamental to the survival of mammals, therefore an 
understanding into the normal biological function within the ovary is essential before 
attempting to investigate ovarian abnormalities which persist in development and 
contribute to infertility.  Many factors have been implicated as essential regulators in 
germ cell development and follicle organisation although the molecular 
underpinnings of what constitutes an oocyte of high quality are essentially unknown 
(Pan et al., 2005).  Investigations into the delicate interplay between the molecular 
mechanisms and follicular productivity remain the focus of this thesis with emphasis 
on the functions of the germ cell specific gene DAZL and its contribution to 
functional follicular development.  In the absence of DAZL oocytes fail to enter 
meiosis, and subsequently die prior to birth leaving the mice infertile (Ruggiu et al., 
1997).  Therefore, not only is the DAZL knockout (KO) mouse an invaluable 
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research tool aiding the investigations into the mechanisms by which DAZL protein 
affects oocyte maturation and hence fertility, it subsequently allows us to investigate 
the heterozygous (Het) phenotype which present with increased fertility.  In order to 
establish why complete functional loss of DAZL is detrimental to fertility but 
reduced function as in the Hets increases the number of viable offspring, it is first 
imperative to consider how DAZL is affecting the development and regulation of the 
oocyte and consequently the follicular unit as a whole.  Furthermore, attempting to 
identify targets of DAZL and pathways in which it may play regulatory roles is 
imperative to identifying the importance of this oocyte regulator.  This review aims 
to deliver an overview of selected mechanisms which are of great importance in 
female reproductive development highlighting the need for a more cohesive 




The development of the mammalian ovary is a complex process requiring the fine 
coordination of specifically defined events including embryogenesis, oogenesis and 
folliculogenesis.   
 
Throughout reproductive development and function there are a number of germ cell 
fates.  These include the loss in fetal life by apoptotic cell death, loss as a result of 
atresia at any stage of follicle development, or they can be recruited into the follicle 
cohort destined for dominance and subsequent ovulation.  The ultimate success of the 
oocyte is fertilisation giving rise to a viable new generation.  All these events require 
the appropriate coordination of many regulatory mechanisms relying on gene 
expression and protein production as selectively discussed in the following sections.  
Furthermore the ovary participates in extensive tissue remodelling required for 
follicular development, ovulation and corpus luteum (CL) formation.  Conclusively 
the ovary is one of the most active endocrine organs both functionally and 
structurally during reproductive life in mammals.  
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1.1.1. Migration of germ cells 
The journey of germ cell existence starts in fetal life with the primordial germ cells 
(PGCs) arising from the extraembryonic epiblast cell precursors located outside the 
embryo.  In the mouse the founding population of PGCs is around 45 and can be 
visualised at embryonic day (e) 7.2 (Tam and Snow, 1981; Ginsburg et al., 1990).  
These PGCs migrate through the hindgut mesentery to the genital ridge which is 
formed from the mesoderm layer and differentiates into the mammalian gonad.  
During the process of migration the PGCs continue to proliferate and begin to 
aggregate with one another, with approximately 3000 cells detectable at e11 in the 
mouse.  This proliferation continues within the genital ridge and by e13.5, around 
25,000 germ cells are present (Monk and McLaren, 1981; Tam and Snow, 1981).   
 
1.1.2. Germ cell cysts formation and breakdown 
It is within the genital ridge that the PGCs combine with the somatic components of 
the gonad and form germ cell cysts (Bendel-Stenszel et al., 1998).  These cysts are 
formed as a result of incomplete cytokinesis during cell division in the fetal mouse 
following germ cell migration into the genital ridge (Pepling and Spradling, 1998).  
Furthermore, from e13.5 after colonisation, the germ cells within the cysts enter 
meiosis.  At the beginning of e17.5 on reaching the diplotene stage of the first 
meiotic prophase the oogonia arrest and are now recognised as oocytes (McLaren, 
2000) (Figure 1.1).   
 
After this episode of proliferation and migration up to 70% of germ cells within each 
cyst actually die between e13 and e16 (Baker, 1972; Coucouvanis et al., 1993; Ratts 
et al., 1995).  In addition it has been postulated that this mass attrition is a process 
devised to eliminate germ cells harbouring chromosomal abnormalities or 
mitochondrial defects leaving only the best selection of germ cells for subsequent 
development (Baker, 1972; Krakauer and Mira, 1999; Morita and Tilly, 1999).  In 
addition to this mass depletion, germ cell cysts also enter a developmentally 
programmed breakdown as a result of invasion by pre-granulosa cells prior to the 
formation of individually selected primordial follicles (Figure 1.1) (Pepling and 
Spradling, 2001; Pepling, 2006).  This invasion and subsequent encasement of the 
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oocytes with pre-granulosa cells is a gonadotrophin independent event, occurring just 
after birth, involving cell specific (e.g. OCT4) and nonspecific (e.g. BMP4 and 
BMP8b) factors and although not fully understood at a molecular level it is clear that 
genetic regulatory control must be interacting between the oocyte and granulosa cells 
(Pepling, 2006).  Furthermore, a role for nurse cell action and gradual breakdown of 
larger cysts into smaller cysts then to individual follicles has also been proposed 




Figure 1.1: Summary of germ cell cyst formation, breakdown and primordial follicle formation in the 
mouse.  The primordial germ cells arrive into the genital ridge at approximately e10, after which germ 
cell cysts form.  From e13.5 the germ cells within the cysts progress through prophase 1 of meiosis 
arresting at the diplotene stage at the beginning of e17.5.  In the neonatal ovary the germ cell cysts 
breakdown and pre-granulosa cells and basal lamina surround the oocytes forming primordial follicles 
(germ cells are represented by yellow and the somatic cells are in red) (Hirshfield, 1991; Barnett et al., 
2006; Pepling, 2006). 
 
1.1.3. Molecular control of germ cell cyst breakdown 
The processes involving germ cell nest formation, breakdown and primordial follicle 
formation are regulated by a number of communicating factors (Pepling, 2006).  
Members of the TGFβ superfamily, specifically BMP15, GDF9 and inhibin α 
(McMullen et al., 2001; Yan et al., 2001b), the transcription factor Figla (Soyal et al., 
2000), the notch signalling pathway (Hahn et al., 2005) in addition to steroids (Chen 
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et al., 2007) have all been identified as essential factors involved in these processes.  
Findings from a number of studies indicate that incomplete cystic breakdown occurs 
in conjunction with an increase in multi-oocyte follicles (MOFs) as a result of 
ablating BMP15 and GDF9 and over-expressing inhibin α (McMullen et al., 2001; 
Yan et al., 2001).  These findings implicate the involvement of these factors directly 
in germ cell cyst breakdown.  Furthermore, female mice lacking Figla show an 
absence of primordial follicle formation perinatally, this is accompanied by a deficit 
in oocytes (Soyal et al., 2000).  Again these findings support the active role for Figla 
in the regulation of initial formation of primordial follicles playing an ,active role in 
modulating germ cell survival (Soyal et al., 2000).  Furthermore, Figla is the 
transcription factor for the zona pellucida genes (ZP1, ZP2 and ZP3) (Liang et al., 
1997) and mutations in these genes confirm that they too are crucial for successful 
follicle formation (Liu et al., 1996; Rankin et al., 1996; Rankin et al., 1999; Rankin 
et al., 2001). 
 
Recent studies have also shown that oestrogen, progesterone and testosterone 
signalling are the primary signals required to initiate oocyte nest breakdown and 
follicle assembly.  In support, on treating rodents neonatally with natural oestrogens, 
compounds with oestrogen-like activities, testosterone or progesterone all resulted in 
an increase in MOFs, suggesting incomplete nest breakdown (Iguchi et al., 1986; 
1988; 1990; 2001; Iguchi and Takasugi 1986; Suzuki et al., 2002; Kezele and 
Skinner, 2003).  However, it is not known whether the effects of progesterone and 
testosterone are direct or indirect due to there ability to convert to oestrogen (Kezele 
and Skinner, 2003). 
 
Evidence is now emerging about the function of a host of critical factors associated 
with primordial follicle development, as described above, and further elucidation into 
the processes involved in the establishment of the primordial follicle pool will 
provide a better understanding of oocyte growth and development.  The role of the 
oocyte and further follicular development will now be discussed. 
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1.1.4. Oocyte growth  
The mouse oocyte takes approximately 2 weeks to reach full size and a further week 
to reach pre-ovulatory maturity (Bachvarova, 1985).  During this growth phase the 
diameter of the mouse oocytes, which are arrested in diplotene stage of the first 
meiotic prophase, increases substantially from 10-15μm in the primordial resting 
follicle to approximately 80μm in the pre-ovulatory antral follicle (Gosden and 
Bownes, 1995) during which both meiotic and developmental competence are 
acquired.  This remarkable enlargement of the oocyte occurs as growth is not delayed 
or interrupted by cell division and by the process of cytoplasmic cleavage.  Moreover 
this substantial growth of the oocyte is a reflection into its maturity with an increase 
in both oocyte diameter and volume.  Throughout oogenesis there are timely 
regulated periods of high transcriptional and translational activity, that alternate with 
phases of relatively low metabolic activity.  However, in concordance with this 
increase in oocyte volume the activity of the growing oocyte is associated with the 
accumulation of RNA transcripts and the synthesis of proteins from both nuclear and 
mitochondrial transcripts.  These products of oocyte activity are essential 
components required for the differentiation and maturation of the oocyte itself (De 
La Fuente and Eppig, 2001) and notably a number of oocyte derived proteins interact 
with the encasing granulosa cells, these are later discussed in detail.  Furthermore 
these oocyte derived factors play important roles later in the activation of the 
embryonic genome and embryonic development (Amleh and Dean, 2002). 
 
It has become increasingly apparent that genetic programming within the oocyte 
plays an important role in orchestrating the multiple events required for successful 
folliculogenesis, fertilisation and early development (Dean, 2002).  To further 
appreciate oocyte growth it is probably more reasonable to observe its function as 
part of a developmental follicle unit rather than an individual cell.  In discussing the 
roles of the oocyte in folliculogenesis it is apparent that oocyte growth is contributing 
to not only self survival and development but is involved in a network of highly 
regulated events. 
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1.2. Follicle development 
The dynamic control of ovarian function is coordinated by a plethora of highly 
regulated control mechanisms.  Major players involved in folliculogenesis are 
undoubtedly the gonadotrophins, however, these factors do not function alone and 
many control systems actively interact.  The process of folliculogenesis involves 
small oocytes surrounded by a single layer of granulosa cells undergoing extensive 
morphological changes to reach a large meiotically competent oocyte surrounded by 
a multiple interconnecting granulosa cell layer further encased by a somatic thecal 
layer (Figure 1.2).  This substantial growth can be divided into two phases, with the 
initial stages being predominantly gonadotrophin independent, and there is 
accumulating evidence that intra-ovarian paracrine signalling plays an important role 
(Kol and Adashi, 1995).  The second growth phase of folliculogenesis is significantly 
regulated by the circulating gonadotrophins, follicle stimulating hormone (FSH) and 
luteinising hormone (LH).  Again intra-ovarian factors have been implicated.  
Although the growth phases have been classified into gonadotrophin independent 
and gonadotrophin dependent the developmental stages of the actual ovarian follicles 
are often classified with reference to their morphology.  More recently it has been 
recognised that the functional physiological state is a more accurate means of follicle 
classification (Hirshfield 1995; Scaramuzzi et al., 1993; Findlay et al., 2002).  Using 
this physiological status, four classes of follicular growth have been identified based 
upon their individual dependency and sensitivity to gonadotrophins.  Follicles can 
therefore be accurately classified as quiescent (primordial), committed to growth 
(preantral and antral), ovulatory or atretic. 
 
It is now recognised that oogenesis and folliculogenesis are highly coordinated 
coupled processes and no follicle would be formed in the absence of an oocyte with 
the oocyte being regulated by its neighbouring granulosa cells.  This intracellular 
communication between the oocyte and granulosa cells is essential for normal 
follicular differentiation and oocyte development.  Events regulating the bi-
directional communication between oocytes and somatic cells results in the 
granulosa cells influencing oocyte development, growth, meiotic arrest and 
transcriptional function.  In addition, the processes occurring within granulosa cells 
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which are controlled by oocytes include proliferation, differentiation, follicle 
formation, cumulus expansion, steroidogenesis and ovulation (Eppig, 2001).  These 
complex cell-to-cell interactions coordinate the development of ovarian follicles, 
from primordial through to antral stages, with the ultimate objective being ovulation 
and successful fertilization.  However, the formation and control of these interactions 
and contribution of each individual cell type to the overall functioning of the follicle 
are poorly understood.  Only a selection of genes having been investigated in depth 
and are known to be essential control factors (Acevedo and Smith, 2005; Sugiura et 















Figure 1.2: Schematic diagram of follicle developmental, survival, ovulation and atresia, showing 
prenatal primordial and postnatal follicle maturation.  From the antral stage of follicle growth follicle 
become gonadotrophin dependent and a decision is made whether the can withstand the reduced 
threshold of the FSH decline and proceed to the pre-ovulatory stage or become atretic (Adapted from 
Barnett et al., 2006; Craig et al., 2007). 
 
An example of how important this bi-directional communication is has been 
demonstrated by recent evidence which has shown that mouse oocytes control 
glycolysis in granulosa cells by regulating expression levels of genes encoding 
essential enzymes.  The oocytes control the intercellular metabolic cooperative 
communication between cumulus cells and oocytes, which is required for energy 
production by granulosa cells essential for oocyte and follicles development (Sugiura 
et al., 2005). 
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Furthermore, oocytes and granulosa cells have the capability of being mutually 
independent in their survival and normal development despite their dual requirement 
for follicle formation.  These independent characteristic substantially aid the practical 
implication of using these individual components for experimental culture 
manipulation and monitoring (Gosden and Boland, 1992). 
 
In addition to providing structural support the theca cells of the follicle aid the 
establishment of mesenchymal epithelial cell-cell paracrine interactions between the 
granulosa cells and theca cells, which is essential for subsequent follicular 
development (Skinner, 1990; Parrott et al., 1994).  Recruitment of theca cells from 
the surrounding somatic tissue to the periphery of the follicle occurs at later 
developmental stages of folliculogenesis.  Intra-ovarian factors have also been 
recognised which may contribute to the coordination of the recruitment and 
regulation of the thecal cell function and Kit Ligand (KitL) has been described and 
identified as a key requirement in theca cell organisation (Parrott and Skinner, 2000).  
It has also been proposed that in addition to granulosa cell-theca cell interactions, 
oocyte-theca interaction occur.  A study using rats has illustrated this oocyte-theca 
interaction, and demonstrates that the oocyte derived factor GDF9 can stimulate both 
basal and LH-stimulated theca interstitial cell androgen biosynthesis (Solovyeva et 
al., 2000). 
 
Granulosa cells of pre-antral ovarian follicles differentiate into two distinct spatial 
and functional populations during advanced follicle transition.  The cumulus 
granulosa cells are associated with the oocyte, and the mural granulosa cells surround 
and line the follicle wall, these two populations do have similarities but there are 
differences in both transcripts and proteins produced (Latham et al., 1999; 2004).  
For instance Kit Ligand mRNA which encodes KitL, previously mentioned to be a 
theca cell organiser, is increased in pre-antral granulosa cells and mural granulosa 
cells of antral follicles compared to KitL mRNA expression in the cumulus cells 
(Joyce et al., 1999).  Furthermore, LH receptor (LHR) expression levels are also 
increased in the mural granulosa cells compared to that of the cumulus cells or pre-
antral granulosa cells (Camp et al., 1991; Peng et al., 1991).  These differences in 
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gene expression suggest alternative functions for these two sub population of 
granulosa cells in follicle and oocyte development, with the cumulus cells 
specialising in oocyte support and metabolism (Haghighat and Van Winkle, 1990). 
 
The events surrounding the process of folliculogenesis include the acquisition of 
FSH receptors (FSHR) on the proliferating granulosa cells which is governed by 
influences imposed by both oestrogen and FSH.  As a consequence of the presence of 
an elevated number of FSHRs, the granulosa cells of the small antral follicle are able 
to respond to FSH.  FSH increases cyclic AMP accumulation, activation of the 
aromatase system, and induces LHR, which subsequently permits the granulosa cells 
to respond to LH.  The circulating serum levels of LH increase during the 
preovulatory LH surge, and consequently a number of events occur: firstly 
resumption of oocyte meiosis, germinal vesicle breakdown releasing the first polar 
body and progression into metaphase stage of meiosis II where the oocyte arrests 
again until fertilisation (Greenwald and Roy, 1994), transformation of the steroid 
enzyme complex from oestrogen to progesterone secretion, follicular rupture, and 
lastly the formation of the corpus luteum.   
 
The following sections of this chapter focus on the cyclic events surrounding 
folliculogenesis including the importance of recruitment and selection, the formation 
of mature follicles encompassing antrum formation and cumulus expansion and 
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1.2.1. Initial and cyclic recruitment  
Recruitment and selection of primordial follicles is fundamentally important 
throughout the duration of female reproductive life.  Only a select number of follicles 
ultimately achieve dominant follicles status developing to the advanced pre-
ovulatory stages with the remaining subordinate follicles from the initial growing 
cohort becoming atretic (Hirshfield, 1992; Hsueh et al., 1994; Baker et al., 2001).  It 
is believed that follicles leave the primordial pool in an ordered sequence and 
become irreversibly committed to growth.  There is recent evidence (Durlingar et al., 
1999; 2002) suggesting that AMH may play an important role in the initial 
recruitment of follicles from the primordial pool.  More primordial follicles are 
recruited in AMH null mice compared to the occurrence of primordial follicle 
recruitment in wild-type mice, with the heterozygous mice taking an in-between 
position (Durlingar et al., 1999, 2002), thus suggesting a dose dependent inhibitory 
effect of AMH on follicle recruitment.  However the rate at which these events take 
place and how additional signalling mechanisms are involved remains to be fully 
investigated (McGee and Hsueh, 2000) (Figure 1.3).   
 
 
Figure 1.3: Life history of ovarian follicles; endowment and maintenance, initial recruitment, 
maturation, atresia or cyclic recruitment, ovulation and exhaustion.  Initial recruitment is from the 
primordial resting pool, follicles develop through the primary stages to the secondary stages 
(gonadotrophin independent).  At the antral stage unless responsive to gonadotrophins follicles 
become atretic.  Eventual depletion of the ovarian follicle reserve occurs (McGee and Hsueh, 2000). 
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The major contributing factor influencing ovarian follicle selection for dominance is 
the decline of circulating FSH (Hirshfield 1991; Hsueh et al., 1994; Chun et al., 
1996), which is brought about by the feedback control of the HPG axis by the 
production of ovarian oestradiol and inhibin (Figure 1.4).  FSH is one of two major 
survival hormones essential for the prevention of programmed demise of growing 
early antral follicles.  In addition FSH also plays a role in the final differentiation of 
granulosa cells which is accompanied by an increase in local production of oestradiol 
(Johnson and Everitt, 2007) and inhibin (Michal et al., 1993; Hayes et al., 1998) in 
preparation for follicular ovulation (Hsueh et al., 1994).  These locally produced 
factors subsequently feedback to the pituitary resulting in a decline in plasma FSH 
concentrations to a level insufficient to maintain the growth of the subordinate less 
advanced follicles (Brown, 1978; McNeilly, 1988; Chappel and Howles, 1991).  The 
dominant follicles survive this declining plasma FSH by virtue of their enhanced 
responsiveness to gonadotrophins in addition to transferring their dependence to LH 
(Webb and England, 1982; Ireland and Roche, 1983).  Even though the granulosa 
cells acquired large numbers of LH receptors, they are prevented from luteinizing 
prematurely by factors in follicular fluid, including oestrogen.  Furthermore as 
previously mentioned the oocyte has also been suggested to secrete factors which 
prevent luteinisation (El-Fouly et al., 1970; Channing 1970; Hubbard and Erickson 
1988; Vanderhyden et al., 1993). 
 
Despite the well documented mechanism for follicle dominance an additional 
regulatory mechanism has been suggested after experimentation using co-cultures of 
intact follicles.  The results from these studies suggest that the contact 
communication between follicles of equivalent stages of growth is an important 
regulator in maintaining dominance.  Furthermore it has been demonstrated that both 
endocrine and intra-ovarian factors from dominant follicles can promote direct 
effects on subordinate follicles, suppressing their development (Baker and Spears, 
1999; Baker et al., 2001).   
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1.2.2. Follicle maturation, ovulation and corpora lutea formation 
The transition from a secondary follicle to an antral follicle is associated with the 
formation of a fluid filled antral cavity with the initial appearance of small fluid 
filled spaces eventually amalgamating to form one large cavity.  The follicular fluid 
is a mix of water, electrolytes, serum proteins and high concentrations of the steroid 
hormones secreted by the granulosa cells (Hirshfield, 1991).  On the formation of the 
antral cavity the granulosa cells subdivide into two different populations (Latham et 
al., 1999; 2004), as previously discussed. 
 
The pre-ovulatory surge of LH is the major influence on the ovulation of the 
dominant oocytes marking the end of the developmental process of folliculogenesis 
(Lee et al., 1996).  In these final stages of follicle maturation after the pre-ovulatory 
LH surge, cumulus expansion (also known as mucification) occurs (Chen et al., 
1990; Espey and Richards, 2002; Richards et al., 2002, Richards, 2005).  The indirect 
actions of gonadotrophins stimulate the cumulus cells to produce hyaluronic acid 
which is a non-sulphated glycosaminoglycan, this then binds to the cumulus cells and 
expands the spaces between the cells, embedding them in a mucinous matrix (Chen 
et al., 1990; Salustri et al., 1990; Camaioni et al., 1993; Tirone et al., 1997).  It is 
fundamentally important that the appropriate composition and assembly of the 
cumulus matrix occurs for successful ovulation, to aid the efficient passage of the 
oocyte through the oviduct, and for fertilization (Richards, 2005; Russell and 
Salustri, 2006)   
 
Before ovulation the pre-ovulatory follicle must be exposed, and respond to, 
adequate LH and FSH levels in order for the eventual CL to secrete elevated amounts 
of progesterone to maintain normal function.  As ovulation approaches, in addition to 
cumulus expansion the oocyte undergoes germinal vesicle (GV) breakdown with a 
formation of a polar body with subsequent oocyte arrest in metaphase II.  The 
basement membrane surrounding the follicle ruptures at the onset of ovulation 
releasing the oocyte for fertilization (Hirshfield, 1991) and only after sperm 
penetration does final maturation and completion of meiosis occur.   
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Following ovulation luteinisation occurs, which is the process by which the follicular 
tissue structurally remodels with thecal and granulosa cell differentiating to form a 
functional CL, a process which can surprisingly occur in only a few hours (Richards 
et al., 1998; Richards et al., 2002).  The formation of the CL is complemented by 
substantial changes in the vascularisation and the steroidogenic capacity of the 
follicle site.  The development of capillaries from pre-existing blood vessels is 
recognised as an essential component for CL formation and function (Reynolds et al., 
2000; Fraser et al., 2000).  Furthermore, the expression of steroidogenic enzymes and 
steroids produced changes dramatically after luteinisation.  The CL becomes a 
substitute site for progesterone production in addition to the luteal cells continually 
synthesising androstenedione and oestradiol.  In addition prolactin plays a critical 
role in the CL maintenance in rodents throughout pregnancy but not in other 
mammals (Albarracin and Gibori, 1991).  The regression of this endocrine gland 
occurs in two phases in the rodent, the first accompanied by a decrease in 
progesterone secretion known as functional regression, and the second occurring 
after the initial decline in progesterone, known as structural regression characterised 
by a decrease in size and weight of the CL (Stocco et al., 2007).  Furthermore this 
regression of the CL occurs as a result of luteal cell death and replacement of the 
vascular supply (Goyeneche et al., 2003). 
 
 
1.3. Control and regulation of follicle progression 
The processes of folliculogenesis discussed above are under tight regulatory control, 
and communication between factors, both pituitary gonadotrophins and steroids, are 
well accepted.  Furthermore, new evidence in recent years supporting the importance 
of intra-ovarian factors as part of this remarkable regulation has emerged despite 
limited knowledge of signalling and control.  Together these factors are responsible 
for all aspects of control and regulation of follicle progression. 
 
1.3.1. Gonadotrophins 
The mammalian ovarian cycle is under the primary control of the hypothalamic 
gonadotropin-releasing hormone (GnRH) regulating the pituitary gonadotrophins, 
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FSH and LH, which form part of the essential hypothalamic-pituitary-gonadal (HPG) 
axis (Figure 1.5).  FSH and LH are both heterodimeric globular glycoprotiens which 
share a common α subunit with the β subunit determining the individual unique 
function (Gharib et al., 1990).  FSH and LH are synthesised in the gonadotroph cells 
of the anterior pituitary with both hormones functionally active through their own 
receptors.  Because activation of the HPG axis is crucial for the onset and 
progression of puberty and reproductive function, mutations affecting gonadotrophin 
actions have a major influence on subsequent developmental processes.  In female 
mice that fail to secrete gonadotrophins as a result of a deletion in the GnRH gene 
(Cattanach et al., 1977) or after gonadotroph ablation (Kendall et al., 1991) or after 
disruption of the gene encoding the common α subunit (Kendall et al., 1995) have 
ovaries containing only primordial, primary and pre-antral follicles.  These results 
indicated that gonadotrophins, although not required for follicle recruitment and 
initial development, are essential for development beyond the antral stage.  
Furthermore the FSHβ transgenic mouse show a similar phenotype of follicle 
development as described above, further indicating that FSH is the critical 
gonadotrophin required after this stage of development (Dierich et al., 1998; Abel et 
al., 2000).  Collectively these studies highlight gonadotrophins to be key regulators 
in the maintenance of follicle growth at the onset of antral formation in the adult 
mouse.   
Chapter 1                                                                                            Literature review 
 17
 
Figure 1.4: Female HPG axis, regulation of ovarian control by GnRH from the hypothalamus acting 
on the pituitary releasing FSH and LH.  FSH and LH are secreted into the general circulation where 
they attach to receptors on the ovary, triggering follicle growth and subsequently ovulation.  The 
ovary is stimulated to produce oestrodiol and progesterone which act in a positive stimulatory/or 
inhibitory affect depending on stage of oestrous cycle.  Activin and inhibin are also produced locally 
and act on the anterior pituitary in an inhibitory manner.  
 
Despite this well characterised role of the gonadotrophins in the development of 
early antral follicles, experiments using cultured large rat preovulatory follicles have 
demonstrated that LH and FSH have been additionally implicated in the increase of 
the apoptotic factors caspase 3 and 7 activities (Yacobi et al., 2004; 2007).  High 
concentration of FSH and LH resulted in an increase in theca cell apoptosis but did 
not induce apoptosis in the granulosa cells in these follicles in culture (Yacobi et al., 
2004).  Although contradictory to the positive effects of FSH and LH, it has been 
suggested that these findings support previous concepts that thecal apoptosis maybe 
the physiologic process underlying gonadotrophin-induced ovulation (Murdoch and 
Gottsch, 2003). 
 
1.3.1.1.FSH and FSH receptor expression and function 
As mentioned FSH is well characterised in its roles associated with follicle growth 
and is considered essential to follicle survival, with receptor expression being 
reduced during atresia (Tilly et al., 1992).  Furthermore FSH sensitivity plays an 
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important role in selection and progression of the antral follicle dominance 
(Uilenbroek et al., 1980; Tilly et al., 1992).   
 
The FSH hypothesis dates back to 1978 (Brown, 1978) and is still believed to be the 
fundamental underlying mechanism for FSH action.  The hypothesis suggests that 
individual follicles from within the initial cohort of recruited developing follicles 
have a FSH threshold level.  Beyond this threshold the follicles must be stimulated 
by FSH to start their pre-ovulatory development and failure of FSH to be maintained 
above the threshold levels results in follicle atresia.  It is thought that the FSH 
threshold is mediated by paracrine and autocrine mechanisms, and although 
discussed later in detail, androgens and activins have been identified as active 
participants (Hillier, 1991a, 1991b).  The follicle(s) whose granulosa cells are most 
responsive to FSH (lowest threshold) become the first in the developing cohort to 
produce and secrete oestrogen, which then feeds back through the hypothalamic-
pituitary axis to suppress FSH secretion (Figure 1.4).  This decrease in pituitary FSH 
results in a reduction of circulating FSH which is insufficient to support the 
development of the remaining follicles (Johnson and Everitt, 2007).  The remaining 
follicles most probably have elevated FSH threshold potentials, consequently they 
are unable to establish growth under the reduced FSH concentrations and become 
atretic (Hillier, 1994). 
 
FSH requires the expression of its cognate receptor (R) to have a functional effect 
and in the rat FSHR mRNA has been localised to the granulosa cells of all sizes 
(Nakamura et al., 1991; LaPolt et al., 1992).  Studies have demonstrated that on 
initiation of granulosa cell growth by stimulation with pregnant mare serum 
gonadotrophin (PMSG) to induce follicular development, FSHR mRNA expression 
and FSH binding sites increase.  This initial increase in FSHR mRNA was 
subsequently demonstrated to decline after initiation of ovulation with hCG (LaPolt 
et al., 1992).  Furthermore, similar observations have been demonstrated in vivo 
whereby the induction of ovulation by recombinant FSH suppressed FSH binding 
and FSHR mRNA expression, thus suggesting that the regulation of FSHR 
expression within the ovary may be biphasic by FSH itself.  Thus, low doses of FSH 
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increase the number of FSH binding sites parallel to the increase of FSHR mRNA 
levels.  In contrast, comparatively high doses of FSH down-regulate FSH receptor-
binding sites and mRNA levels suggesting that there is a suppression of FSH gene 
expression and protein synthesis related to an increase in FSHR occupancy and 
internalization of FSH to the granulosa cells (LaPolt et al., 1992; Hsueh and LaPolt, 
1992).  Furthermore, studies using the HPG knockout mouse models have 
demonstrated that despite the absence of functional FSH ligand, FSHR mRNA is 
present suggesting that there may be additional factors that act to induce the 
expression of the FSHR (Adashi, 1994; Abel et al., 2003). 
 
1.3.1.2.LH and LH receptor expression and function 
The physiological functions of LH include direct stimulation of androgen production 
by the theca cells (Zeleznik and Hillier, 1984).  Furthermore, LH is required to 
maintain the dominant status of the pre-ovulatory follicles.  However there is 
evidence, as with FSH, that excessive exposure of LH to the ovaries can have 
adverse effects on the development of the selected pre-ovulatory follicles (Chappel 
and Howles, 1991; Hillier, 1993).  Premature luteinisation of the granulosa cells can 
occur in addition to having detrimentally effecting oocytes development (Chappel 
and Howles, 1991; Picton and McNeilly, 1991).  Therefore it has been suggested that 
whereby there is a threshold for FSH stimulation there may be a ceiling effect of LH 
action (Hillier, 1993).  When these ceiling levels are exceeded during the mid-cycle 
surge of LH, further division of the granulosa cells ceases and the process of 
luteinisation occurs.  This ceiling effect of LH has been further explored in vitro by 
monitoring granulosa cell proliferation and steroid production.  On treatment with 
low dose of LH, steroidogenesis of the granulosa cells was enhanced, but on 
treatment with a high dose of LH, enhanced synthesis of progesterone was observed 
accompanied by a suppression of aromatase activity and an inhibition of growth 
(Overes et al., 1992; Yong et al., 1992). 
 
As mentioned LH exerts its effects through binding to its cognate receptor, which 
belongs to the seven transmembrane domain G-protein associated receptors (Segaloff 
and Ascoli, 1993).  Within the ovary, LHR can be detected in theca cells where they 
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regulate androgen production, as well as in luteinising granulosa and luteal cells 
where they regulate progesterone production.  LHRs are also located on the 
granulosa cells of pre-ovulatory follicles which have been adequately stimulated by 
FSH where they are coupled to aromatase (Richards et al., 1987). 
 
1.3.2. Steroid control 
Sex steroids play a define role in the growth and differentiation of all reproductive 
tissue with oestradiol and progesterone being recognised as the major players in the 
mammalian female.  Steroid secretion by the antral follicle involves the interplay of 
androgens, oestrogens, and progestins with their impact on ovarian function 
determined by the availability of the ligand, receptor expression and the repression or 
induction of relevant regulatory genes (Drummond et al., 2002).  Within the follicle a 
two-cell two-gonadotrophin model exists which describes the interaction between the 
theca and granulosa cells in addition to the stimulatory effects of the gonadotrophins, 
all of which are necessary for steroid synthesis and oestrogen production (Figure 1.5) 
(Drummond, 2006).   
 
Both the granulosa and thecal cell compartments contribute to follicular fluid and 
serum levels of steroids with the granulosa cells being the major cellular source of 
the production of the ovarian hormones, oestradiol and progesterone, whereas the 
theca cells are the site of androgen production (Figure 1.5) (Drummond, 2006).  
Much of the established data on the role and regulation of ovarian steroid comes 
from experiments investigating nuclear receptor knockout mouse models which 
consequently lead to the disruption of the steroid signalling mechanisms, hence 
preventing steroids fulfilling their unique roles in follicle development.  An overview 
of the production and functions of progestins, androgens and oestrogens within the 
ovary are now discussed. 
 




Figure 1.5: Steroid biosynthesis within the granulosa and thecal cells of the ovary.  Initially within the 
theca cholesterol is converted to pregnenolone which in turn is metabolised to testosterone through a 
series of substrates.  This two cell two gonadotrophin model is initiated when androgens produced by 
the theca are transported to the granulosa where they are aromatised into oestrogen (Drummond, 
2006). 
 
1.3.2.1.Progesterone production and function 
Progesterone is synthesised predominantly in the theca cells, stromal cells and luteal 
cells (Duleba et al., 1999) and is most notably associated with playing important 
functional roles in ovulation, implantation and the maintenance of a viable pregnancy 
(Graham and Clarke, 1997).  As with most steroids progesterone actively functions 
on binding to its own receptor(s).  Two forms of the progesterone receptor (PR) have 
been identified namely PR-A and PR-B, with each having a different functional role 
(Spelsberg et al., 1972; Kastner et al., 1990; Conneely et al., 2002; Conneely et al., 
2003).  It has been demonstrated that PR-A is dominant over PR-B and that the ratio 
of these two receptors can determine cellular response.  Hence different groups of 
genes are believed to be controlled by the different receptors in response to 
progesterone binding (Tora et al., 1988; Meyer et al., 1992; Tung et al., 1993; Vegeto 
et al., 1993).  PRs are localised to the thecal layer of cells surrounding small antral 
follicle and have been identified on the granulosa of pre-ovulatory follicles which 
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had been exposed to LH/hCG inducing the LH surge or were undergoing 
luteinisation (Park and Mayo, 1991) thus supporting a role for progesterone and 
expression of its receptors in ovulation and luteinisation.   
 
The use of transgenic mouse models has provided a wealth of information into the 
mechanisms surrounding PR function (Lydon et al., 1995), with the PR KO females 
presenting with functionally normal ovaries.  However, these animals fail to ovulate 
even after gonadotrophin stimulation with their granulosa cells undergoing 
luteinisation which interestingly suggests that PR is not essential for CL formation 
(Robker et al., 2000).  These finding are somewhat controversial as it has been 
previously acclaimed that progesterone acting as least partly via the PRs are required 
for luteinisation (Natraj and Richards, 1993).  It is now acknowledged that on the 
development of PR-A and PR-B individual KOs, PR-A is the necessary PR for 
ovulation with these females being infertile but not PR-B as these KO mice are 
functionally fertile (Mulac-Jericevic et al., 2000; Mulac-Jericevic et al., 2003).  This 
further supports the evidence that these two PRs mediate alternative actions of 
progesterone (Mulac-Jericevic and Conneely, 2004). 
 
There is additional evidence that some actions of progesterone, including inhibition 
of apoptosis and insulin-dependent mitosis, are mediated by an alternative non-
genomic mechanism of PR (Peluso et al., 2006).  These alternative mechanisms are 
probably mediated by recently discovered progesterone binding proteins or progestin 
membrane receptors although not extensively studied (Peluso and Pappalardo, 1998; 
Bramley, 2003; Peluso, 2003; Cai and Stocco, 2005; Peluso, 2006). 
 
1.3.2.2.Androgen production and function 
One of the most recognisable and important functions of androgens in the 
mammalian ovary as previously stated is their role in the synthesis of oestrogen, 
serving mainly as a substrate of P450 aromatase mediating the conversion to 
oestrogen (Dorrington et al., 1975; Tetsuka and Hillier, 1996; Hillier and Tetsuka, 
1997; Drummond, 2006).  This increase in oestradiol production in conjunction with 
an increase in progesterone production facilitates the roles of androgens in 
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supporting follicle growth by enhancing the FSH mediated differentiation of 
granulosa cells (Weil, 1999; Drummond, 2006).  Furthermore androgens are 
associated with female reproductive pathologies, most notably polycystic ovarian 
syndrome (PCOS) in humans, a condition resulting from an excess production of 
ovarian androgen (Ehrmann, 2005).   
 
Exogenous androgens have been shown to exert both inhibitory and stimulatory 
effects at different stages of follicular development (Walters et al., 2008).  Studies 
analysing the functions of androgens have demonstrated that testosterone, 
androstenedione and dihydrotestosterone can all stimulate follicle growth (Murray et 
al., 1998; Wang et al 2001).  However androgen function has also been implicated in 
the regulation of follicle atresia by the indirect inhibition of FSH-stimulation in a 
developmental manner (Harlow et al., 1988) and directly through induction of 
follicle atresia (Hillier et al., 1979; Azzolin et al., 1983).  However as a result of 
androgens capabilities of steroid conversion with the potential to exert further 
indirect actions, results from many studies are difficult to interpret accurately and 
present conflicting inhibitory and stimulatory data (Walters et al., 2008).   
 
The mouse androgen receptors (AR) are mainly located on the granulosa cells and in 
cells within the ovarian stroma (Schreiber and Ross 1976; Hirai et al., 1994; Tetsuka 
et al., 1995) and have been recently localised to the mouse oocytes (Szoltys and 
Slomczynska 2000; Gill et al., 2004).  Depending on species investigated expression 
of AR occurs in the granulosa cells of mainly preantral and antral follicles, with 
evidence that immunoexpression is more intense for AR within the cumulus and 
antral granulosa cells, with reduced expression in the peripheral layers of the 
granulosa in the rat (Tetsuka et al., 1995).  The expression of AR declines and 
androgens are metabolised as opposed to exerting direct effects on folliculogenesis 
during the stages of late preovulatory development (Hillier and Tetsuka, 1997).  
More recently AR KO mice have been produced efficiently utilising the Cre/LoxP 
system providing definite proof for AR mediated actions within the ovary and in 
follicle development (Yeh et al., 2002; Hu et al., 2004; Shiina et al., 2006; Walters et 
al., 2007).  These studies have emphasised the importance of AR in age related 
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female fertility, through optimising conditions for follicle growth and play vital roles 
at ovulation (Yeh et al., 2002; Hu et al., 2004; Shiina et al., 2006; Walters et al., 
2007; Walters et al., 2008).   
 
1.3.2.3.Oestrogen production and function 
The local intra-follicular actions of oestrogen have been historically recorded with its 
actions vital to female reproductive physiology preparing the female reproductive 
tract for conception (Hisaw, 1947).  The biosynthesis of oestrogen is first detected in 
the late pre-antral follicles where it requires the cooperation of both the granulosa 
and theca cells and FSH and LH, as described above (Figure 1.6).  Small antral 
follicles are incapable of producing androgen substrate for aromatisation to oestrogen 
(Carson et al., 1981).  However, subsequent follicle growth is characterised by an 
increase in aromatase activity, androgen synthesis and hence oestrogen production 
(McNatty, 1982; Drummond, 2006).  This increase of oestrogen is also responsible 
for facilitating granulosa cell differentiation including the induction of receptor 
systems for FSH, LH and prolactin influencing post-receptor mechanisms (Richards, 
1980; Drummond, 2006).  Oestrogen plays a major role in the endocrine control of 
follicular development whereby it acts to suppress the FSH release by the pituitary 
gland (Figure 1.4).  Furthermore, this suppression subsequently minimises the 
stimulation of additional pre-ovulatory follicles and additionally causes discharge of 
the mid-cycle surge of LH by the pituitary gland triggering ovulation (Hillier, 1990, 
1994).   
 
Oestrogens, as with the androgens and the progestins, signal via its receptors, ERα 
and ERβ (Green et al., 1986; Kuiper et al., 1996; Chu and Fuller 1997; Petersen et 
al., 1998).  ERβ is predominantly expressed within the ovary increasing in 
expression coinciding with granulosa cell proliferation, with ERα mRNA levels 
remaining constant (Byers et al., 1997; Drummond et al., 1999).  Utilising the 
genetic manipulation of KO models the absence of these two receptors individually 
ERα (ERKO) and ERβ (BERKO) or collectively (αβERKO) has been investigated.  
Although these models are not oestrogen free, a further transgenic model the 
oestrogen depleted mouse which lacks functional aromatase (ArKO) has been further 
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exploited to investigate the essential role of oestrogen on ovarian development 
(Lubahn et al., 1993; Couse et al., 1997; Krege et al., 1998; Couse et al., 1999; 
Dupont et al., 2000; Britt et al., 2001). 
 
The main findings from these comprehensive studies conclude that ERKO females 
are phenotypically acyclic, infertile and possess hyperemic ovaries devoid of CLs.  
Furthermore, folliculogenesis is arrested at the antral stage with follicles becoming 
cystic and haemorrhagic (Lubahn et al., 1993; Couse et al., 1997).  However, on 
treatment with gonadotrophins prepubertal ERKO mice can ovulate (Rosenfeld et al., 
2000) suggesting that the processes of folliculogenesis, ovulation and CL formation 
can occur in the absence of ERα, although not efficiently.  Furthermore, prolonged 
exposure of ERKO mice to a GnRH antagonist prevent the haemorrhagic cyst 
formation (Couse et al., 1999 a, b) indicating that their ovarian phenotype manifests 
as a consequence of elevated LH levels (Couse et al., 1999b; Schomberg et al, 1999).  
Interestingly, the BERKOs have small ovaries presenting with some arrested 
follicular development but these individuals are fertile with normal gonadotrophin 
levels.  Although fertile, this process is severely compromised with a reduced 
number of offspring which is consistent with the reduced numbers of CL present and 
hence reduced ovulation (Krege et al., 1998).  The ovarian phenotype of the 
αβERKO is again distinct from that of the ERKO and BERKO (Couse et al., 1999b; 
Dupont et al., 2000).  In the absence of both receptors ovaries undergo follicular 
trans/re-differentiation to phenotypically resemble seminiferous cord like structures 
containing Sertoli like cells as a result of elevated LH.  It can therefore be concluded 
from these studies using the ER knockout models that both ERα and ERβ have 
significant roles in the maintenance of fertility and ovarian function. 
 
Furthermore, the ArKO mouse oestrogen depletion model defines how far follicles 
can grow in the total absence of oestrogen (Fisher et al., 1998; Britt et al., 2001).  
The morphology of these ovaries consists of abnormal follicles which are represented 
by seminiferous tubule-like structures with Sertoli like cells apparently arising from 
the trans/re-differentiation of granulosa cells (Britt et al., 2001) similar to that 
observed in the αβERKO models (Couse et al., 1999 a b; Dupont et al., 2000).  In 
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addition the ArKO females present with retarded follicle development as follicles 
arrest at the antral stage and, combined with no ovulation these finding emphasise 
the importance of oestrogen is follicle development.  Overall it can be notably 
concluded from these KO studies that the roles of oestrogen and its functional 
receptors are obligatory for normal progression of folliculogenesis. 
 
1.3.3. Intra-ovarian regulators 
It has been clearly acknowledged that gonadotophins, FSH and LH (Section 1.3.1) 
and steroid hormones, progestins, androgens and oestrogens (Section 1.3.2) are 
fundamental in the control, regulation and function of ovarian development and 
maintenance of the cyclic processes of folliculogenesis.  In addition to these local 
and systemic endocrine factors, intra-ovarian regulators have been identified to be 
critical in supporting these intricate processes surrounding folliculogenesis.  Intra-
ovarian factors synthesised within the follicle maintain direct intra-follicle control of 
differentiation, granulosa cell proliferation and apoptosis accompanying and 
moderating the gonadotrophic control of these processes.  Understanding this intra-
ovarian communication between the oocytes and granulosa cells and the importance 
of the bi-directional control is vital in complementing what is known regarding the 
endocrine control of the ovary.  A wealth of emerging evidence in the past 10 years 
supporting the actions of these autocrine/paracrine locally produced factors has 
arisen and despite the collective data of numerous in vitro studies surrounding these 
factors, the coordination and control of these mechanisms in vivo are not clearly 
defined.  In the next section, the role of a number of intra-ovarian factors are 
discussed in particular members of the TGFβ family, activin, inhibin, follistatin, 
BMPs and GDF9.   
 
1.3.3.1.TGFβ family signalling 
The TGFβ superfamily consists of over 30 extracellular signalling molecules which 
are structurally related but functionally diverse proteins.  These TGFβ molecules 
collectively regulate many functions in a variety of tissues, and a number have been 
demonstrated to be locally expressed within the ovarian follicle; GDF9, BMP15, 
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inhibins, activins, TGFβ, BMPs 2, 4, 6, 7 and AMH (Findlay, 1993; Nishimori and 
Matzuk, 1996; Knight and Glister, 2001; Richard, 2001; McNatty et al., 2001).   
 
The signalling of TGFβ molecules is brought about by transmembrane 
serine/threonine kinase receptors (R) type I and type II receptors, both of which are 
essential for the transduction of TGFβ members into the cell.  Collectively five types 
of RII, which are considered constitutively active and seven types of RI have been 
identified, providing a variety of potential signalling requisites and functional 
outcomes (Knight and Glister, 2003).  The activation and translocation of TGFβ 
molecules is assisted by the involvement of Smad proteins.  The Smad proteins are 
ubiquitously expressed in nearly all cell types in the body and to date 8 different 
Smad proteins have been identified which can be classified based on their active 
function.  They are either receptor activated Smads 1, 2, 3, 5 and 8, common-partner 
Smad 4 or inhibitory Smads 6, 7.  On binding of the TGFβ ligands to the 
transmembrane serine/threonine kinase RII receptors, activation and dimerisation 
with RI occurs forming a tetrameric signalling complex.  Depending on the 
combination of receptors that are activated different activator Smads are recruited 
through phosphorylation by the RI receptor.  The receptors activate Smads and 
subsequently form oligomeric complexes with the common Smad 4 after which 
translocation to the nucleus occurs.  On translocation target genes are then regulated 
via interaction with a multitude of transcription factors, co-activators and co-
repressors (Kaivo-oja et al., 2006).  In general terms the Smad 2/3 pathways is 
utilised by TGF-βs, activins and GDF9 whereas the Smad 1/5/8 pathway is utilised 
by BMP15, BMP2, 4, 6 and 7 (Table 1.1).  More than one pathway can be transduced 
by the same ligand and in addition to the implications of extracellular, intracellular 
and transcriptional regulation and accessory proteins, combinations of complexes 
and regulatory outcomes are multiple (Findlay et al., 2002; Kaivo-oja et al., 2006).  
The inhibitory Smads do as they suggest and can block TGFβ signalling by either the 
binding of the inhibitory Smad 7 to the RI or by Smad 6 competing with activated 
Smad 1 for binding to the Smad 4.  Furthermore, Smad 7 can inhibit the activation of 
both the TGFβ/activin and BMP pathways, whereas Smad 6 only inhibits BMP 
signalling (Attisano and Wrana, 2002; Shi and Massague, 2003). 
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Although Smad proteins are ubiquitously expressed in most cell types and TGFβ 
family members are involved in signalling elsewhere, selective disruption of the 
individual Smad genes has highlighted some important issues regarding their 
function with evidence of specific action of Smad 3 in the ovary.  Although not 
ovarian specific it is important to recognise the following Smad KO phenotypes, 
emphasising their diverse roles.  Mice homozygous and heterozygous for KO of 
Smads 1, and 5 result in embryonic death suggesting roles for these proteins in the 
regulation of embryogenesis (Arnold et al., 2006).  To date there is unpublished 
evidence that the Smad 8 mutants are viable and fertile (Z.Huang et al., in Pangas et 
al., 2008).  Partial loss of exon 1 of Smad 7 results in smaller mice with altered B cell 
responses as a result of a defective immune system (Li et al., 2006).  Smad 6 mutant 
homozygous mice display with cardiovascular impairments (Galvin et al., 2000).  
Although not mentioned in these publications it cannot be ruled out that these Smads 
are involved in ovarian signalling with the published phenotypes being of interest.   
 
Table 1.1: Summary of identified signalling pathways of TGFβ superfamily members within ovary 
(adapted from Kaivo-oja et al., 2006). 
Ligand Expressed by RII RI Smads References 
GDF9 Oocytes BMPRII ALK5 Smad 2/3 Mazerbourg et al., 2004, Roh et al., 
2003; Vitt et al., 2002 
BMP15 Oocytes BMPRII ALK6 Smad 1/5/8 Moore et al., 2003 
BMP6 Oocytes, granulosa BMPRII/ActRIIA/B ALK2/3/6 Smad 1/5/8 De Caestecker, 2004; Shimasaki et al., 
2004; Ebisawa et al.., 1999 
TGFβ 1, 2, 3 Granulosa, theca TβRII ALK5 Smad 2/3 Lin et al., 1992; Franzen et al., 1993 
Activin A/B Granulosa ActRIIB ALK4 Smad 2/3 Attisano et al., 1992; ten Dijke et al., 
1994a 
Inhibin α Granulosa ActRIIA/B ? ? Mathews et al., 1991 
BMP-2 Granulosa BMPRII/ ActRIIA ALK3/6 Smad 1/5/8 Rosenzweig et al., 1995, Yamaji et al., 
1994 
BMP-3 Granulosa ActRIIB ? ? Gamer et al., 2005 
AMH Granulosa AMHRII ALK2/3/6 Smad 1/5/8 Baarends et al., 1994, Visser et al., 
2001, Gouedard et al., 2000, Jamin et 
al., 2002 
BMP4 Theca BMPRII/ ActRIIA ALK3/6 Smad 1/5/8 Rosenzweig et al., 1995, Yamaji et al., 
1994, ten Dijke et al., 1994a 
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The Smad 3 homozygous null mice are viable although fertility is somewhat reduced 
compared with wild type mice (Tomic et al., 2002; 2004).  In the absence of Smad 3 
the ovarian surface epithelium appears distinctly morphologically altered, being 
thickened with enlarged cuboidal cells instead of being flat with thin cells as 
observed in the wildtype.  Furthermore it has been suggested that Smad 3 may 
regulate growth of primordial follicles to the antral stage although it may not affect 
the size of the primordial follicle pool at birth (Tomic et al., 2002).  In addition it has 
been suggested that Smad 3 may regulate the expression of Bax and Bcl-2, but not 
Bcl-x, Cdk-2, and PCNA suggesting a role in programmed cell death and not 
proliferation.  Collectively, these data suggest that Smad 3 specifically plays an 
important role in the regulation of ovarian follicle growth and female fertility (Tomic 
et al., 2002; Symonds and Tomic, 2003). 
 
1.3.3.2. Activin, inhibin and follistatin 
The inhibins and activins have a basic molecular structure, made up of three separate 
subunits which form the various heterodimers (Figure 1.6).   
 
 
Figure 1.6: Basic molecular structure inhibins and activins.  Subunits are initially synthesised as 
precursors.  The α subunit can associate with either βA or Bβ to form inhibin A or inhibin B.  The β 
subunits can dimerise to form the activins (adapted from Ethier and Findlay, 2001). 
 
A wealth of information surrounding the actions of activin, inhibin and follistatin has 
been documented since their discovery and despite the overwhelming evidence of 
their action there are still many unanswered questions surrounding their function.  
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Much work to data has focused on the use of in vitro studies, using isolated follicles, 
granulosa cell, theca cell and oocyte culture systems.  More recently the use of 
transgenic mouse models have been exploited to support the critical roles of activins, 
inhibins and follistatin providing evidence regarding their roles in ovarian 
development and functional regulation (Knight and Glister, 2001; Pangas and 
Matzuk, 2004).  Compelling evidence has been collated to implicate the involvement 
of these intra-follicular mediators as autocrine/paracrine modulators with effects on 
the granulosa cells, theca cells, the oocytes and actions in the CL (Knight and Glister, 
2003) (Figure 1.7).  The general function of these three TGFβ molecules, activin, 




Figure 1.7: Summary diagram of inhibin, activin and follistatin expression and functions in granulosa 
cells at different stages of follicle development, indicating their putative regulatory functions at the 
intraovarian and peripheral level.  ↑↓ indicate increase or decrease of function.  Follistatin can 
neutralise the biological activity of activin through its capacity to bind activin.  (Note that expression 
of inhibin A and follistatin is maintained in primate corpus luteum, but declines after ovulation in 
other species. * indicate roles restricted to primate species) (Knight and Glister, 2001). 
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1.3.3.3. Activin 
Activins have been shown to play a host of roles in the developing ovary in a number 
of different species, with its most notable roles being its involvement in granulosa 
cell proliferation and in FSH regulation (Figure 1.7) (Findlay, 1993; Hillier, 1994; 
Mather et al., 1997).  In the presence of FSH activin responds biphasically, acting in 
an inhibitory fashion at low doses and stimulatory at high doses (Xiao et al., 1992).  
It has been suggested that follicle progression from the late preantral (gonadotrophin 
independent) to the early antral stage (gonadotrophin dependent) may be mediated by 
the actions of activin promoting the expression of the FSH receptor on the granulosa 
cells (Hasegawa et al., 1988; Xiao et al., 1992).  This has been further supported 
during studies demonstrating that after treatment with activin A growth of isolated 
preantral follicles from immature rats but not same stage follicles from adult rats was 
induced, demonstrating the role of activin in the acquisition of granulosa cell 
responsiveness to FSH by regulating the FSH receptor in these immature follicles 
(Findlay, 1993; Findlay and Drummond, 1999).  It has also been shown that cultured 
granulosa cells harvested from both small and large follicles exhibit enhancing 
proliferation after treatment with activin, supporting the intrafollicular 
autocrine/paracrine action of activin on granulosa cell proliferation and 
differentiation (Li et al., 1995; Miro and Hillier, 1996; Zhao et al., 2001).  
Furthermore, an overproduction of activin as identified in the mouse model with a 
targeted deletion of the inhibin α subunit was shown to be associated with 
uncontrolled proliferation of the granulosa cells with the subsequent development of 
ovarian tumours, thus further supporting activins role in granulosa cell proliferation 
(Matzuk and Bradley, 1992).   
 
Activin receptors are expressed in the oocytes (Cameron et al., 1994; Sidis et al., 
1998) and evidence from studies performed in the monkey and rat suggests that 
activins derived from the cumulus granulosa cells affect nuclear and cytoplasmic 
maturation of oocytes (Sadatsuki et al., 1993; Alak et al., 1996).  On deletion of the 
activin type IIB receptor follicle development is arrested at the early antral stage, 
consistent with activin being functionally active in granulosa cell proliferation and 
differentiation (Nishimori and Matzuk, 1996).  However, this coincided with a 
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reduction in plasma FSH, evidently compromising the assessment between the 
indirect effects of reduced pituitary FSH and the direct intra-ovarian effect of activin 
receptor IIB deletion (Nishimori and Matzuk, 1996).   
 
Activin activity is neutralised by follistatin and since one of the primary actions of 
activin is to induce FSHR expression in the developing follicle, the efficiency of this 
process is best achieved in the absence of follistatin.  In vitro studies have 
demonstrated that granulosa cells from small follicles have reduced follistatin 
compared to larger follicles, which are more likely to acquire FSH receptors.  This 
supports the action of activins in promoting FSHR acquisition and gonadotrophin 
follicular dependence (Shimasaki et al., 1989; Nakatani et al., 1991).   
 
1.3.3.4. Inhibin 
Two forms of inhibin exist (A and B) both of which are present in the mouse ovary 
(Knight, 1996).  Inhibin plays a direct role in the negative feedback system (Figure 
1.3) modulating pituitary FSH secretion during follicle growth.  Dominant follicles 
produce increasing amounts of inhibin and follistatin which in turn reduces the 
activity of activin up-regulation of thecal androgen production, the increase in 
inhibin reduces pituitary FSH secretion and acts to maintaining follicle dominance.  
There have been inconclusive results surrounding the identification of inhibin 
specific receptors and it is thought that they mediate most of their function through 
competitively binging to the activin type II receptors although this does not then 
stimulate type I receptor phosphorylation (Zimmerman and Mathews, 1996; Martens 
et al., 1997; Chapman and Woodruff, 2001).  Furthermore, TGFβ type III receptor, 
also referred to as betaglycan has been shown to promote a high affinity associated 
between inhibin and activin type II receptor, acting as a putative inhibin co-receptor, 
thereby providing a mechanism of activin antagonism even at low concentrations of 
inhibin (Lewis et al., 2000; Bernard et al., 2001; Gray et al., 2002). 
 
Studies in cattle have demonstrated that inhibin B concentrations from follicular fluid 
are inversely correlated to follicle size, whereas inhibin A concentrations are 
positively correlated with follicle size suggesting a developmental transition in their 
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individual functions (Knight and Glister, 2003).  Additionally studies using a number 
of different species including the rodent (Hsueh et al., 1987) have demonstrated that 
in thecal cells inhibin A, the product of gonadotrophin-responsive osetrogen-active 
granulosa cells, can enhance LH induced androgen production.  These findings have 
been further supported using cultures of intact rat follicles.  A decrease in androgen 
secretion was shown after incubation with a neutralising antibody against inhibin, 
supporting the positive action of endogenous inhibin on thecal androgen production 
(Smyth et al., 1993).   
 
1.3.3.5. Follistatin 
Follistatin (FST) is structurally unrelated to the inhibins despite having similar 
function in suppressing pituitary FSH (Ueno et al., 1987).  The main physiological 
function of FST is its ability to neutralise the actions of activins and, to a lesser 
extent inhibins through binding to the β subunit (Shimasaki et al., 1991).  In addition 
the binding affinity of FST for activin is similar to that of activin binding to its own 
receptors (Mathews, 1994; Knight and Glister, 2003).  Furthermore, FST has been 
shown to reduce oocyte developmental competence and neutralise the effects of both 
endogenous and exogenous activin, consistent with its functional role as an activin-
binding protein (Silva and Knight, 1998).  As a result of its activin binding 
properties, FST has also been demonstrated to be involved in promoting follicle 
atresia, associated with a decrease in oestradiol and inhibin production and an 
increase in progesterone or luteinisation, depending on the stage of follicular growth 
(Knight and Glister, 2003).  There are reports using bovine follicles which show that 
intrafollicular concentrations of FST do not vary throughout growth, hence 
suggesting a developmental regulated bio-availability of activin A, due to the effects 
free activin A/inhibin (Knight and Glister, 2003).  However, expression of FST has 
been shown to be up-regulated in granulosa-lutein cells as a result of the 
administration of hCG, suggesting a possible role as an important regulator of the 
gonadotrophin-dependent luteal support mechanism (Tuuri et al., 1994).  Although 
mostly derived from in vitro data these investigations into the actions of activins, 
inhibins and follistatin in the ovary clearly suggest that these are regulatory paracrine 
compounds are actively involved in folliculogenesis (Knight and Glister, 2001).   
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1.3.3.6.GDF9 and BMP15  
Two oocyte expressed TGFβ family members which have been extensively studied 
in recent years are GDF9 and BMP15, both of which are essential for ovarian 
development and female fertility (Juengel et al., 2004).   
 
Evidence suggests that oocyte specific GDF9 acts as a paracrine regulator involved 
in early follicle development, with its expression beginning in primary follicles in the 
mouse.  Much of what is known regarding the function of GDF9 has come from 
studies using the transgenic GDF9 mouse KO model.  There is now no doubt that 
GDF9 is fundamentally important in the development of the follicle.  On deletion of 
GDF9, granulosa cell proliferation significantly decreases accompanied by abnormal 
oocyte growth with follicles failing to develop beyond the primary stage (Dong et al., 
1996; Carabatsos et al., 1998).  These abnormal follicles remain steroidogenically 
active and are arranged in clusters resembling corpora lutea, in addition, cells within 
these abnormal follicles have been shown to express luteal markers.  Furthermore, it 
has been demonstrated that these follicles fail to undergo cell death suggesting that 
the granulosa cells of these follicles require GDF9 for continued growth but also to 
become competent to undergo apoptosis (Elvin et al., 1999).  However, this failure to 
undergo cell death may be due to follicle arrest occurring at the primary stage of 
development where apoptosis is uncommonly detected.  Furthermore, an up-
regulation of kit ligand and inhibin α in the primary follicles suggests that these two 
secreted factors expressed by the granulosa cells may be directly regulated in a 
paracrine fashion by GDF9.  This extensive transgenic mouse study into the 
molecular mechanisms surrounding the intra-ovarian regulation by GDF9 has 
contributed greatly to the understanding of this TGFβ family member.  In vitro 
studies further support evidence that GDF9 is involved in the early stages of follicle 
development whereby oocyte derived GDF9 has been shown to stimulate the 
proliferation and suppress the FSH-induced differentiation of rat granulosa cells (Vitt 
et al., 2000). 
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BMP15 is also an oocyte-derived factor but, compared to GDF9, mice lacking 
functional BMP15 have a relatively normal folliculogenesis pattern with impairment 
observed at ovulation and the ability for the oocytes to be fertilised thus reducing 
overall fertility (Yan et al., 2001b; Wu and Matzuk, 2002).  A more extreme 
phenotype is observed in naturally occurring point mutations of BMP15 in the sheep 
(Inverdale and Hanna) with the homozygous BMP15 mutants, FecX1/FecX, having 
their follicular development arrested at the primary stage, similar to the GDF9 mouse 
(Galloway et al., 2000; McNatty et al., 2001).  Interestingly the heterozygous 
individuals have an increased ovulation rate resulting in multiple pregnancies 
suggesting a dose depended effect of BMP15 on folliculogenesis in the sheep 
(Galloway et al., 2000; Yan et al., 2001b).  This dose dependent mechanism has also 
been identified in the DAZL KO mouse whereby heterozygous expression results in 
multiple pregnancies compared to the Wt homozygous (Section 1.6.1) (McNeilly et 
al., 2000).  Furthermore, although not well documented the function of BMP15 has 
been shown to modulate FSH action in rat granulosa cells by suppressing FSHR 
expression (Otsuka et al., 2001).   
 
In addition to these studies into single mutations of GDF9 and BMP15, heterozygous 
double crosses generating GDF9+/−; BMP15−/− have been investigated.  The 
generation of these mice show enhanced Bmp15 null phenotype (Yan et al., 2001b).  
Furthermore cumulus cells from these mutant mice were unable to adhere to the 
oocyte, and no cumulus expansion was observed, suggesting that each of these 
ligands use the same signalling machinery during the periovulatory period of 
folliculogenesis (Yan et al., 2001b).   
 
Collectively these results support the roles of principally GDF9 in rodents and 
BMP15 in sheep in the early stages of follicle development associated with granulosa 
cell proliferation, and there is further evidence that GDF9 and BMP15 may play 
roles in the later stages of folliculogenesis possibly associated with FSH modulation 
and cumulus expansion (Elvin et al., 1999; 2000; Yan et al., 2001b; Juengel et al., 
2002).  Furthermore, there is recent evidence which suggests that heterodimers can 
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exist when these subunits are co-expressed in vitro but their biological activity 
remains to be tested in vivo (Liao et al., 2003). 
 
1.3.3.7.Anti-Müllerian hormone  
Anti-Müllerian hormone (AMH) is most notably recognised as having a role in 
inducing müllerian duct regression in the male fetus during development (Josso et 
al., 2001).  However, AMH is a further member of the TGFβ superfamily which has 
been investigated and implicated in intra-ovarian signalling.  AMH is first detected in 
the granulosa cells of the recruited primordial follicles, suggesting a possible role for 
AMH in controlling follicle growth (Durlinger et al., 1999; Durlinger et al., 2001).  
Interestingly, AMH is not expressed in follicles following dominance selection, 
indicating that the pattern of expression may have an important role in the regulation 
of both the number of growing follicles and their further selection for ovulation 
(Visser et al., 2007).  Data from in vitro studies using rat pre-antral follicles have 
further demonstrated that AMH can enhance the FSH-induced increase in follicle 
diameter and cell number (McGee et al., 2001).  Furthermore, the AMH null mouse 
model has been used to investigate the roles of AMH in folliculogenesis in vivo 
(Durlinger et al., 1999).  AMH null mice display an increased recruitment of 
primordial follicles accompanied by reduced FSH levels.  Interestingly, these mice 
do not have proportionally more preovulatory follicles suggesting that in the absence 
of AMH, follicles may be more sensitive to FSH (Durlinger et al., 1999; Visser et al., 
2007).  In comparison over expression of AMH leads to the inhibition of Müllerian 
duct differentiation in females, resulting in a blind vagina with no detectable uterus 
or oviducts.  At birth the ovaries of these females have a reduced number of germ 
cells which are subsequently lost and somatic cells organise into structures 
resembling seminiferous tubules.  Furthermore these structures are then thought to 
degenerate as they are undetectable in adult females (Behringer et al., 1990).  
Together these models of AMH depletion and over expression clearly indicate an 
imperative role for AMH in not only sexual differentiation but on follicle 
development and recruitment. 
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1.4. Programmed cell death   
The emphasis of the first part of this review focused on the importance of 
engagement between control and regulation of factors supporting the development of 
primordial germ cells and follicles throughout folliculogenesis.  These processes are 
without a doubt controlled by a substantial number of identifiable molecules, 
including the gonadotrophins, steroids and intra-ovarian growth factors which 
communicate and principally act as survival factors.  Parallel to these complex 
interactions supporting development are the opposing events of programmed cell 
death.  The interaction between the factors that promote survival and those that leads 
to atresia of follicles, oocytes and CLs are crucially important in ovarian biology. 
 
The first description of apoptosis was within the rabbit ovary to which the process 
was call chromatolysis (Flemming, 1885).  The ultrastructural features of apoptosis 
include condensation of the nuclear chromatin into circumscribed masses, 
convolutions of the nuclear and cellular outline, fragmentation and budding of the 
cell and the production of the membrane bound apoptotic bodies, and phagocytosis 
of the apoptotic bodies by macrophages.  These descriptions are still recognised 
today as the main characteristics of apoptosis (Hussein, 2005). 
 
Apoptosis can be generally described as a means for multicellular organisms to 
eliminate unwanted cells in response to developmental signals or toxic stimuli 
without the release of toxic cell contents, as occurs with necrosis (Quirk et al., 2003).  
Apoptosis can be achieved by two different response mechanisms: one mechanism is 
triggered by the binding of extrinsic death molecules to cell surface receptors (death 
receptor mediated events) while the other is generated by intrinsic mitochondrial 
mediated events arising from within the cell (Figure 1.8) (Danial and Korsmeyer, 
2004; Hussein et al., 2005; Jin and El-Deiry 2005).   
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Figure 1.8: Intrinsic and extrinsic apoptosis signalling pathways, both of which are inducible in the 
granulosa cells (image: www.researchapoptosis.com/.../signaling/index.m). 
 
The focus of this current section is mainly on the natural processes of apoptosis in 
the ovary and the factors involved.  However it is important to note that pathological 
insults, in the form of either environmental biohazards or clinical therapies such as 
chemotherapeutic agents, can contribute to premature ovarian failure and subsequent 
infertility by interfering in the intrinsic program of apoptosis present in oocytes 
(Tilly, 2001). 
 
1.4.1. Follicle atresia 
Of the original 26,000 germ cells observed prenatally in the mouse approximately 
10-15,000 of this germ cell reserve die prior to birth (Dean, 2002).  For the majority 
germ cells which survive this initial wave of apoptosis in the fetal and newborn 
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ovary, their fate within follicles is not any better as apoptosis continues to decimate 
the oocyte pool through a process generally referred to as follicle atresia (Kim and 
Tilly, 2004).  As discussed in previous sections follicle selection is a highly regulated 
process and follicle atresia accounts for the substantial loss of many recruited but not 
selected follicles over the reproductive lifespan.  It has been thought that, depending 
on the stage of follicle development, the cell type responsible for the initiation of 
atresia alters.  The oocyte appears to initiate atresia in the resting or primordial 
follicles (Gougeon, 1996; Perez et al., 1999) whereas the initiation of apoptosis is 
transferred to the granulosa cells in later stages of development at the critical point of 
ovulatory selection (Hughes and Gorospe, 1991; Tilly et al., 1991; Johnson, 2003).  
It is important to acknowledge that all follicles are not alike.  Both the susceptibility 
to apoptosis and the regulators of follicle survival change during each stage of 
development determining the fate of follicles.  Furthermore, it has been demonstrated 
that follicle atresia occurs in conjunction with proliferation, with a higher incidence 
of follicle atresia observed in larger proliferating gonadotrophin-dependent follicles 
compared to small slow growth gonadotrophin-independent follicle.   
 
Apoptosis permits the safe disposal of cells at the point in time when they have 
fulfilled their biological function since this process can be completed within minutes 
in single cells.  However the breakdown and disappearance of a whole follicle takes 
several days depending on the size (Hussein, 2005).  As discussed apoptosis is 
central to many functional aspects of the ovary with many molecular pathways 
involved, of which the Bcl-2 family, caspases and members of the TGFβ family play 
imperative roles.  The recent advancements in molecular biology and the use of 
transgenic models has been invaluable in contributing to our understanding of 
ovarian apoptosis, but as a result of the complexity of the interactions follicular 
apoptosis remains only partly understood.  There is a plethora of molecular 
mechanisms thought to be associated with the ovarian dynamics of atresia, with new 
molecular candidate being continually identified.  Furthermore as a result of studies 
within this thesis a new novel molecule, PDCD4, has been identified to play a role in 
ovarian apoptotic mechanism but will be subsequently discussed in detail.  
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Molecules from both the intrinsic and extrinsic apoptotic signalling pathways and 
their potential roles in ovarian-related cell death are now discussed.   
 
1.4.2. Caspase 
Caspases are proteases, both initiator caspases (8 and 9) and effector caspases (3, 6 
and 7) are required for activation of the caspase cascade.  On activation of the 
caspase cascade, enzymes and proteins essential for cell viability are targeted and are 
cleaved, resulting in cell degradation and death.  Caspases are activated in two ways 
in the granulosa cells: (i) cell surface receptors; and (ii) by members of the Bcl-2 
family of proteins.  Several members of the caspase family namely, 2, 3, 9, 11 and 12 
have been directly implicated in mediating apoptosis within the ovary using genetic 
models of these caspases (Bergeron et al., 1998; Matikainen et al., 2001; Morita et 
al., 2001). 
 
Inactivation of caspase 2 gene in mouse embryonic stem cells results in a marked 
decrease in developmental germ cell death resulting in an excess number of germ 
cells.  Consequently, a significantly greater number of primordial follicles are present 
postnatally when compared to the wild-type controls (Bergeron et al., 1998).  
Alternatively in the absence of caspase 11 female mice are born with a severe 
depletion of germ cells, suggesting a different action compared to caspase 2 (Morita 
et al., 2001).  However, it has been confirmed from experiments using caspase 11: 
caspase 2 double mutants that the germ cell loss observed in caspase 11-deficient 
females was dependent upon functional caspase 2 activity (Morita et al., 2001).  
Moreover, ovaries from caspase 9 deficient mice contain large numbers of 
developing follicles and as a result of apparent failure of granulosa cell apoptosis the 
entire follicle fails to complete atresia (Bergeron et al., 1998).  The effector caspase, 
caspase 3 is present in its inactive (unprocessed) form within granulosa cells of 
healthy follicles, with atretic follicles possessing increasing concentrations of the 
cleaved activated form (Boone and Tsang, 1998).  Furthermore the caspase 3 KO 
mouse model has demonstrated that the normal progression of apoptosis in granulosa 
cells from preantral to preovulatory follicles is dependent upon the activity of 
caspases 3 and 7 (Matikainen et al., 2001).  Abnormal atretic follicles containing 
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granulosa cells that failed to be eliminated by apoptosis were detected in the caspase 
3 mutant.  In addition oocyte death whether initiated as a result of developmental 
cues or pathological insults was unaffected in the absence of caspase 3 (Matikainen 
et al., 2001).  Ultimately these findings reinforces the conclusion that there are cell-
specific apoptotic pathways present within the ovary and suggests that the paracrine–
autocrine signals that initiate germ cell versus somatic cell death may differ. 
 
1.4.3. Bcl-2 family 
The B cell/lymphoma-2 family (Bcl-2) of proteins have been recognised as central 
contributors involved in the execution and control of regulated apoptosis (Adams and 
Cory, 1998; Chao and Korsmeyer, 1998; Minn et al., 1998; Reed, 1998).  Both pro-
apoptotic (Bax, Bcl-xS, Bad, Bak, Bid, Bik/Blk, Bim, Hrk, Bok/Mtd) and anti-
apoptotic (Bcl-2, Bcl-xL, Mcl-1, A1, Bcl-w, NR-13Bax, Bcl-2-associated x protein) 
molecules have been identified.  Their actions include forming checkpoints between 
factors on the cell surface and internal death signals, which then activate the required 
caspase cascade accordingly (Sato et al., 1994).  An example of the integration of the 
apoptotic mechanism can be demonstrated by the mitochondria mediated apoptotic 
event which uses the death signals to cause the pro-apoptotic Bcl-2 proteins 
(especially Bax) to allow cytochrome c to leak out of the mitochnodria.  This 
cytocrome c from the mitochondria in addition to the apoptotic protease activating 
factor 1 (Apaf-1) subsequently bind to caspase 9, activating the caspase cascade, 
resulting in cell death (Figure 1.8) (Morita and Tilly, 1999).  It has been suggested 
from the studies to date that the fate of any given follicle whether it be atretic 
degradation or developmental survival ending in ovulating is ultimately determined 
by the end-result of a complex interaction between multiple Bcl-2 family members 
(Kim and Tilly, 2004). 
 
1.4.3.1. Pro-apoptotic Bax 
Bax is a pro-apoptotic factor demonstrated to be actively involved in follicle atresia 
and is the most studied member of the Bcl-2 family to date (Kim and Tilly, 2004).  It 
has been demonstrated that apoptosis within the fetal ovary is correlated with an 
increase in Bax expression, with no observed difference in the expression of Bcl-2 
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(Felici et al., 1999).  Additionally an increase in Bax expression at both the mRNA 
and protein level in a number of species has been demonstrated to be consistently 
correlated with granulosa cell demise and follicle atresia (Tilly et al., 1995; Gebauer 
et al., 1999; Zwain et al., 2001; Vitale et al., 2002; Yoon et al., 2002).  Collectively 
these findings suggest that Bax is probably involved in multiple apoptotic-initiated 
pathways, both in the oocyte and granulosa cells. 
 
Evidence for the physiological function of Bax has been provided by the generation 
of the Bax-deficient mouse.  One of the major observations from this model is the 
accumulation of unusual atretic follicles containing numerous atrophic granulosa 
cells that presumably failed to undergo apoptosis (Knudson et al., 1995).  Subsequent 
studies have additionally highlighted that the Bax deficient mouse displays a 
significantly reduced incidence of immature follicle atresia due to defective oocyte 
apoptosis postnatally, consequently prolonging the reproductive lifespan of these 
mice (Perez et al., 1999). 
 
1.4.3.2. Anti-apoptotic Bcl-2 
The major participant as a pro-survival molecule in apoptotic events is Bcl-2 
classified as a proto-oncogene preventing apoptosis and has been demonstrated to 
play a role within the ovary.  In mice a deficiency of Bcl-2 leads to the formation of a 
smaller cohort of resting primordial follicles (Ratts et al., 1995).  Although unclear it 
has been suggested that this reduced cohort may result from an increase in apoptosis 
of germ cells either in fetal life, postnatally or, possibly, a combination of both (Kim 
and Tilly, 2004).  In comparison the over-expression of Bcl-2 within the ovary 
results in an increase in ovulation rate, an indication of apoptotic down-regulation 
(Hsu et al., 1996). 
 
 
1.5. Transgenic mouse technology 
The use of transgenic mouse models have been repeatedly acknowledged and 
discussed in many parts of this descriptive review surrounding ovarian development.  
The use of this invaluable biological tool has highlighted the actions of many 
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individual genes and a remarkable magnitude of data is now in place regarding many 
of the key players in ovarian development.  Thus, mouse genetics have provided 
unique insights into the function of multiple genes involved in the processes 
associated with oocyte growth and follicle maturation and will continue to do so in 
the future (Amleh and Dean, 2002).  Many genetically modified mice now exist, 
either produced spontaneously or by design which show impairments in reproductive 
function and performance (Matzuk and Lamb, 2002; Rajkovic and Matzuk, 2002; 
Pangas and Matzuk, 2004).  Consequently cellular and molecular characterisation of 
a number of these deficiencies has led to the identification of similar abnormalities in 
infertile humans (Vanderhyden 2002).  
 
There are currently no oocyte cell lines, and transgenic animals remain the mainstay 
of research into the mechanisms of germline origin, differentiation and development.  
Mouse models represent invaluable tools to study in vivo genetics of mammalian 
oogenesis and to understand the mechanisms that lead to infertility at a molecular 
level (Pangas and Rajkovic, 2005).  The DAZL mouse offers us a unique opportunity 
to address oocyte survival and intra-ovarian endocrinology and functionality (Ruggiu 
et al., 1997).   
 
 
1.6. DAZL (Boule, DAZ) 
The human DAZ gene was first detected after an investigation into azoospermia in 
infertile men, which is a condition whereby no sperm is present in the semen (Reijo 
et al., 1995).  It has been identified that deletions within the Azoospermia Factor 
(AZF) region of the human Y chromosome may contribute to azzospermia, and of 
the deleted regions DAZ has been identified as a common mutation.  DAZ is now 
considered essential for germ cell development and mutations or loss of function 
associated with infertility in the males (Lee et al., 1998; Ferlin et al., 1999;Kuo et al., 
2004; Reynold and Cooke, 2005).  Further investigations have led to the 
identification of the mouse autosomal homologue, DAZL (Cooke et al., 1995).  
DAZL is highly homologous to DAZ, with 83% similarity in the coding region of the 
cDNA, similar RNP/RRM (putative RNA-binding) domains and both of these genes 
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encode RNA binding proteins (Saxena et al., 1996; shan et al., 1996; Yen et al., 
1996; Chai et al., 1997).  Generally, RNA binding proteins play a fundamental role 
in the complex regulation of germ cell development, particularly in meiosis (Urano et 
al., 2005) and this complex process is subject to strict control at both levels of 
transcription and translation (Reynolds et al., 2005).  A number of studies have 
identified specific mRNAs that are bound by the DAZ-related proteins in vitro, 
(Mains and Wasserman, 1999; Maegawa et al., 2002; Venables et al., 2001; Jiao et 
al., 2002; Urano et al 2005; Fox et al., 2005), with only a selected few showing true 
in vivo interactions (Reynolds et al., 2005, 2007), with focus remaining upon male 
spermatogenesis.  Despite a number of potential target molecules having been 
identified in the testes their possible function within the ovary has not been 
investigated.  Therefore identification of DAZL substrate mRNAs will now enable a 
detailed mechanistic assessment of the consequences of DAZL binding to target 
mRNAs within the ovary and to further elucidate the dose effect demonstrated by the 
Het females. 
 
1.6.1. DAZL animal model 
Most of what we know regarding the biology of DAZL and family members (Boule 
and DAZ) has come from studies conducted in non-mammalian vertebrates or male 
spermatogenesis.  Ruggiu et al., (1997) were the first to confirm that the mouse 
DAZL gene was essential for development and survival of germ cells in both ovary 
and testis and from this initial work the molecular contribution to germ cell 
functionality has been explored.  However, to date there has been little emphasis on 
the molecular function of DAZL within the ovary aside from the work previously 
accomplished in our lab (McNeilly et al., 2000; Elaine Watson, PhD, 2007).  In the 
mouse it is now recognised through transgenic manipulation that in the absence of 
DAZL, germ cells fail to develop into follicles and are subsequently ablated from the 
ovary (Ruggiu et al., 1997), emphasising a fundamental role for DAZL in the 
processes involved in germ cell development and possibly follicle formation. 
 
From the initial investigations utilising the transgenic DAZL model, the female 
phenotype was selected for further investigation to attempt to identify potential 
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DAZL mRNA targets.  Organogenesis of the DAZL KO ovary appears normal, with 
a large number of pachytene cells present at e15.  However there is a recognisable 
depletion in germ cell number by e19, with complete oocyte ablation postnatally 
(Figure 1.9) (Ruggiu et al., 1997).  The KO females are therefore classified as 
completely infertile presenting with severely reduced or no follicular structures 
within the ovary.  Furthermore the cells within their small ovaries are 
immunonegative for AMH and sulphated glycoprotein-1, an indication of the 
absence of small follicles and CLs consecutively (McNeilly et al., 2000).  
Interestingly, these ovaries show positive immunoexpression for 3β-hydroxysteroid 
hydrogenase, 17α-hydroxylase and aromatase, indicating the presence of 
steroidogenically active cells which are capable of producing oestrogen (McNeilly et 
al., 2000).  In addition the KO mice have estrogenic uteri supported by normal 
plasma concentrations of oestradiol (McNeilly et al., 2000).  The investigations into 
the KO DAZL female phenotype are ongoing within our laboratory providing an 
interesting model for ovarian investigation in the absence of oocytes (McNeilly et al., 
2000).  An interesting observation was noted following breeding of these transgenic 
animals whereby the Het females produced significantly larger litters compared to 
the Wt (Figure 1.10) (McNeilly et al., SSR 2007) suggesting that their follicles may 
be more sensitive to FSH (McNeilly et al, 2000).  The increased ovulation rate was 
associated with reduced levels of plasma FSH and increased levels of circulating 
inhibin B, suggesting that there may be more small follicles present or an increase 
inhibin B production from each follicle. 
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Figure 1.9: Histological photomicrographs of ovaries from d21 (A) Wt and (B) KO.  Arrow indicates 








WT HET WT HET
First litter         Second litters
Wt n = 46              Het n = 42
***                   ***
 
 
Figure 1.10: Histogram of Wt and Het litter sizes across two consecutive litters (Values are means ± 
SEM).  *** denotes <0.001 significance (McNeilly et al., SSR 2007). 
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It has been proposed that since Het mice have elevated plasma inhibin B levels 
compared to the Wt, DAZL protein may not only have a direct functional role within 
the oocytes but functions indirectly on the capacity of granulosa cells to produce 
inhibin.  Furthermore the increase in ovulation rate and subsequent litter size may be 
determined by either an increase in initial follicle recruitment, or enhanced function 
of individual follicles once selected into the growing cohort of follicles destined for 
dominance (McNeilly et al., SSR 2007).  This increased selection may be due to an 
amplified sensitivity to FSH, thereby reducing follicle atresia of more sensitive 
follicles.   
 
In addition previous work within our laboratory prior to the current studies assessed 
the ovarian follicle number in addition to follicle FSH sensitivity between DAZL Wt 
and Het female mice.  Studies investigating whether follicle reserve was responsible 
for the increase in litter size observed in the Het females were performed with the 
ovarian follicle reserve from d21 pre-pubertal mice untreated mice, mice treated with 
10iu FSH or ovine follicular Fluid (oFF) determined.  Findings from these 
investigations conclude that untreated Het mice had a significantly greater 
percentage of antral follicles (<0.05) compared to Wt, however the difference was 
eliminated when endogenous FSH levels were suppressed by the oFF treatment or 
increased by exogenous FSH treatment, suggesting that FSH sensitivity is greater in 
the Het follicles compared to the Wt.  In addition the antral follicles from the 
untreated Het mice had greater granulosa cell and follicle areas.  Further studies 
investigating in vivo maturation of cultured follicles showed no difference in the 
endocrinology of Wt and Het follicles after culture with 1iu and 0.1iu FSH.  
However at 0.001iu FSH the Het follicles secreted higher levels of oestradiol 
(p<0.001) and inhibin A (p<0.05) suggesting greater maturity in the Het follicles 
(Watson, PhD 2007) 
 
Furthermore after investigations comparing follicle health and atresia no difference 
in AMH (health) and cleaved caspase 3 (atresia) immunostaining between the Wt 
and Het in primary, secondary and antral follicles for untreated, FSH treated and oFF 
treated Wt and Het mice.  However there were significantly more secondary follicles 
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from Het FSH treated mice which stained positively for AMH but were negative for 
cleaved caspase 3(p<0.01) suggesting a higher proportion of healthy follicles 
compared to the Wt.  Overall follicle activation from the reserve pool and atresia 
rates did not differ overall between Wt and Het follicles in untreated and oFF treated 
mice.  However there was evidence of a greater activation or maintenance of healthy 
follicles after FSH treatment in Het mice 
 
Moreover, evidence from these previous studies (McNeilly et al., 2000; Watson, PhD 
2007) suggests that DAZL plays a fundamental role in the intra-ovarian 
communication between oocytes and somatic cells, sensitising the follicle to FSH.  It 
can be suggested that activation, maintenance, sensitivity and maturity may all be 
consequently altered between the DAZL Wt and Het follicles.  How this occurs has 
yet to be elucidated and despite a plethora of information regarding this RNA 
binding protein, the underlying functional mechanism and roles in ovarian 
development remain unidentified. 
 
 
1.7. Thesis aims 
Infertility or, more specifically, ovarian failure, arises as a result of many potential 
reasons, including extrinsic and intrinsic endocrine, steroidal or intra-ovarian control, 
ovarian pathology or disruption to the genetic control of the critically essential 
pathways involved in the complex developmental roles described above.  There is 
emerging evidence pinpointing exact timings and essential roles for many factors 
with DAZL being a major candidate critical for oocyte survival.   
This review has focused and highlighted a number of ovarian specific events and the 
roles that selected molecules play.  It has highlighted the complexity of the processes 
involved in oogenesis and folliculogenesis.  Investigating the functions of the germ 
cell specific DAZL will hopefully identify key pathways which may be targets to 
manipulate fertility and eventually enable scientist and clinicians to target problems 
associated with ovarian failure in humans. 
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The main aim for the experimental work detailed in this thesis was to further 
investigate how DAZL affects ovarian function, investigating why functional copy 
number (Wt and Het) of DAZL increases fertility and what physiological function 
does DAZL have on oocyte development and follicle function.  To addresses these 
aims, firstly functional copy number was investigate to establish if DAZL expression 
contributed to an alteration in oocyte gene expression and hence regulatory control 
between the Wt and Het females (Chapter 3).  Furthermore, direct and indirect 
approaches were adopted to identify potential DAZL binding mRNAs by in silico 
approach (Chapter 4) using the putative DAZL binding motif and by in vivo 
immunoprecipitation (Chapter 5).  The emergence of one potential candidate was 
investigated further and identified a novel role in CL regression (Chapter 6).  Finally 
in vitro follicle culture studies were utilised to investigate the intra-ovarian 
communication between the somatic cell and oocytes to further elucidate if DAZL is 
functioning directly or indirectly to affect oocyte and follicle development differently 
between the Wt and Het females (Chapter 7). 
 




Chapter 2: General materials and methods 
2.1. Animal experimentation  
All studies were approved by the Home Office (United Kingdom) and performed 
under license number 60/3232 held by Professor Alan McNeilly in accordance with 
the Animals Scientific Procedures Act, 1986.   
 
2.1.1. Animal accommodation 
Experiments were conducted at the BRF (Biological Research Facility), Little France 
(Edinburgh) using DAZL Wt and Het female mice.  Animals were housed and bred 
in a temperature (20-25°C) and light controlled room (14-h light, 10-h dark 
photoperiod) with food (standard laboratory CHOW) and water provided ad libitum.  
Daily management and care of the animals was carried out by animal technician 
Mark Fisken (MRC). 
 
2.1.2. DAZL genotype 
In all studies the female mice used were from our established colony of in-house 
breeding pairs (BRF) originally generated by a conventional knockout approach 
(Ruggiu et al., 1997).  Heterozygous matings were subsequently used to provide 
offspring of mixed genotype. 
 
2.1.3. Sacrifice and disposal of animals 
Mice were euthanized at d10, d21 or adulthood by CO2 inhalation within a sealed 
chamber followed by cervical dislocation in accordance with Schedule 1 of the 
Home Office regulations.  Animal carcases were disposed of using the correct Health 
and Safety regulation in accordance to animal tissue and incinerated clinical waste.  
 
 




2.2. Tissue collection 
2.2.1. Ovary dissection  
The abdomens of the mice and surrounding bench were sprayed with 70% ethanol 
prior to dissection to eliminate any possibility of introducing infection.  The 
abdominal cavity of each mouse was carefully opened with a longitudinal incision 
using sterile autoclaved dissection scissors and forceps.  The ovaries were located, 
carefully removed and any surrounding visceral fat tissue and attached oviduct were 
disconnected before the ovaries were either: 
• Snap frozen on dry ice for subsequent messenger RNA (mRNA) analysis or 
protein extraction (Section 2.3; 2.6).  
• Fixed in Bouins (2 hours) or 4% Neutral Buffered Formalin (NBF) (24 hours) 
before being transferred into 70% ethanol for paraffin imbedding (Section 
2.7).  
• Placed in HANKS (balanced salt solution modified, with sodium bicarbonate, 
without phenol red, calcium chloride and magnesium sulfate, liquid, sterile-
filtered, cell culture tested) (Sigma, Aldrich, UK) for further microdissection.   
• Placed in warmed L-15 medium (Sigma) for follicle dissection (Section 7.2). 
 
2.2.2. Oocytes  
Oocytes were manually dissected from follicles in HANKS solution using 27G 
needles (BD microlance) attached to 1ml syringes (BD Plastipak, Spain).  Follicles 
were punctured to release the oocyte and any surrounding granulosa cells were 
removed from these oocytes by repeated pipetting before being collected using a 
capillary tube and mouth pipette (Sigma), under a dissection microscope (Leica).  
Collected oocytes were the snap frozen on dry ice for subsequent RNA analysis and 
PCR.   
 
2.2.3. Follicles 
Intact follicles were manually dissected from the ovary by carefully teasing the ovary 
apart taking great care not to disrupt the basement membrane between adjacent 
follicles.  Follicles of different sizes were selected using a calibrated graticule in the 




eye piece of the dissection microscope (taking into account the distortion produced 
by the contours of the embryo dishes in which the dissections were taking place).  




Tissue samples of testis, spleen, heart, liver, kidney, lung and adrenal were located 
and dissected, snap frozen on dry ice for further RNA or protein extraction or fixed 
in Bouins or NBF.  These tissues were used for subsequent tissue screens or as 
control tissues. 
 
2.3. Ribonucleic acid (RNA) extraction  
2.3.1. Guidelines for the use of RNA 
It is careful to note that RNA molecules are subject to nuclease digestion by RNases, 
which act by catalysing and hydrolysing RNA into smaller components.   RNases are 
present on the skin and in the atmosphere therefore it is essential that gloves were 
used at all times.  Equipment was cleaned and RNase-free filtered tips, plastics and 
solutions were used. 
 
2.3.2. Extraction 
RNA is comprised of three component subtypes representing the processes of 
translation and transcription: messenger RNA (mRNA), transfer RNA (tRNA) and 
ribosomal RNA (rRNA).  Total RNA was extracted using either mini or micro 
RNAeasy® Kits (Qiagen) following the total RNA isolation from the animal tissue 
manufacturer’s protocol.  The micro kit allows reliable RNA isolation from small 
samples, such as oocytes whereas the mini kit is more suited to larger tissue samples 
such as whole ovary or testis.  Carrier poly-A RNA was added to samples of low 
yielding properties at the time of lysis at 4ng/µl.  The addition of small amounts of 
poly-A RNA used as carrier RNA do not interfere with subsequent RT-PCR, even 
when oligo-dT is used as a primer for reverse transcription. 
 




Briefly, samples were lysed using 350µl of supplied RT buffer supplemented with 
1% β-Mercaptoethanol (Sigma) and homogenised using a hand held homogeniser 
(Sigma-Aldrich).  350µl of ethanol (VWR) was added to the tissue lysate to provide 
ideal binding conditions for the RNA prior to the sample being loaded onto the 
RNeasy MinElute spin column.  The RNA binds to the silica-gel membrane and 
traces of DNA that may copurify were removed by a DNase treatment (Qiagen) on 
the RNeasy spin column.  The DNase treatment was applied to the column and left 
on the bench at room temperature for 15 minutes.  The DNase and any contaminants 
are efficiently washed away by a series of washes using supplied solution RW1 
(350µl), the column was dried using 80% ethanol, and pure, concentrated RNA was 
eluted from the column in 14µl of water.     
 
2.3.3. Assessment of RNA 
RNA quantity was assessed using a NanoDrop® ND-1000 Spectrophotometer 
(Nanodrop Technologies, Wilmington, DE, USA).  When using the nanodrop 1.5ul 
of sample is required and the absorbance is measured at 260 and 280 nm.  The 
sample is pipetted onto the end of a fibre optic cable (the receiving fibre), a second 
fibre optic cable (the source fibre) is then brought into contact with the liquid sample 
causing the liquid to bridge the gap between the fibre optic ends.  The gap is 
controlled to both 1mm and 0.2mm paths.  A pulsed xenon flash lamp provides the 
light source and a spectrometer utilising a linear CCD array is used to analyse the 
light after passing through the sample.  The instrument is controlled by special 
software run from a PC, and the data is logged in an archive file on the PC (Figure 
2.1).  The nucleic acid concentration is automatically calculated using the Beer-
Lambert law (Equation 2.1), which predicts a linear change in absorbance with 
concentration.  The ratio of absorbance at 260 and 280 nm is used to assess the purity 
of RNA.  A ratio of 1.8-2.0 is generally accepted as “pure” for RNA.  If the ratio is 
appreciably lower, it may indicate the presence of protein, phenol or other 








Beer-Lambert law Equation 
A=εCI 
 
A=absorbance at a particular wavelenghth 
C= concentration of nucleic acid 
I= path length of the spectrophotometer cuvette (typically 1cm) 





Figure 2.1: Output data from the nanodrop showing the 260:280 ratio, absorbance peak and the 
concentration of RNA in the sample. 
 
2.3.4. Reverse transcriptase polymerase chain reaction 
The polymerase chain reaction (PCR) is an extensively used molecular technique for 
the rapid and efficient amplification of cDNA reverse transcription from RNA to 
quantify gene expression.  For samples containing <50ng RNA complementary DNA 
(cDNA) was prepared using Sensiscript® Reverse Transcription for first-strand 
cDNA synthesis (Qiagen), while for samples containing >50ng RNA Omniscript 
Reverse transcription was used.  The reaction components are listed in Table 2.1 and 




once made the reaction was incubated for 60min at 37°C using PTC200 (Peltier 
Thermal Cycler) PCR block.   
 
Table 2.1: Reaction components for Qiagen sensiscript cDNA synthesis 
Reagent Master Mix X 1 (µl) Final Concentration 
10x RT Buffer 2 1x 
dNTP mix 5mM each (dNTP) 2 0.5mM each dNTP 
Oligo dT (10µM) 0.4* 1 µM 
Sensiscript/Omniscript RT 1** 10 units per reaction 
RNase free H2O variable  
Template (RNA) variable <50ng (per reaction Sensiscript) 
>50ng (per reaction Omniscript) 
Total 20  
* Taqman concentration 
**diluted 1:1 with 1x RT Buffer 
 
2.3.5. Oligo dT and random hexamer primer choice 
Most cDNA reactions used oligo (dT) primers which anneal selectively on the 
poly(A) tail of mRNA.  The use of oligo (dT) reduces the cDNA complexity and 
amount since poly A+ RNA represents only 1%-2% of total RNA compared to 
random hexamer primers which can be used for transcription of the 5'-end regions of 
mRNA.  However, oligo (dT)s are recommended when performing RT-PCR of a new 
mRNA targets and produce RT-PCR products more consistently than random 
hexamers.  Random hexamers are required to be used when performing Taqman 
probe/primers PCR reactions. 
 
2.3.6. PCR reaction 
All standard PCR reactions were performed using Qiagen HotStartTaq DNA 
Polymerase.  HotStartTaq is supplied in an inactive state that has no polymerase 
activity at ambient temperatures thus preventing extension of non-specifically 
annealed primers and primer–dimers which may form at low temperatures during 




PCR setup and the initial PCR cycle.  The PCR reaction is a thermoregulated cyclic 
process whereby the double stranded cDNA is separated, specific primers annealed 
to the gene of interest and newly synthesised DNA is formed (Figure 2.2). 
  
Figure 2.2: The first cycle of a polymerase Chain Reaction (PCR) A cycle consists of three steps: 
strand separation, hybridization of primers, and extension of primers by DNA synthesis. 
 
The components of the PCR reaction are shown in Table 2.2 (for negative controls 
the reverse transcriptase was omitted), reactions were incubated using the PTC200 








Initial activation step:  95°C for 15 minutes 
3 step cycling 
Denaturation:   94°C for 1 minute 
Annealing:   60°C for 45 seconds 
Extension:   72°C for 1 minute 
Number of cycles:  34 cycles   
Final extension:  72°C for 10 minutes  
 
Table 2.2: Reaction components for Qiagen Hotstart Taq Polymerase  
Master Mix X 1 (µl) 
10 x buffer 1 
25µm MgCl2 0.6 
ddH2O 6.62 
20µm Primer 3’ 0.25 
20µm Primer 5’ 0.25 
10 mM dNTPs 0.2 




2.3.7. Agarose gel electrophoresis 
After the PCR reaction, separation of DNA product molecules on agarose gels 
(Section 2.13) allowed visual confirmation of DNA size and concentration.  TBE 
buffer (45mM Tris borate, 1mM EDTA pH8) was used for high resolution of DNA 
fragments typically less than 500bp in length.  Ethidium bromide (Sigma-Aldrich, 
UK) and latterly “Safeview” (NBS Biologicals) were used as visualising agents and 
were added to the gel at a final concentration of 5ug/ml.  6x loading buffer 
(Promega) was used to visualise the loading of the PCR product sample and increase 
the density of the sample.  Products from the PCR reactions were compared with 
100bp molecular markers (Promega, UK) to check they were the correct amplified 




size.  A voltage of 100 volts was applied to the gel for 20 minutes (Bio-Rad Power 
Pack).  Visualisation of DNA in the presence of the fluorescent intercalculating 
agents was undertaken using an ultraviolet transilluminator (302um wavelength) and 
photographed using an integrated camera (Gene Flash, Syngene, Bio Imaging).   
 
2.3.8. Oligonucleotide primer design 
Oligonucleotides were designed specifically for use in RT-PCR and SYBR green real 
time RT-PCR using a combination of Primer 3 and MWG-biotech software.  When 
designing the requisite pair of specific oligonucleotide primers several guidelines 
were used in the selection process.  The length of the primer molecule was 
constrained to between 18 and 22 bases with a melting temperature (Tm) between 55 
and 65 °C where possible using the calculation below: 
 
Tm = (G+C x4°C)+(A+T x2°C)  G = guanine 
     C = cytosine 
     A= adenine 
     T = thymine 
 
Secondary structure formation was checked for avoiding the occurrence of hairpin 
loop formation and intra-molecular annealing.  Finally, for quantitative Real Time 
PCR the product length was controlled to 100-250 base pairs for an optimal reaction. 
 
 
2.4. Real time semi quantitative RT PCR 
2.4.1. Light cycler (Roche) 
Quantitative PCR was carried out using QuantiTect™ SYBR® Green PCR (Qiagen) 
on the Roche Light Cycler system (Roche).  SYBR Green dye binds to all double-
stranded DNA, and thus any nonspecific products and primer–dimers formed during 
real-time PCR will negatively affect quantification of the target gene.  The 
QuantiTect SYBR Green PCR Kit overcomes this problem with a unique PCR buffer 
that promotes highly specific annealing of primers to the PCR template.  In addition, 
the buffer contains HotStarTaq DNA Polymerase, which provides the most stringent 




hot start compared with other polymerases.  The unique composition of the RT-PCR 
buffer and HotStarTaq DNA Polymerase enable quantification of even low-
abundance transcripts with as low as 5 copies of a target accurately detected 
(Qiagen).  The master mix (Table 2.3) was aliquoted into each capillary at a volume 
of 9µl and 1µl of cDNA from each sample diluted 1:2 was added to the master mix.  
Sample were analysed in triplicate.   
 
Capillaries were centrifuged at 0.6 rpm for 10 seconds to ensure mixing of sample 
and master mix, before being loaded carefully into the light cycler carousel.  Once 
the run was complete the PCR product was run on 2% agarose gel to confirm 
amplification of a single product of the correct size.   
 
Table 2.3: Reaction components of SYBR green real time PCR 
Component X 1 (µl) Final Concentration 
2x QuantiTect SYBR green PCR Mastermix* 5 1x 
Primer A (20μM) 0.5 0.5 µM 
Primer B (20μM) 0.5 0.5 µM 
H2O 3 variable 
Template 1 <1 µg/reaction 
Total 10  
*Provides a final concentration of 2.5mM MgCL2 
 
Due to the limitations of the sample number (n=32) on the light cycler, the SYBR 
green reaction was transferred to the Taqman machine (ABI PRISM 7900HT), where 
96 samples can be analysed at the same time.  
 
 



















Figure 2.3: Diagram of how fluorescent SYBR green incorporates into the PCR reaction 1: annealing, 
2: extension and intercalation, 3: denaturation and reannealing 4: further extending and intercalation 
of SYBR green (adapted from http://www.sigmaaldrich .com/img/assets/9421/PCR-Quant_PCR.pdf). 
 
2.4.2. Taqman SYBR Green 
Using Optical 96-well fast thermal cycling Plate with Barcode (code 128) and 
QuantiTect™ SYBR® Green PCR (Qiagen) 96 reactions can take place at one time.  
The reaction master mixture (Table 2.3) was aliquoted for each sample into separate 
plate wells with cDNA added at 1µl/10 µl reaction mix and again each sample was 
run in triplicate.  An optical adhesive cover was used to seal the plate and the PCR 
reaction was then run on the ABI PRISM 7900HT (Applied Biosystems) using 
optimised fast conditions (Figure 2.4). 
 





Figure 2.4: Thermal Cycle protocol for SYBR green reactions. 
 
2.4.3. Primer validation and Analysis   
Accurate quantification of gene expression levels requires a standard curve to 
validate the primers.  To generate this standard curve, a dilution series was made 
from a cDNA sample.  Real-time PCR assays were carried out in triplicate in order to 
minimise the contribution of pipetting and PCR variation.  In addition to the samples 
to be quantified and the dilution series for the standard curve, mock reactions lacking 
template as a control were also used to verify that there was no potential 
contamination of any solution with PCR product, which is always a concern with any 
PCR-based procedure.   
 
The Applied Biosystems software collects fluorescence data throughout the PCR 
cycle and automatically analyses baseline and amplification parameters.  Baseline 
fluorescent intensity is subtracted from each analysed PCR samples, and an 
amplification plot is generated.  Using data from samples designated as standard 
points with assigned concentration numbers, an arbitrary threshold level is set and Ct 
values for all PCR samples were calculated, allowing generation of a standard curve 
and corresponding correlation coefficients (R2) and slope (PCR efficiency).  A high-




quality standard curve should have an R2 greater than 0.995 and PCR efficiency 
between 90 and 100%.  Based on this standard curve, the concentrations of all 
unknown samples can be derived using the equation of the graph of the standard 
curve.  Averages were taken among replicates.  Generally, this automatic analysis of 
real-time raw fluorescent data is sufficient and was used in the current studies.  In the 
experiments carried out in this thesis normalization of data was performed assuming 
equal efficiency of cDNA synthesis, imput cDNA and efficiency of PCR reaction 






Figure 2.5: SYBR green analysis, amplification plot, dissociation curse and standard plot highlighting 
the R2 value and slope efficiency.  




2.4.4. Advantages and disadvantages of SYBR green PCR 
There are advantages and disadvantages in using the SYBR green PCR reaction over 
Taqman primer probe analysis.  SYBR green can be used with specific primers and 
can be used to monitor the amplification of any double-stranded DNA sequence 
without the requirement of a probe which may reduce assay setup and running costs.  
However the primary disadvantage of the SYBR Green I dye chemistry is that it can 
generate false positive signals because SYBR Green I dye can bind to any double-
stranded DNA.  Thus non-specific double-stranded DNA sequences may occur as a 
result of primer dimer interactions. 
 
2.4.5. Taqman quantitative RT-PCR 
Quantitative PCR was also performed using the Assay-On-Demand Gene 
Expression™ system (Applied Biosystems) on an ABI Prism 7900 Sequence 
Detection System (Applied Biosystems). The Taqman® Assay-on-Demand probes 
have a FAM™ reporter dye at the 5’ end of the Taqman MGB (minor groove 
binding) probe and a non-fluorescent quencher dye at the 3’ end.   
 
2.4.5.1.Principles of the Taqman reaction 
Briefly, cleavage of the probe separates the reporter dye from the quencher dye, 
which results in increased fluorescence of the reporter.  This only takes place if the 
specific probe has hybridised to the target sequence of cDNA.  Accumulation of the 
PCR products is detected directly by monitoring the increase in fluorescence of the 
reporter dye (Figure 2.6).  The expression level of the gene of interest was related to 
an endogenous control, 18S ribosomal RNA and negative controls were included in 
each run.  The uses of an internal reporter primers increases the specificity of 
quantification of the PCR reaction compared with the SYBR green method, but 
analysis of the same sample by both methods gave similar results. 
 


















































Figure 2.6: Schematic diagram showing polymerisation, strand displacement, cleavage, and 
completed polymerisation steps in the Taqman PCR reaction (adapted from Applied Biosystems, 
Chemistry guide, online). 
 
All reagents were obtained from Applied Biosystems and samples run in triplicate on 
96 well MicroAmp Fast Optical reaction plates (Applied Biosystems).  For each 
sample the PCR reaction was prepared to give a total volume of 10µl in each well 
and the plate was sealed with an adhesive cover (Applied Biosystems). 
 
2.4.5.2.Primers 
Primer and probe sequences were either designed using Primer Express software and 
synthesized by PE Biosystems or by Biosource Europe SA (Nivelles, Belgium) by 
Linda Nicol (FST, inhibin βB, AR11a, LHR and FSHR) or were supplied assay on 
demand by PB biosystems (aromatase, inhibin α, inhibin βA and AMH).  Ribosomal 
18S primers and probe were from a Taqman Ribosomal RNA Control Reagents kit 









Table 2.4: Sequences of primers and probes used for Taqman RT-PCR analysis 
 
Gene Forward primer 5’-3’ Reverse primer 5’-3’ Probe (FAM labeled) 
LHR  ttttatcctgtcaattcttgtgccaaccca ccttcgtgaacactgcgtaca actgtcaccaactcaaaagttctg 
FSHR  gcctgcccatggatatcg aggccagggcgttgagtac ctttgtcgcagctgtatgttatggccctc 
Inhibin βB atgtcccctgccagttca ctcaggagggaaagtgcattg ttgccctcccgcctgctcc 
AR11a  aagttcgaggctggcaagtc  caacacctctggagccatatacct cgggtaccaacctgccatggg 
FST gggctggatgggaaaaccta cggctgctctttgcatctg cgcaacgaatgtgcactcctcaagg 
    
 Assay on Demand   
Aromatase Mm00484049_m1   
AMH Mm00431795_m1   
Inhibin α Mm00439682_m1   
Inhibin βA Mm00434338_m1   
 
2.4.6. Analysis 
Absolute quantification was performed on the ABI Prism sequence detection system 
using Real Time PCR.  Real Time PCR reactions are characterised by the point in 
time during cycling when amplification of a target is first detected rather than by the 
amount of target accumulated at the end.  The earlier the target is detected the more 
cDNA is present.  
 
Figure 2.7: Example of an amplification plot after a successful Taqman RT-PCR reaction. 




The amplification plot produced from the Taqman PCR shows the amount of reporter 
dye generated during the amplification stage (Figure 2.7).  This amplification is 
directly related to the amount of PCR product formed, which in turn is related to the 
expression level of the target gene.  The FAM Ct (threshold cycle) value corresponds 
to the cycle number at which the fluorescence generated crosses the threshold level.  
The threshold level is defined as the point at which an increase in signal is associated 
with an exponential increase of PCR product.  The Ct value is directly related to the 
amount of PCR product with a change in Ct value of one equating to a two-fold 
difference in initial cDNA concentration.   
 
Analysis of the results was carried out using the comparative Ct method.  This is 
used to analyse changes in expression of a target gene relative to another reference 
sample.  For each sample, the ΔCt was calculated which refers to the difference 
between the FAM Ct (gene of interest) and the 18S Ct which normalises the 
amplified signal against the total mRNA content.  The mean ΔCt for the triplicates 
was calculated and used to determine the ΔΔCt, which is the difference between the 
ΔCt of the experimental sample compared to that of the control or untreated sample.  
The amount of amplified target is given the value of 2- ΔΔCt which is based on the 
mathematical equation that describes the exponential amplification of the PCR 
reaction: Xn = Xo x (1+Ex)n where Xn is the number of target molecules at the 
threshold at cycle n, Xo is the initial number of target molecules, (1+Ex) is the 
efficiency of the target gene amplification and n equals the number of cycles.  
Assuming that the efficiencies of the target and endogenous control reactions are 
equal, the 2- ΔΔCt value is a measure of relative quantification and is used here to 
show the fold difference in mRNA expression of the samples relative to the control 





Genotyping was carried out on tail tips collected at sacrifice of littermates to 
distinguish between DAZL genotypes.  The genotyping PCR previously established 




(MRC, HGU, Edinburgh) was performed on a crude digestion of the tail tips 
whereby 100ul of 25mM NaOH (BDH) 0.2mM EDTA (Digest 1) (Sigma) was added 
to each sample and digested for 20 minutes at 95°C (Omnigene, PCR machine).  The 
reaction was centrifuged before the addition of 40mM Trizma HCL (Digest 2) to stop 
the digest reaction and the sample vortexed and centrifuged.  The digest was then 
used for the genotyping PCR. 
 
2.5.2. Genotyping PCR 
The genotyping PCR was carried out using Abgene Hot Start Taq under optimal PCR 
conditions (Table 2.5) using specifically designed primers (Table 2.6).  For each 
individual sample 50µl of master mix was added to a 0.2ml PCR tube, with 5µl of 
tail tip digest, dH20, Digest 1 or Digest 2 (as negative controls).  The PCR reaction 
was performed as previously mentioned (Section 2.3.6) but in a final volume of 50μl.  
The gel was photographed using a UV transilluminator, where the top band 
represents Wt, bottom band KO and the presence of both bands Het genotypes 
(Figure 2.8).  
 
Table 2.5: Reaction components for Genotyping PCR (Abgene, Epson, UK) 
Master Mix X 1 (µl) 
10 x buffer 5 
25µm MgCl2 4 
ddH2O 39.1 
20µm Primer u660/661 0.6 
20µm Primer u662/663 0.6 
10 mM dNTPs 0.5 










Table 2.6: Primer sequences for DAZL genotyping  
Primer Forward 5’-3’ Reverse 5’-3’ 
U660/661 CAg Tgg CTT gAA ATT ATC  gCT TCC TCT TgC AAA ACC AC  




Figure 2.8: Photomicrograph of a PCR distinguishing between DAZL genotypes. 
 
 
2.6. SDS PAGE/Western Blotting 
SDS PAGE and western blot analysis can detect individual proteins of interest from a 
mixture of a great number of proteins.  The Licor odyssey fluorescent detection 
system was used for all Westerns performed. 
 
2.6.1. Protein extraction 
Total protein was extracted from mouse tissues previously dissected (Section 2.2) 
and frozen (-70ºC) tissues using RIPA buffer (Section 2.13) containing a protease 
inhibitor cocktail (Roche).  The tissue was homogenised in 50-200µl RIPA buffer 
using a handheld motor driven grinder (Sigma).  The homogenate was centrifuged at 
2500rpm for 10 minutes.  The protein rich supernatant was collected in a fresh 1.5ml 
tube and stored at -70ºC until use. 
 
2.6.2. Protein quantification 
Protein samples were quantified in order to carry out comparative expression 
analysis.  A Biorad DC protein assay kit (Biorad Laboratories, Hemel Hempstead, 
UK) was used to determine concentration according to the manufacturer’s 
instructions.  This kit is a colorimetric assay which is based on the reaction of the 




protein with an alkaline copper tartrate solution and Folin Reagent.  This assay is a 
two step process firstly involving the reaction between protein and copper in an 
alkaline medium, and secondly the reduction of the Folin reagent by the copper-
treated protein.  The colour analysed is mainly due to the amino acids tyrosine and 
tryptophan, and to a lesser extent cystine, cysteine and histadine.  The reduction of 
Folin reagent produces a blue colour observed with a maximum absorbance at 
750mm and a minimum at 405nm (Lowry et al., 1951 and Peterson and Gary 1979).  
Briefly, a standard curve was set up using solutions of known concentrations of BSA 
in RIPA buffer.  These standards along with the samples of unknown concentration 
were subjected to a two-step assay based on the Bradford method of protein 
quantification.  The samples are then read on a spectrophotometer plate reader 
(Labsystems Miltiskan EX; VWR) at 690nm.  The concentration of each unknown 
sample was determined using the standard curve produced from the protein 
standards. 
 
2.6.3. Sample preparation 
Tissue samples previously quantified (Section 2.6.1) were diluted in PBS to the 
desired concentration and 5µl loading buffer added (Section 2.12).  The samples 
were boiled for 5 min immediately before loading each protein sample into the wells 
on the gel, between 20-100µg of the denatured protein sample was loaded per well 
(see individual experiments). 
 
2.6.4. SDS PAGE 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) is a 
technique used to separate protein according to their electrophoretic mobility and 
molecular weight.  For each gel, 5µl of molecular weight marker (Odyssey) was 
loaded into at least one lane.  This marker contains proteins of known molecular 
weight thus allowing identification of the target protein at the correct molecular 
weight and allows visualisation of the transfer of protein from gel to membrane.  
Protein samples were run on 10% acrylaminde gel (Section 2.12) (with 3% stacking 
gel) in an electrophoresis tank, containing SDS Running Buffer (Section 2.12), at 
100V to resolve the proteins according to their molecular weight.  Electrophoresis 




was stopped when the bromophenol blue dye reached the bottom of the gel, approx 2 
hours. 
 
2.6.5. Transfer of proteins 
To further analyse the protein, the glass plates were carefully separated allowing 
access to the gel which contains the separated proteins.  The proteins were then 
transferred to a membrane by western blot analysis.  The components of the blotting 
apparatus included two porous pads, 6 pieces of 3mm Whatman paper and 
nitrocellulose membrane (Immobilin-P; Millipore, Bedford, UK) which was 
rehydated in methanol for 30 seconds and then washed in transfer buffer prior to use 
(Figure 2.9).  This arrangement allows the separated proteins to transfer from the gel 
towards the anode until they reach the solid support membrane.  The chamber was 
filled with the transfer buffer and attached to a power pack for 1h at 100V.  An ice 
pack was added to the chamber to prevent over heating as a result of the applied 
current and to allow optimal transfer conditions. 
 
 
Figure 2.9: Western Blot transfer set up 
 
2.6.6. Probing the membrane  
Once transfer was complete the membrane was blocked using Odyssey® blocking 
buffer (LiCor, Nebraska, USA) diluted in PBS (1:1) and incubated for 1h at room 
temperature.  This stage blocks any non-specific binding sites on the membrane.   




2.6.6.1.Primary antibody  
The membrane was subsequently incubated overnight with the primary antibody 
diluted in Odyssey® blocking buffer/PBS-Tween (PBST) at 4ºC. The antibodies and 
dilutions used are detailed in table (Table 2.7). 
 
Table 2.7: Primary antibodies used in Western Blot analysis 
Antibodies Source dilution 
DAZL  Abcam 1:1000 
Β-tubulin Abcam 1:1000 
 
After primary antibody incubation the membrane was rinsed in PBST (4 x 5 minutes) 
so that any residual primary antibody was eliminated from the membrane. 
 
2.6.6.2.Secondary antibody 
The appropriate secondary antibody which were fluorescently labelled and directed 
against the host species of the primary antibody (Table 2.8) were diluted 1:5000 in 
the blocking buffer and incubated with the membrane for 1h at room temperature.  
Finally the membrane was washed in PBST (4 x 5 min) to remove excess antibody 
before analysis.   
 
Table 2.8: Summary of secondary antibodies used on Western blots for LiCor detection  
Fluorescent antibody Species Supplier Excitation wavelength (nm) 
Alexafluor®680 Donkey anti goat Molecular Probes 680 
IR Dye 800 Goat anti mouse Rockland 800 
Alexafluor®680 Goat anti mouse Molecular Probes 680 
Odessey 680 Goat anti mouse Odessay 680 
 
2.6.7. Protein expression analysis – LiCor technology 
Protein expression was analysed on a LiCor fluorescence detection system (LiCor). 
The LiCor allows detection of two proteins simultaneously using different coloured 




fluorescent markers and fluorescent filters.  Membranes were washed in PBS alone 
to remove any residual Tween-20 prior to analysis.   
 
2.7. Tissue fixation and processing 
2.7.1. Tissue fixation 
Tissues were either fixed in NBF (Section 2.12) for 24 hours or Bouins (Triangle 
Biomedical Sciences, Lancashire, UK) for two hours before being placed in 70% 
ethanol prior to tissue embedding.  Subsequent immunohistochemisty used NBF 
fixed tissue unless otherwise stated. 
 
2.7.2. Tissue processing and paraffin embedding 
The tissue was processed and dehydrated through a series of graded alcohols on a 
17.5h cycle using an automated Leica TP-1050 processor (Leica Microsystems, 
Milton Keynes, UK).  Processed tissue was saturated and embedded by hand in 
liquid paraffin wax and cooled.  The finished wax blocks were stored at room 
temperature prior to use. 
 
2.7.3. Sectioning of paraffin blocks 
5µm paraffin sections were cut using a hand-operated microtome (RM2135; Leica, 
Germany) from chilled wax blocks.  Sections were floated at 45ºC ± 5ºC in a water 
bath (Lamb RA, model E/65) onto coated slides (Superfrost ® plus, BHD Laboratory 
Supplies, Poole, Dorset, UK) and stacked in a metal rack before being dried 
overnight in an oven at 55ºC (Lamb RA, model E28.5). 
 
 
2.8. Tissue staining and Immunohistochemistry 
2.8.1. Immunohistochemistry for paraffin embedded tissue 
Slides were then dewaxed in xylene (5 min) and hydrated through graded alcohols at 
20 second intervals (absolute alcohol; absolute alcohol; 95% alcohol and 70% 
alcohol) and washed in water.   
 




2.8.2. Heat mediated antigen retrieval 
Antigen retrieval was carried out to recover epitopes that undergo changes during the 
fixation process.  Cross-linking of various unrelated proteins occurs and may result 
in a loss of immunoreactivity of the target antigen (Boenisch et al., 2001).  Antigen 
retrieval was achieved by pressure cooking in 0.01M Citrate buffer (pH 6.0), under 
pressure for 5 minutes followed by a 20 minute cooling period before being placed in 
water.   
 
2.8.3. Blocking non-specific sites 
Endogenous peroxidase activity, which would otherwise interfere with horseradish 
peroxidase amplification, was blocked with 3% (v/v) hydrogen peroxide in methanol 
(both BDH laboratory supplies) for 30 min at room temperature.  Slides were rinsed 
in tap water followed by 2 x 5 minute washes in Tris-buffered saline (TBS; 0.05M 
Tris-HCl, pH 7.4, 0.85% NaCl).   The slides were removed individually from the 
TBS wash and dried carefully around the tissue section using tissue paper 
 
This step was followed by an Avidin-Biotin block carried out according to the 
manufacturer’s protocol (Vector Laboratories, Peterborough, UK) which prevents 
non specific endogenous avidin/biotin signalling.  Avidin was added directly to the 
tissue section for an incubation period of 20 minutes, followed by 2 x 5 minute 
washes in TBS then incubated for a further 20 minutes with the Biotin. 
 
Non-specific binding of the secondary antibody was prevented by incubation with 
the appropriate non-immune block.  This consisted of a solution containing serum 
from the species in which the secondary antibody was raised diluted 1:4 in TBS 
containing 5% bovine serum albumin (BSA; Sigma).  Blocking serum was added to 
each section for 30 minutes during which slides were kept in a humidified chamber 
at room temperature.  
 
2.8.4. Primary antibodies 
The blocking buffer was removed by tapping the slides on tissue paper and replaced 
with the primary antibody diluted in the appropriate blocking serum.  The slides were 




incubated overnight in a humidified chamber at 4ºC.  Antibodies and the conditions 
used for each are shown in Table 2.9.  Negative controls were included in each run 
where the non-immune block was left on slides and no primary antibody was added.  
The slides were subsequently washed in TBS (2 x 5 min). 
 
Table 2.9: Primary antibodies used in immunohistochemisrty 
Antibody Species Source Dilution Retrieval 
DAZL Mouse Setotec 1:100 Citrate 
PCNA Rabbit Novocastra 1:1000 Citrate 
BrdU Mouse Roche Diagnostics 1:50 Citrate 
Pdcd4 Goat Santa Cruz 1: 100 Citrate 
Cleaved caspase 3 Rabbit Cell signalling 1:300 Citrate 
 
2.8.5. Secondary antibodies 
After the TBS washes, secondary biotinylated antibodies diluted 1:500 in the 
appropriate blocking serum were added to the sections and incubated for 30 minutes 
at room temperature (Table 2.10).  The secondary antibodies used were raised 
against the host species of the primary antibodies.   
 
Table 2.10: Summary of secondary antibodies used 
Host species Target species Source Dilution 
Goat biotynalated Rabbit Dako 1:500 
Goat Mouse Dako 1:500 
Rabbit Goat Dako 1:500 
 
2.8.6. Antigen detection and counterstaining 
Following washes in TBS (2x5 minutes), the biotinylated secondary antibody was 
linked to horseradish peroxidase (HRP) by a 30 minute incubation with avidin-
biotin-HRP complex (ABC-HRP; DAKO, High Wycombe, UK) diluted in Tris-HCl 
(pH 7.4) 1:1000.  This was followed by two 5 minute washes in TBS.   
 
2.8.7. DAB immunostaining 
Antibody localisation was determined by application of liquid diaminobenzidine 
(DAB) substrate chromogen system (DAKO, High Wycombe, UK) for 1-5 min until 




the brown positive staining in control sections was optimal; the colour reaction was 
stopped by immersion in water.  This brown staining is due to DAB being an 
electron donor that oxidises in the presence of peroxidase in order for a colour 
change to take place.  The successive stages of the immunohistochemical technique 












Figure 2.10: Principles of direct immunostaining showing the interaction between the biotynalated 
secondary antibody and the detection reaction using avidin-biotin  HRP and DAB. 
 
Harris’s haematoxylin (Section 2.12) was used to counterstain the tissue section, 
staining the cell nuclei blue.  Scotts tap (Section 2.12) water was used to develop the 
blue colour.  Slides were rinsed in tap water and subsequently dehydrated in graded 
alcohols and cleared in two 5 min washes of xylene.  Slides were then mounted with 
glass coverslips (VWR) using pertex (Cell Path).  Immunostained sections were 
photographed using a Provis AX70 microscope (Olympus Optical, London, UK) 
fitted with a digital camera (Canon DS6031; Canon Europe, Amsterdam).  Captured 
images were then transferred to a PC and compiled using Adobe Photoshop 7.0 









2.9.1. LH and FSH 
All blood sampling and radioimmunoassay were performed by Judy McNeilly.  After 
CO2 administration, blood was collected by cardiac puncture using a heparinized 
syringe from mice before cervical dislocation.  Blood samples were centrifuged at 
8000rpm for 10 minutes for plasma separation and the plasma stored at -20C until 
required for assay assessment.  The concentrations of plasma LH and FSH were 
measured by RIA using reagents supplied by the NIDDK with all samples for each 
hormone assayed repeated in duplicate.  The reference preparations used were rat LH 
RP-1 and rat FSH RP-3, and the minimum detectable concentrations were 0.2 and 1.2 
ng/ml for LH and FSH, respectively.   
 
 
2.10. BrdU injections dose  
Bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) is a synthetic analogue of 
thymidine commonly used in the detection of proliferating cells in living tissues.  
BrdU is incorporated into the newly synthesized DNA of replicating cells (during the 
S phase of the cell cycle), substituting thymidine during DNA replication.  Cells 
which have been undergoing proliferating can then be detected 
immunohistochemically (Section 2.8) using an antibody specific for BrdU.  Since 
BrdU can replace thymidine during DNA replication mutations can occur, therefore 
termination of the animals after injection is essential as there is a potential health 
hazard, although this is a rare event.  BrdU was administered at a dose of 
1mg/1ml=100ul via intraperitoneal injection physiological saline (0.9% NaCl, w/v). 
 
 
2.11. Statistical analysis 
Values are expressed as means ± SEM, and data were analysed using Student’s 
unpaired t-test or one-way ANOVA following Bonferroni post test using GraphPad 
Prism (version 5, GraphPad software Inc., San Diego, CA).  Chi-square (two-tailed) 
test was used to analyses data for survival vs. burst rate of follicles.  Only when there 




were statistically significant differences are these indicated by asterisks, * P<0.05, 
**P<0.01 and ***P<0.001. 
 
 
2.12. Commonly used solutions 
All chemicals were supplied by Sigma unless otherwise stated. 
1% electropheresis gel: 
   1g agarose 
   45ml H2O 
   (Microwave 5 minutes med/high) 
   5ml TBE  
   0.5μl safeview 
 
Acid alcohol:   70% ethanol 
   1% concentrated HCl 
 
Bounin’s solution: Picric acid can now only be bought by industry so Bounin’s 
solution is made by Triangle Biomedical Sciences Ltd, 
Lancashire, UK. 
 
4% NBF:  100ml 40% formaldehyde (BDH) 
   900ml Distilled Water  
   4g Sodium dihydrogen phosphate monohydrate (BDH) 
   6.5g Disodium hydrogen phosphate anhydrous (BDH) 
 
Citrate buffer : Citric acid 42.02g (monohydrate; Sigma) 
Distilled H2O 1900ml 
Add concentrated NaOH to pH 5.5 
Make up to 2L and pH to 6 
Use as 0.01M, diluting in distilled H2O 
 




Harris’s Haematoxylin:  
2.5g Haematoxylin (Triangle Biomedical Sciences)  
25ml absolute alcohol 
   50g aluminium potassium sulphate + 500ml distilled H2O 
   Combine both solutions and boil 
Add 1.25g Mercury oxide 
Cool solution in ice then filter 
Add 4ml glacial acetic acid/100ml Haematoxylin 
 
Scott’s Tap Water: Potassium chloride 10g 
   Magnesium sulphate 100g 
   Tap water 5L 
 
TBS:   Tris (Sigma) 60.5g 
   NaCl (Sigma) 87.6g 
   HCL (BDH) 300ml 
   Adjust to pH 7.4 using concentrated HCL 
 
RIPA:   (5X RIPA buffer)  
ml 5M NaCl 
25ml 1M Tris-HCl (pH 7.4) 
5ml 0.5M EDTA 
5g deoxycholate sodium 
0.5g SDS 
Protease inhibitor cocktail (Roche) was added to 1X RIPA at 
100µl/ml. 
 
SDS Gel Loading Buffer (Laemmli buffer):  
   62.5 mM Tris, pH6.8 
   2% SDS 
   1% B-mercaptoethanol 
   5-10% Glycerol 




   0.01% Bromophenol Blue 
4% Stacking Gel: 0.75ml Acrylamide 40%              
0.5ml 2% bis               
 1.25ml 1.25M Tris pH 6.8     
0.1ml SDS 10%          
7.65ml H20  
Polymerize with 100µl 10% APS and 25µl of Temed      
 
10% Running Gel: 2.5ml Acrylamide 40%                                  
   0.5ml 2% bis                         
   1ml 3.15M Tris, pH 8.8                
0.1ml SDS 10% 
4.42ml H20  
Polymerize with 50µl 10% APS and 5µl of Temed   
 
Electrophoresis buffer 10x (4°C): 
192ml 1M Glycine      
25ml 1M Tris base      
10ml SDS 10%          
Make up to 1000ml using dH2O   
 
Transfer buffer 1 (4°C):   
192ml 1M Glycine   
25ml 1M Tris base   
10ml SDS 10%       
200ml MeOH 
Make up to 1000ml using dH2O 
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Chapter 6: Ovarian role of putative DAZL target 
PDCD4  
6.1. Introduction 
The methods used in Chapter 5, whereby the DAZL consensus sequence (Venables 
et al., 2001) was employed to identify DAZL targets within the mouse genome had 
been previously exploited to identify potential DAZL candidates within the human 
genome (Ismail, MSc 2007).  Once again a high number of potential targets were 
identified and by process of elimination by ovarian specificity and potential function, 
the candidate gene identified and selected for further investigation was programmed 
cell death factor 4 (PDCD4).  PDCD4 was not originally identified in the mouse 
bioinformatics trawl, but on investigation into the expression of the consensus 
sequence within the mouse gene homologue it was revealed that a DAZL binding 
motif was located at the 3’mRNA of this potential target (Figure 6.1).  Furthermore, 
with the understanding that DAZL affects litter size by a mechanism unknown, a 
potential function for PDCD4 in programmed cell death within the developing 
follicle resulting in an increase in ovulation and decrease in atresia in the Het females 
led to further investigation of this potential target. 
 
 
Figure 6.1: Human and mouse PDCD4 mRNA sequences exposing potential DAZL binding motifs 
present within the 3’ UTR. 
 
PDCD4 is also known as MA3 (Shibahara et al., 1995), TIS (Onishi et al., 1998) 
197/15a (Azzoni et al., 1998) H731 (Cmarik et al., 1999) and DUG (Goke et al., 
2002) and was originally isolated as a gene activated in cells during apoptosis and 
commonly up-regulated upon induction of cell death (Shibahara et al., 1995).  
Furthermore, PDCD4 has been identified as a translation factor which to bind to 
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eIF4A (Goke et al., 2002; Yang et al., 2003; 2004), inhibiting protein translation and 
expression is strongly associated with a decline in tumour progression.  Latterly, 
PDCD4 has been briefly reported to be expressed abundantly in oocytes and in 
embryos through the two-cell stage (Jurisicova et al., 1998), but how and when it 
functions within the steroidogenically active ovary is unknown.  In addition it has 
been reported that PDCD4 deficient mice which express many detrimental 
phenotypic characteristics (spontaneous lymphomas, significantly reduced life span, 
altered oncogenesis and inflammation) also develop multi-organ cysts which 
involved the ovary in 50% of animals (Hilliard et al., 2006).  Furthermore, PDCD4 
expression has been shown to be down-regulated in ovarian tumors (Bonome et al., 
2005).  Interestingly, unilateral ovarian hyperplasia and cystic tumour formation are 
also characteristic features of the DAZL KO ovary (McNeilly et al., SRF 2008) 
which might suggest that the lack of DAZL may be linked to a decrease in 
expression of PDCD4 controlled apoptotic control hence tumour growth.  Thus, 
PDCD4 may be involved as a positive regulator in programmed cell death within the 
ovary or indeed as a functional component of the transcription mechanism involving 
DAZL and eIF4A.  These potential connections were the major motivating factors 
for the studies in this chapter and in order to investigate the possibility that PDCD4 
plays an active role associated with DAZL and in particular regulating programmed 
cell death, it was necessary to expand and clarify the understanding on PDCD4 
expression and localisation within the ovary.  These parameters were therefore 
investigated first and related to potential function, again recognising that the 
functional copy number of DAZL in the Het phenotype may be having interacting 
effects.   
 
During these investigations of the potential role of PDCD4 as a DAZL target it 
became apparent that this cell death associated protein was abundantly expressed 
within the developing ovary, and of particular interest, was the difference in nuclear 
to cytoplasmic localisation within the corpus luteum.  Further to these findings, 
induced follicle atresia, natural apoptosis associated with pro-oestrous, and 
interruption to pregnancy through the use of luteolytic mediators bromocriptine and 
cloprostenol were also investigated to determine potential functional roles of PDCD4 
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within the ovary.  Having an understanding of the cellular and molecular 
mechanisms that activate and execute programmed cell death in the female germ line 
has implications for therapeutic management as does understanding the importance 
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6.2. Materials and Methods 
6.2.1. Identification of PDCD4  
In brief, by the same in silico approached used in Chapter 5 (Section 5.2) the human 
genome was subjected to a BLAST search (NB: the initial BLAST search was 
performed by Dr Wail Ismail with all subsequent analysis and investigations 
performed by myself) using the different permutations of the DAZL binding motif 
(Venables et al., 2001) to identify potential putative RNA targets to which DAZL 
may bind and regulate mRNA expression.  As mentioned a potential DAZL binding 
site is located in the murine PDCD4 sequence, however investigation of the patterns 
of expression and elucidation of potential function were required.  To verify PDCD4 
expression within Wt and Het oocytes (d21) and Wt and Het ovarian tissues (d21 and 
d10 mice) specific oligonucleotide primer sets were designed for mouse PDCD4 and 
used to detect reverse transcription products by conventional PCR (Section 2.3.4).  In 
addition real-time light cycler SYBR green PCR was performed to detect differences 
in PDCD4 transcript number between the two genotypes (Section 2.4).  The protein 
expression of PDCD4 was detected using immunohistochemistry, performed using 
the standard protocol (Section 2.8).   
 
6.2.2. Role of PDCD4 in ovarian apoptosis 
To investigate the potential roles of PDCD4 as a putative DAZL target the genes, in 
additions to its recognised pro-apoptotic function, studies were designed using mice 
to observe natural atresia in follicles and corpora lutea, induced follicle atresia, and 
disrupted CL function through induced luteolysis.   
 
6.2.2.1.Natural ovarian apoptosis 
Pro-oestrus animals were used to investigate natural atresia associated with corpus 
luteum degeneration during the oestrous cycle, whereby old luteinized corpora lutea 
undergoing functional regression should be present.  Cycling adult virgin mice were 
smeared daily (Judy McNeilly) to determine the stage of the oestrous cycle. The 
sample vaginal smears were analysed under a microscope to determine the cytology 
of the cells present, hence determine cycle stage.  Animals were selected depending 
on the stage of cycle for ovarian collection and further analysis. 
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6.2.2.2.Induced apoptosis: modulation by FSH withdrawal 
In order to investigate apoptosis within developing follicles a regime was designed 
whereby folliculogenesis was induced by the administration of recombinant human 
FSH (rech FSH) to pre-pubertal mice (d21) followed by FSH withdrawal.  The 
withdrawal of FSH from the system was achieved by neutralising the exogenous rech 
FSH by treatment with a rabbit anti-human FSH antibody (M91: 100μl ip) and 
endogenous FSH secretion was also inhibited by treatment with ovine follicular fluid 
(oFF; 100μl ip: Crawford et al., 2004) as a source of inhibin (Figure 6.2).  The 
antibody against FSH should immuno-neutralise the circulating recombinant FSH 
whereas the oFF inhibits secretion of any endogenous FSH present through a direct 
action on the pituitary (Brown et al., 2001).  This regime of FSH stimulation 
followed by acute withdrawal was hypothesised to induce follicle atresia.  Four 
animals were used in each treatment group. 
 
 
FSH               FSH FSH BrdU Cull
10iu                10iu 10iu 5mg/kg
FSH              FSH FSH Ab oFF BrdU Cull
10iu               10iu 10iu 5mg/kg  
Group 2
-withdrawal
Day 1 Day 2
Group 1
-stimulation





Figure 6.2: Schematic summary of FSH treatment regime applied to d21 pre-pubertal mice to induced 
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6.2.2.3.Chemically induced luteolysis 
Luteolysis is the natural structural and functional degradation of the CL.  However it 
can be chemically induced by direct and indirect methods.  Bromocriptine and 
cloprostenol were selected as luteolytic agents to investigate cell death within the CL 
and in understanding their disruptive mechanism to induce cell death it may aid the 
identification of potential roles of PDCD4 protein within the ovary.  Bromocriptine is 
a chemical dopamine agonist which inhibits prolactin synthesis and secretion by 
directly binding to dopamine D2 receptors on the pituitary lactotrophs (Vance et al., 
1984).  A decrease in prolactin results in a reduction of progesterone and hence 
induces luteolysis within the CL of the pregnant rodent (Zetser et al., 2001).  
Cloprostenol is a functional analogue of prostaglandin F2α having a specific 
luteolytic action at the ovarian level.  It causes functional and morphological 
regression of the CL in ungulates, marmosets and rodents (Nancarrow et al., 1982; 
Summers et al., 1985; Torjesen and Aakvaag, 1986) followed by a return to oestrous 
and normal ovulation.  The functional hypothalamic-pituitary-ovarian axis and the 
disruptions caused by bromocriptine and cloprostenol are summarised in Figure 6.3. 
 
Female mice caged with a stud male were checked daily for the appearance of 
vaginal plugs indicating mating and potential conception.  On the seventh day of 
gestation the females were injected intra peritoneal (ip) with bromocriptine (4mg/kg; 
120μg/30g mouse, Sigma) (2-bromo-α-ergocrytine.methanesulfonate salt B2134-
25MG 095K1528) or with cloprosetenol ((Estrumate synthetic Prostaglandin 
Schering-Plough Animal Health) dose 5μg/mouse)).  Sixteen hours after the 
luteolytic treatments, the animals were given injections of BrdU, (5mg/kg ip) and 
subsequently the mice were euthanized after an additional two hours.  Body weight 
was recorded, blood was collected by cardiac puncture and the ovaries were removed 
and weighed.  The number of visible corpora lutea were counted, the condition of the 
uterus noted and the number of implantation sites were recorded.  Ovaries were fixed 
in NBF (Section 2.7), for subsequent analysis and blood collected for LH and FSH 
radioimmunoassay (Section 2.9, performed by Judy McNeilly). 














































Figure 6.3: Summary of hypothalamic-pituitary-ovarian interaction during the luteal phase: actions of 
bromocriptine and cloprostenol on prolactin function and luteolysis. 
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6.2.3. Analysis 
To assess the degree of induced atresia, whether natural, by FSH withdrawal or by 
inducement of luteolysis, ovaries from the different treatment groups were sectioned 
and immunostained for markers of proliferation (PCNA or BrdU (Section 2.8)) and 
the apoptotic marker cleaved caspase 3, in addition to PDCD4, the protein of interest.  
Observations were made on the relationship between PDCD4 localisation and 
expression compared to that of cleaved caspase 3 expression.  Visual analysis of 
cleaved caspase 3 expression was performed from the ovaries which had been 
subjected to FSH stimulation/withdrawal.  In addition mRNA expression of PDCD4 
and cleaved caspase 3 was analysed using SYBR green RT-PCR (Section 2.4.2).  
The number of corpora luteum were recorded in the induced luteloysis groups in 
addition to the appearance of the nuclear compared to cytoplasmic localised 
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6.3. Results 
6.3.1. PDCD4 as a potential DAZL target 
It is assumed that the functional copy number of DAZL would potentially determine 
the transcription levels of functional DAZL targets.  Therefore the expression of the 
recently identified putative target PDCD4 was firstly compared between the DAZL 
Wt and Het females.  PDCD4 mRNA expression levels were investigated in d21 
oocyte pools (localised DAZL expression) and d10 ovaries (uniform population of 
same stage oocytes) as previously used in Chapter 3.  The expression levels of 
PDCD4 were unchanged between the Wt and Het samples at both d21 (oocyte pools) 















Figure 6.4: Quantitative analysis of PDCD4 mRNA fold difference between Wt and Het in d21 
oocyte samples (n=5) and d10 ovaries (n=5).  Values are means ± SEM (Wt █ and Het █). 
 
6.3.2. Novel expression of PDCD4 in the mouse ovary  
Having confirmed that PDCD4 mRNA was present in the mouse ovary, and although 
no differences in mRNA expression were detected between the Wt and Het, we then 
established the pattern of PDCD4 protein expression within ovarian tissue using 
immunohistochemistry.  Initially d21 ovary, adult ovary with corpus luteum present, 
oviduct, DAZL KO d21 ovary and tumor samples from a DAZL KO ovary were 
analysed to enable a more informed interpretation of PDCD4 expression within the 
female reproductive tract.  Review of PDCD4 protein immunoexpression revealed 
positive cytoplasmic localisation within the oocytes of the d21 ovary, both in the 
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small primordial oocytes and oocytes within the larger pre/antral follicles (Figure 6.5 
A).  In addition PDCD4 was located to the granulosa cell cytoplasm, with light 
immunostaining present in the surrounding thecal layers (Figure 6.5 A).  PDCD4 
protein expression was additionally localised to the ovarian surface epithelium (OSE) 
surrounding the ovary where expression was strong (Figure 6.5 B) and to the 
steroidogenic cell of the corpus luteum (Figure 6.5 B).  Within the corpus luteum 
PDCD4 was expressed in both the cytoplasm and in the nucleus, which prompted 
further investigation (Section 6.3.4 and 6.3.5).  Furthermore, the oviduct epithelial 
cells intensely expressed PDCD4 protein (Figure 6.5 C) as did the OSE and cells 
within the KO ovary (Figure 6.5 D).  In the KO ovarian tumor and consistent with 
previous reports illuminating the decrease in PDCD4 expression associated with 
tumor progression, PDCD4 immunoexpression appeared reduced in the ovarian 
tumor sample (Figure 6.5 E).   
 
The observations of PDCD4 expression and the striking nuclear localization in cells 
within the CL compared to cytoplasmic expression in the granulosa cells of follicles 
suggested possible translocation of this protein with regards to its active function.  
These observations subsequently contributed to the series of investigations 
addressing natural and induced apoptotic functions within the ovary to identify 


















Figure 6.5: Immunoexpression of PCDC4 in representative sections of d21 ovary (A), adult ovary 
corpus luteum (B), oviduct (C), d21 DAZL KO ovary (D) and a tumor from a DAZL KO ovary.  
Scale bar represents 100µm. 
 
6.3.3. PDCD4 mRNA and protein expression during follicle apoptosis 
Evaluation of cell proliferation markers, PCNA and BrdU were investigated using 
immunohistochemistry after FSH stimulation or after FSH withdrawal of d21 
ovaries, to enable the detection of proliferating cells (Figure 6.6).  PCNA is a cell 
cycle protein which holds DNA polymerase delta to DNA with expression increasing 
during the G1-phase, peaking at the S-phase, and declining during the G2/M-phases 
of the cell cycle (Foley et al., 1993).  PCNA was detected within granulosa cells and 
stromal cells (Figure 6.6 A and B) of the two treatment groups.  As a result of the 
prolonged expression through the cell cycle no obvious differences were observed 
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between the two treatment groups, although cells did show different degrees of 
staining intensity which one would expect.  Furthermore, BrdU is present only the S 
phase of the cell cycle within which it is incorporated into newly synthesized DNA 
of replicating cells, substituting thymidine during replication.  In comparing the 
subsequent sections (Figure 6.6 C and 6.6 D), large atretic follicles have a substantial 
reduction in BrdU protein expression compared to the surrounding proliferating 
follicles.   
 
In comparison to these intrinsic proliferative markers, cleaved caspase 3 was used to 
identify apoptotic regions within the ovary and used as a comparative marker for the 
expression of the pro-apoptotic PDCD4.  An increase in cleaved caspase 3 
expression was notably observed after the FSH withdrawal treatment, clearly 
indicating follicle atresia (Figure 6.6 E).  Both an increase in pyknotic nuclei and an 
increase in cytoplasmic cell degradation was observed.  This increased cleaved 
caspase 3 expression was not observed in the FSH stimulation group (Figure 6.6 F).  
Interestingly even in the classified atretic follicles identified by the expression of 
cleaved caspase 3 and pyknotic nuclei, cell proliferation was also observed with 
reference to BrdU and PCNA positive immunoexpression, although expression of 
BrdU was reduced.  There was no identifiable difference in the localization or 
intensity of PDCD4 protein between the two FSH treatment groups.  If PDCD4 is 
acting as a pro-apoptotic factor in follicles one would presume either a decrease in 
expression at the onset of induced follicle atresia or a functional translocation to 
activate its activity within the apoptotic cell of the follicle. 
 
In order to further investigate the possibility that PDCD4 may play a role in ovarian 
apoptosis, ovaries from the d21 animals subjected to the FSH stimulation and 
withdrawal were additionally used to analyse cleaved caspase 3 and PDCD4 mRNA 
expression.  Interestingly the expression of cleaved caspase 3 was reduced after the 
FSH withdrawal treatment compared to FSH stimulation treatment, in contrast to the 
apparent increase in protein expression.  However, cleaved caspase 3 mRNA may 
have become degraded as a result of apoptosis despite protein remaining.  In support 
Chapter 6                                               Ovarian role of putative DAZL target PDCD4  
 158
of the absence of change in the expression of PDCD4 protein, no difference in 
PDCD4 mRNA expression was observed between the two treatment groups (Figure 
6.7), further suggesting that PDCD4 is not involved in induced follicle atresia 
regardless of its association as a pro-apoptotic factor. 
 
Figure 6.6: Immunoexpression of PCNA (A: FSH withdrawal and B: FSH stimulation), BrdU (C: 
FSH withdrawal and D: FSH stimulation), Cleaved caspase 3 (E: FSH withdrawal and F: FSH 
stimulation) and PCDC4 (G: FSH withdrawal and H: FSH stimulation).  Scale bar represents 100µm. 
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Figure 6.7: Quantitative analysis of cleaved caspase 3 and PDCD4 mRNA levels after FSH 
stimulated █ compared to FSH withdrawal █ treatment d21 ovaries (n=4).  Values are means ± SEM. 
 
6.3.4. PDCD4 protein expression during natural apoptosis 
In order to investigate a process of natural apoptosis within the ovary and in addition 
to the PDCD4 protein localisation identified within the CL, pro-estrous animals were 
screened again for the two proliferative markers PCNA and BrdU (Figure 6.8 A-D).  
Representative images from two different animals confirmed that there is extensive 
proliferation occurring in the pro-estrous ovary, with a reduced expression of PCNA 
within the corpora luteum and only a few BrdU positive cells.  Apoptotic follicles 
were observed within the pro-estrous ovaries, and as indicated by cleaved caspase 3 
protein expression, very few cells within the CL are apoptotic (Figure 6.8 E-F).  
Furthermore, the expression of PDCD4 notably changed within the CLs examined, 
ranging from light cytoplasmic expression with limited nuclear expression (Figure 
6.8 G) to more intensely expression and localised to the nucleus in the steroidogenic 
cells (Figure 6.8 H).  These differences observed in CL PDCD4 immunoexpression, 
visually correlated to the expression of cleaved caspase 3, whereby, when PDCD4 
was light with reduced nuclear expression a higher number of positive cleaved 
caspase 3 cells were present with the CL.  Conversely, when nuclear PDCD4 
expression was observed in the CL, little or no cleaved caspase 3 was identified. 





Figure 6.8: Representative photomicrographs depicting immunoexpression of proliferation markers 
PCNA (A and B), BrdU (C and D), apoptotic marker Cleaved caspase 3 (E and F) and protein under 
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6.3.5. PDCD4 protein expression in chemically induced luteolysis 
Exposure to bromocriptine and cloprostenol induced functional luteolysis and 
disruption of pregnancy compared to the non-treated pregnant controls.  Variation in 
the effects on the uterus, implantation sites and ovary were recorded (Table 6.1). 
 
Table 6.1: Ovarian and uterine observations of chemically induced luteolysis. 
Treatment Day of pregnancy Observation 
Bromocriptine 8 Uterus red and swollen 
 8 Very swollen 
 9 Swollen enlarged uterus 
 8 8 visible implantation sites 
   
Cloprostenol 6 10 visible implantation sites 
 6 6 visible implantation sites 
 7 11 visible implantation sites 
 8 White ovaries, implantations but not healthy 
 9 White ovaries, implantations but not healthy 
   
Control 8 11 visible implantation sites 
 7 9 visible implantation sites 
 8 12 visible implantation sites 
 
Changes in CLs were clearly visible in the different treatment groups when 
compared to the non-treated control, with the result that abnormally unorganized 
areas of cells were present.  The structural analysis of the CL suggest that upon 
chemically-induced luteolyis, CL degradation and structural regression is 
accompanied with an infiltration of epithelial type cells, which do not express 
PDCD4 protein (Figure 6.9 C, D and F).  The degree of abnormally organized cells 
and infiltration of epithelial type cells varied substantially.  It was clearly evident that 
the CL present in the non-treated pregnant controls (Figure 6.8 G and H) were more 
uniform in structure presenting with healthy round steroidogenic cells in contrast to 
the treated groups showing luteolyic changes in the CLs.  In addition the control 
animal showed a more overall cytoplasmic expression of PDCD4 in comparison to 
PDCD4 expression being nuclear and cytoplasmic in the treated animals.  
Furthermore, overall expression of PDCD4 was higher in the treated animals, thus 
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suggesting that the intensity and nuclear localization within the CL is linked to the 
morphological changes and structural regression as a result of disruption of prolactin 
function.  Although not shown there was very little cleaved caspase expression 
present in the CLs analysed from both the treatments inducing luteolysis, with the 
majoring of CLs remaining negative.  The highest proportion of caspase 3 expressing 
CL was from the bromocriptine treatment groups, suggesting that the actions of the 
two luteolytic factor are possibly inducing regression at a different rate.  Differences 
were also notable between the pregnant CLs and the pro-estrous CLs (Figure 6.9 A 
and B (pregnant) and G and H (pro-estrous)), with the pro-estrous CLs expressing a 
higher degree of nuclear expression compared to the mainly cytoplasmic expression 



























Figure 6.9: Representative photomicrographs depicting immunoexpression of PDCD4 in CLs of pro-
estrous animals (A and B), bromocriptine (C and D), cloprostenol (E and F) and the non-treated 
pregnant control (G and H).  Black arrows indicate representative areas with nuclear localization, red 
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The plasma levels of the gonadotrophins LH and FSH were measured after exposure 
to the luteolytic factor bromocriptine which disrupt prolactin secretion, and 
cloprostenol a PGF2α analogue which acts directly with the CL.  FSH levels were 
comparable to in all treatment groups.  However there was a reduction in LH after 
treatment with cloprostenol compared to LH levels observed in the control and 
bromocriptine animals, although due to the large variations observed in LH levels 













Figure 6.10: Changes in mean (±SEM) plasma concentrations of LH and FSH in non-treated pregnant 
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6.4. Discussion 
6.4.1. PDCD4 as a putative DAZL target 
This study is the first to identify PDCD4 not only as a potential DAZL mRNA target 
but additionally reports the temporal expression of PDCD4 within ovarian tissue.  
The initial identification of PDCD4 led to an extensive investigation in an attempt to 
elucidate probable PDCD4 functions within the ovary, with particular reference to 
the CL.  The identification of the DAZL consensus sequence within the mouse 
PDCD4 homologue suggests a potential role for this gene in DAZL-mediated 
regulation and control.  As previously investigated (Chapter 3 and 4), the functional 
copy number of DAZL is believed to be affecting the productivity of folliculogenesis 
and subsequently increasing the rate of ovulation and hence number of offspring in 
the Hets.  Comparison of PDCD4 mRNA between Wt and Het mice, no differences 
were detectable between PDCD4 mRNA levels in d21 oocytes or d10 ovaries were 
observed, suggesting the control mechanisms of the mRNA expression are not 
altered as a result of reduced functional copy of DAZL.  Although, it cannot be 
completely ruled out that PDCD4 is a functional target of DAZL until in vivo 
interactions are disproven.  This will require further optimisation of the 
immunoprecipitation technique (Chapter 4) for ovarian tissue in addition to 
investigating different approaches altogether to determine in vivo interactions. 
 
6.4.2. Potential ovarian function of PDCD4  
There are limited publications describing the expression of PDCD4 within the ovary.  
It has been detected within the oocyte and throughout blasotcyst development in the 
mouse, and the study states that its function is unknown although associated with 
apoptosis (Jurisicova et al., 1998).  Furthermore, from a microarray study comparing 
human ovarian tumours, PDCD4 mRNA expression was shown to be notably 
decreased.  Again elucidation of its function was not discussed (Bonome et al., 
2005).  However, this decrease in expression may be due to cellular transformation 
and progression of tumour growth rather than representative of a role for PDCD4 in 
ovarian function.  Therefore we report here for the first time the temporal expression 
of PDCD4 within the mouse ovary, in addition to suggesting potential involvement 
of this protein in functional luteolysis.  Evidence has been presented that PDCD4 is 
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detected at the mRNA and protein level in oocytes, which is supported by previous 
findings (Jurisicova et al., 1998), and additionally, protein has been localised to 
granulosa cells, the ovarian surface epithelium, oviduct epithelium and luteinised 
granulosa cells.  Due to this extensive expression of PDCD4 in the female 
reproductive tissue in addition to its host of roles in pro-apoptotic mechanisms 
(Shibahara et al., 1995), the likelihood of PDCD4 being a direct target of the oocyte 
specific DAZL remains low.  However PDCD4 may well play a significant role in 
the control and development of both the oocytes and surrounding ovarian structures.  
This chapter has highlighted that there are still many mechanisms within the ovary 
which remain unsolved and with regards to intra/extracellular control of CL during 
luteolysis the striking nuclear expression of PDCD4 cannot be overlooked.  To 
understand the possible ovarian function of PDCD4 an understanding in to its 
functional role elsewhere has been examined and discussed. 
 
6.4.3. Function of PDCD4 
PDCD4 was originally isolated in a search for genes that were activated as a result of 
apoptosis (Shibahara et al., 1995).  In addition work investigating species homology 
indicates that PDCD4 is highly conserved during evolution indicating its importance 
in biological function (Lankat-Buttgereit et al., 2004) and has been related to a 
variety of functions within different tissue and cell systems but how it actually works 
is still to be fully elucidated.  More recently, interests lies in the observation that 
PDCD4 has a tumor suppressor functioning by targeting and inhibiting translation 
and transformation.  It has been identified that translation initiation factor (eIF4A) is 
a major binding component of PDCD4 (Yang et al., 2003) and like the translation 
initiation factor 4G (eIF4G), PDCD4 can interact with the RNA helicase eIF4A via 
its component MA3 domains.  This competitive binding between PDCD4 and eIF4G 
results in an inhibition of translation by interfering with the assembly of the initiation 
complex consisting of the translation factors eIF4G, eIF4E and eIF4A (Goke et al., 
2002; Yang et al., 2003).  As a result, it seems that in the absence of PDCD4, eIF4A 
would be left unchecked to increase the amount of inefficiently translated mRNAs, 
thereby causing the cells to proliferate aberrantly leading to cancer (Jansen et al., 
2005).  It is important to note that this initiation complex has also been implicated in 
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the control of DAZL mediate transcription in Xenopus, whereby DAZL binds to Poly 
(A) binding proteins which are actively involved in the translation initiation complex 
(Gray et al., 2000; Collier et al., 2005). 
 
Studies performed in PDCD4 deficient mice support the role of PDCD4 as a 
suppressor of tumorgenesis in vivo and additionally indicate its involvement in 
inflammation initiation by selectively inhibiting protein translation in the immune 
system (Hilliard et al., 2006).  It has been shown in culture that the expression of 
PDCD4 is dramatically up-regulated in association with early event apoptosis as a 
result of serum starvation.  Furthermore, it has been suggested that PDCD4 may be 
involved in both the intrinsic and extrinsic pathways of apoptosis (Goke et al., 2002). 
 
Interestingly, unlike other documented translation factors that are constitutively 
expressed under physiological conditions, PDCD4 is normally expressed at low 
levels but is dramatically up-regulated under conditions that induce programmed cell 
death or transformation (Shibahara et al., 1995; Onishi et al., 1998; Goke et al., 
2002).  Therefore, the differences observed in PDCD4 immunoexpression at the time 
of functional luteolysis within the CL sequentially determine how much functional 
translation suppression is occurring regarding protein initiation and hence molecular 
function of PDCD4. 
 
In the present study PDCD4 was predominately localised to the cytoplasm of 
granulosa cells of both healthy and atretic follicles and oocytes, with the notable 
difference in cellular compartmentalisation observed in the CL, most probably as a 
result of stage of regression and luteinisation.  Thus, the differences observed further 
suggest that PDCD4 is an active molecular component within the CL, almost 
certainly associated with cell death.  In light of these findings and in support of the 
difference observed, PDCD4 has been reported to be localised to the cytoplasm 
(Yang et al., 2003) and to the nucleus (Schlichter et al., 2001a; b).  In a subsequent 
study PDCD4 protein was detected in the cytoplasm and/or in the nucleus, depending 
on the cells or their growth state (Yoshinaga et al., 1999).  Collectively these 
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observations suggest that in addition to the reported roles of PDCD4 in protein 
translation within the cytoplasm, PDCD4 may have an important functional role 
within the nucleus.  To clarify PDCD4 localisation, a further (Bohm et al., 2003) 
investigation revealed that PDCD4 can actually shuttle between the cytoplasm and 
nucleus, with nuclear location dominantly selected under normal growth conditions.  
In contrast to normal growth conditions, in serum depleted cells PDCD4 protein is 
located in the cytoplasm (Bohm et al., 2003).  These findings suggest that this 
transfer in localisation from the cytoplasm to the nucleus is responsible for active 
translation inhibition thereby initiating apoptosis.  In contradiction to this, it has been 
suggested that nuclear accumulation of PDCD4 occurs prior to apoptosis (Zhang et 
al., 2006).  More recently it has been identified that phosphorylation of PCDC4 by 
Akt is the cause of the nuclear translocation (Palamarchuk et al., 2005) and 
phosphorylation of PDCD4 in vitro and in vivo occurs in a P13K-dependent manner, 
causing nuclear translocation.  This action of phosphorlation inactivates PDCD4 in 
its function as an inhibitor of AP-1 mediated transcription.  Members of the TGFβ 
superfamily have also been implicated in PDCD4 regulation, with PDCD4 increasing 
after treatment of transfected PDCD4 Huh7 cells with transforming growth factor-β.  
This increase in PDCD4 not only coincided with the occurrence of apoptosis and 
caspase activation but was reversed by the transfection of Smad7 (a known 
antagonist of TGFβ1) suggesting that Smad7 protect cells from TGF β1 mediated 
apoptosis (Zhang et al., 2006).  Although somewhat under investigated, these studies 
suggest that PDCD4 may function in both the nucleus and the cytoplasm, with 
nuclear expression associated with normal growth and cytoplasmic expression 
associated with apoptosis.  Furthermore, translocation from the cytoplasm to the 
nucleus may be associated with inactivation of PDCD4 and initiation of eIF4G 
transcription. 
 
A coincidental common linkage has been formed between catenins and cadherins 
which have been identified both as putative DAZL targets as part of the 
bioinformatics trawl in Chapter 5, and to PDCD4.  It has been shown that 
knockdown of PDCD4 expression stimulates the translocation of β-catenin into the 
nuclei, which in turn activates β-cateninsol T cell factor (Tcf)-dependent 
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transcription, and AP-1 dependent transcription.  Thus, it has been suggested that 
PDCD4 regulates the expression of E-cadherin since both mRNA and protein levels 
of E-cadherin are decreased as a result of PDCD4 knock down.  Additionally E-
cadherin is a binding partner of β-catenin and therefore a decrease in E-cadherin 
expression resulted in an increase of cytoplasmic free β-catenin (Wang et al., 2007).  
Given that these two proteins, β-catenin and E-cadherin, are both potentially 
regulated by PDCD4 and catenin-1 and N-cadherin have been identified as putative 
targets of DAZL, communication between these groups of molecules may be linked 
and, although not by a directly functional interaction, may play important roles in 
translational control of interacting mechanisms. 
 
More recently novel findings have identified that suppression of PDCD4 expression 
is vital for the invasive activity of COX-2 mediated by PGE (2) and IL-8, and that 
PDCD4 increases TIMP-2 expression to inhibit breast cancer cell invasion (Nieves-
Alicea et al., 2008).  COX-2, TIMPs and PGE are all recognised as regulatory factors 
within the CL and most certainly play a dominant role in luteolysis (Bardin, 1970; 
Smith et al., 1999; Wiltbank and Ottobre, 2003).  It is well established that 
prostaglandins are involved in initiation of luteolysis in a number of species 
including rodents (Bardin, 1970; Smith et al., 1999; Wiltbank and Ottobre, 2003).  
With these data a plausible function for PDCD4 within the CL may be that increased 
expression associated with cytoplasmic localisation could increase TIMP 2 and 
hence aid structural regression of the CL.  This suggestion is supported by studies 
performed in rats where the expression of TIMP-2 mRNA in the regressing CL 
suggests an involvement in luteal demise (Simpson et al., 2001).   
 
The identification and molecular function of PDCD4 are recent discoveries and 
despite the documentation of potential roles the molecular function remains to be 
fully investigated, although some aspects of its function are beginning to emerge.  
The main functions remain to be associated with protein translation with PDCD4 and 
eIF4G having similar homolog thus being involved in translation suppression within 
the cytoplasmic compartment.  This localisation is enhanced as a direct result of 
serum starvation, inducing apoptosis, with nuclear representation associated with 
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normal growth.  All these documented mechanisms are transferable to the ovary, and 
in particular to the CL, where we observe an increase in cytoplasmic expression of 
PDCD4 as a result of removal of the luteolytic effects of prolactin.  This increase in 
PDCD4 cytoplasmic intensity is accompanied by an increase in nuclear expression 
and further augments the possibilities of multiple functions within different cellular 
compartments.  In addition to these findings it has also been shown that PDCD4 has 
intrinsic RNA binding properties although this has not been extensively investigated 
(Bohm et al., 2003).  We can suggest that cytoplasmic expression is aiding the pro-
apoptotic mechanisms of PDCD4 whereby protein translation is hindered allowing 
programmed cell death to occur.  Furthermore nuclear expression is exacerbating the 
signalling outcomes and could be contributing indirectly to the cell fate.  Even 
though this is the first study suggesting an active role of PDCD4 within the CL, the 
identity of RNA targets would additionally aid the clarification of the mechanistic 
properties of PDCD4.  In conclusion these speculative suggestions require functional 
confirmation, with the need to amalgamate all the potential associated systems to 
collate an overall theory of PDCD4 function and apply them to the ovarian 
requirements. 
 
6.4.4. PCNA v BrdU 
PCNA and BrdU were utilised in the current studies as markers of cell proliferation, 
and as comparative factors for PDCD4 immunoexpression.  In all studies, a large 
proportion of cells were actively labelled for PCNA compared to the BrdU.  It has 
been recognized that PCNA can be continuously expressed in cells that are not 
actively dividing possibly due to its long half-life (Morris and Mathews 1989; Scott 
et al., 1991).  PCNA has also been shown to be involved in DNA repair, which is not 
directly associated with proliferation (Celis and Madsen, 1986; Toschi and Bravo, 
1988; Shivji et al., 1992; Wood and Shivji, 1997), which could also have contributed 
to the fact that a high proportion of cells were PCNA labelled compared to BrdU. 
 
6.4.5. Apoptosis of the ovary 
In the ovary the critical decisions between cell survival and cell death involve 
extensive communication between groups of pro-apoptotic and pro-survival 
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molecules.  It is believed that this highly regulated coordination is entirely a quality 
control mechanism, supporting the viable oocyte with potential to ovulate and to 
eliminate those oocytes and follicles that become atretic.  It is well documented that 
programmed cell death plays an important role in the regulation of ovarian 
maintenance with controlled cell death present at numerous stages of oogenesis and 
folliculogenesis.  DAZL is undoubtedly essential for oocyte survival and by 
mechanisms not yet identified it may be contributing to the fate of the oocytes since, 
in the absence of DAZL, oocytes are lost after birth in mice.  DAZL therefore could 
possibly be linked to factors initiating cell survival, including possible interactions 
with PDCD4.  Thus we investigated the potential involvement of PDCD4 in ovarian 
apoptotic mechanisms, in both follicle atresia and luteolysis of the CL. 
 
Alternative treatment regimes were designed to initiate follicle atresia by FSH 
withdrawal and to initiate functional luteolysis by the administration of two known 
luteolytic agents, bromocriptine and cloprostenol.  FSH withdrawal undoubtedly 
induced follicle atresia in ovaries of d21 mice with extensive up-regulation of 
cleaved caspase 3 protein expression.  As a result of this onset of apoptosis, cleaved 
caspase 3 mRNA was reduced following FSH withdrawal suggesting functional 
transcription had ceased and cell death was occurring.  Even though PDCD4 has 
been targeted as a pro-apoptotic factor, induced upon apoptotic initiation, there was 
no difference in mRNA or protein expression in response to FSH withdrawal.  One 
suggestion is that although PDCD4 was present in the cytoplasm in the developing 
follicle it remains functionally quiescent at the onset of rapid withdrawal of FSH as 
alternative death mediated pathways are recruited.  Comparatively, follicle atresia is 
a quick and efficient process occurring rapidly within the ovary continuously 
whereas luteolysis is the gradual regression of the CL, which is both a functional and 
morphological process. 
 
From the visual analysis of pro-estrous ovaries and after luteolytic treatment, it can 
be concluded that CLs are present at different stages of progression and regression 
with luteolysis occurring at different rates.  PDCD4 phosphorylation (Palamarchuk et 
al., 2005) and hence translocation of functional protein to the nucleus may be 
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involved in the slow programmed cell death observed in the CL via shuttling 
between cytoplasm and nucleus.  PDCD4 protein expression was remarkably 
different between CLs in the same ovary possibly due to the stage of regression of 
each CL.  Not only did the intensity of cytoplasmic expression alter, nuclear 
expression was observed.  Taking in to account that both old CLs from previous 
cycles and new CLs from the current cycle are present in the pro-estrous ovaries and 
not supporting pregnancy with their progesterone secretion, nuclear localisation of 
PDCD4 was inversely correlated with the expression of cleaved caspase 3.  It 
became apparent that when PDCD4 was nuclear in the examined CL, cleaved 
caspase 3 expression was barely detectable.  However when there was an increase in 
cytoplasmic expression and reduced nuclear expression of PDCD4, suggesting an 
increase in translation inhibition, there was a marked expression of cleaved caspase 3 
cells within these regressing CLs.  These observations suggest that caspase 3 is 
functionally required for apoptosis to proceed normally during luteal regression but 
that enhancement of PDCD4 within the cytoplasm may aid the onset of cleaved 
caspase 3 expression with both contributing to luteolytic degradation (Carambula et 
al., 2002).  Extending this investigation into the inducement of functional and 
structural regression of the CL, by inducement of luteolysis, a similar pattern of 
PDCD4 and cleaved caspase 3 was observed.  Again it was notable that there was 
increased intensity of PDCD4 both nuclear and cytoplasmic staining upon 
inducement of luteolysis whether by bromocriptine or cloprostenol emphasising a 
potential functional role in programmed cell death within the CL.  As previously 
mentioned cleaved caspase 3 was only observed in CL in which there was a decrease 
in nuclear PDCD4 expression, and only in the CL from the bromocriptine and pro-
oestrous models.   
 
Finally, despite the original identification of PDCD4 mRNA as a potential target for 
DAZL mediated functions it has become evident that this novel transcription 
suppressor may be playing a significant role in luteolysis.  The abundant expression 
and localisation of PDCD4 in the CL may be key finding in regulating and 
facilitating events within the CL of the mature ovary.  One can now propose that 
there is a possible role for PDCD4 in programmed cell death associated with 
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structural CL regression.  The observed difference in PDCD4 localisation from high 
cytoplasmic expression and nuclear localisation may be associated with the caspase 
cascade induction.  In contrast, in follicles it has been shown that PDCD4 is probably 
not involved in cell death as no difference in protein or mRNA levels were detected 
as a result of natural or induced follicle atresia.  The mechanisms and control of 
PDCD4 now require further investigation to explore the possible mechanisms of this 
protein and to determine whether PDCD4 plays a substantial role in preventing and 
controlling cell proliferation by means of mediated control over programmed cell 
death.   
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Chapter 4: DAZL target identification  
4.1. Introduction 
Careful characterisation of DAZ homologous sequences in a variety of animal 
species has led to the identification and classification of the “DAZ” gene family.  
This group of genes consists of three members: BOULE, DAZ-like (DAZL) and 
DAZ (Cooke et al 1996; Eberhar et al., 1996; Carani et al., 1997; Houston et al., 
1998; Maegawa et al., 1999; Karashima et al., 2000; Xu et al., 2001).  Members of 
this family are considered critical for germ cell development and are believed to be 
master regulators in germline gene expression, although they exhibit variations in 
phenotypic outcome depending on species and sex (Zeng et al., 2007).  The human 
DAZ gene was originally isolated from the AZFc region on the long arm of the 
human Y chromosome which is often deleted in individuals who present with non-
obstructive azospermia or severe oligospermia (Reijo et al., 1995).  The biological 
function of this gene and its involvement in infertility remains unclear partly due to 
the absence of Y-link DAZ orthologues in mammals lower than the old world 
monkeys.  Unlike the human, the murine homologue is autosomal and situated on 
chromosome 17, with expression exclusive to the male and female gonad (Cooke et 
al., 1996). 
 
Attention has been given to the molecular interaction of DAZ proteins because of the 
presence of a highly conserved RNP-type RNA recognition motif, characteristic of 
DAZ proteins and indicative to RNA-protein interactions.  A role for the DAZ-
related proteins in translation regulation was first proposed by the identification of a 
genetic interaction in Drosophila between Boule and meiosis-specific CDC25 
homologue, Twine (Mains and Wasserman, 1999).  Furthermore, it has also been 
reported that DAZL can bind to the 5’UTR of CDC25c in vitro (Venables et al., 
2001).  In contradiction to these findings, CDC25a and not CDC25c and Tpx1 
mRNA were shown to specifically interact with a GST-DAZL fusion protein (Jiao et 
al, 2002).  In addition DAZL has also been shown to be associated with Pumilio2 
(Pum2) a potential translation repressor (Moore et al., 2003).  Subsequently, Sdad1 
was selected as a candidate mRNA to which both DAZL and the DAZL-interacting 
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protein Pum2 bound simultaneously (Fox et al., 2005).  Mouse DAZL additionally 
binds polyA+ RNA and has been shown to be associated with actively translating 
polyribosomes (Tsui et al., 2000), implying that DAZL may be functioning as an 
mRNA stabiliser and/or involved in translational regulation.  In addition, members of 
the DAZ family have been shown to act directly to stimulate translation of RNAs 
bound through the recruitment of 80S ribosomes via an interaction with poly(A)-
binding proteins (PABPs) (Collier et al., 2005).  DAZL has also been suggested to 
play a role in the transport of specific mRNAs as it forms a specific interaction with 
the dynein light chain component of the dynein–dynactin motor complex (Lee et al., 
2006).  It has been recognised that TSSK 1, 2 and 4 3’UTRs bind to mouse and 
human DAZL (Zeng et al., 2008).  TSSK genes are expressed almost exclusively to 
the mature testis and have been associated with regulatory event in spermatogenesis.   
 
In addition to these protein: RNA interactions, DAZ family proteins can interact with 
a number of other proteins, many of which are themselves RNA binding proteins and 
are capable of forming hetero- and homodimers with other DAZ family members.  
These associated proteins include DAZAP1, DAZAP2, hQK3, DZIP1, DZIP2, 
DZIP3, (Ruggiu and Cooke, 2000; Tsui et al., 2000a; Xu et al., 2001; Moore et al., 
2003, 2004; Urano et al., 2005; Lee et al., 2006).  The functional significance of 
many of these protein interactions and mRNA targets remains to be clarified in vivo, 
although it seems highly probable that interactions with different proteins and 
mRNAs will have significantly different biological outcomes.  
 
It is only recently that two studies have determined true in vivo DAZL mRNA 
targets, MVH and Sycp3, which were identified as co-immunoprecipitated to be 
directly associated with the endogenous DAZL protein (Reynolds et al. 2005; 2007).  
Firstly, MVH is a well recognised essential germ cell specific gene and it has been 
shown that germ cells of male DAZL KO mice (<d19 post partum) contain reduced 
levels of MVH protein, indicating that DAZL-mediated regulation of MVH 
translation is crucial for mammalian spermatogenesis.  However, female DAZL KO 
mice are completely lacking in ovarian germ cells postnatally.  Therefore germ cell 
specific MVH will be undetectable and it may be that completely different 
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mechanisms are in place between the two genders.  Sycp3 is also recognised to be 
essential for meiosis (Yuan et al., 2002), specifically for the formation of the 
synaptonemal complex lateral element.  In addition the Sycp3 knockout model 
displays a block in meiotic prophase which resembles the DAZL KO phenotype and 
in the DAZL KO male, Sycp3 protein expression is also reduced indicating that it 
may be regulated by DAZL.  Furthermore, the absence of Sycp3 in the female mouse 
promotes aneuploidy in oocytes by inducing defective meiotic chromosome 
segregation (Yuan et al., 2002), again showing similar characteristic phenotype to the 
DAZL KO. 
 
With reference to the KO DAZL model, whereby DAZL protein is absent, genuine in 
vivo DAZL targets would not be subjected to normal translational regulation.  As 
demonstrated in Chapter 3, the Het animals also appear to undergo alterations in 
translational regulation, accounted for by the reduced gene expression which 
theoretically reduces protein production and hence, subsequent RNA binding 
function.  In an attempt to identify targets one proposed suggestion was that a 
decrease in translation regulation due to DAZL function, could lead indirectly to a 
decrease in stability levels of target mRNAs (Jacobson and Peltz, 1996).  This would 
result in differences in transcript levels between KO, Het and Wt animals.  Hence the 
targets would have different mRNA expression levels, bearing in mind that not only 
is DAZL absent in the KO model, but so are the postnatal female germ cells. 
 
Attempts to identify a consensus binding sequence for murine DAZL have produced 
conflicting results (Venables et al., 2001; Jiao et al., 2002), almost certainly 
reflecting the differences in experimental approaches taken and the multitude and 
complexity of in vivo interactions.  The results from a study using a combined three-
hybrid and SELEX approach, suggests the general consensus binding sequence as 
(G/CUn)n (Venables et al., 2001).  Furthermore the results from a subsequent study 
which used recombinant GST-tagged DAZL in mouse testis extract, defined a 26 bp 
motif which was present in eight of the DAZL bound mRNAs (Jiao et al., 2002).  
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Despite the plethora of published DAZL mRNA targets and protein interactions, the 
function of DAZL still remains elusive.  As mentioned, it is unclear whether 
comparable mechanisms are functioning between the male and female germ cells, 
and with the difference in meiosis occurrence in germ cell development the 
likelihood of altered regulatory control mechanisms is highly probable.  Although 
target mRNAs have been identified, these results are biased to male spermatogenesis 
with limited data present from the female, now expanded by the studies in Chapter 3.  
In addition there are probably many targets yet to be determined.  Therefore, the 
main aim of the current study was to explore the biological functions of DAZL 
during oocyte development exploiting techniques used to identify true in vivo targets.  
In this way it was hoped to identify how DAZL is functioning within the ovary in 
vivo and to identify the potential mechanisms which are contributing to the Het 
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4.2. Materials and methods 
4.2.1. UV crosslinking immunoprecitpitation  
The Ultraviolet (UV) cross-linking and immunoprecipitation (CLIP) method exactly 
as described previously (Ule et al., 2003; Renolds et al., 2005; 2007) was used to 
identify mRNAs associated with DAZL protein in vivo (Figure 4.1).  Endogenous 
DAZL protein was immunoprecipitated from Wt and Het mouse oocytes, ovaries or 
testis homogenates and the co-purified RNA isolated.  Control immunoprecipitations 
were carried out using an anti-DAZL antibody in the presence of the peptide to 
which it was raised (negative control) or using testis tissue homogenate looking at 
the MVH gene expression (positive control) (Reynolds et al., 2005).  All work 
carried out on the DAZL mouse line required their genotypes to be known before any 
progression of experiments.  Genotyping for wild type, heterozygous and knock out 
animals was achieved by PCR (Section 2.5). 
 
4.2.2. Tissue preparation 
Large pools of Wt and Het mouse oocytes (500) were manually dissected from d21 
ovaries in Hanks Balanced Salt Solution (GIBCO) on ice before cross-linking three 
times with 4000 µJ of UV (CL-1000 Ultraviolet Crosslinker (UVP, Amlab)). The 
suspension was agitated thoroughly between each irradiation.  In addition, intact Wt 
and Het d10 ovaries were also used as they contain a greater number of small 
primary and primordial follicles expressing higher or more concentrated levels of 
DAZL protein (eight ovaries were grouped for each sample).  Testis from adult 
DAZL mice were used as a positive control, the testis was removed from its bursa 
and the seminiferous tubules teased apart to form a thin layer, thus exposing a large 
surface area prior to crosslinking.   
 
The direct irradiation from UV light forms covalent bonds between proteins and 
mRNA which are in direct contact (DAZL protein: mRNA target).  It is important to 
mention that the efficiency of this reaction is low but compensated for by the 
subsequent PCR reaction amplification in the final stages of this pulldown.  The 
covalent bond formation between the protein and mRNAs of interest allows the 
application of rigorous purification procedures therefore obtaining highly purified 
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complexes between the protein and the target mRNAs.  In addition cross-linking 




Following cross-linking the samples were centrifuged at 6000rpm for 2 minutes.  
Aliquots of supernatants were taken for Western blot analysis at each stage of the 
experiment to confirm pull-down of the correct protein, DAZL.  The formed pellet 
was resuspended in 1x PXL (1x PBS containing 0.1% SDS, 0.5% deoxycholate, 
0.5% NP-40) before being homogenised by a hand held rotary homogeniser (Sigma).  
The samples were then spun in a micro-centrifuge at 13000rpm for 10 minutes at 4ºC 
and a further sample of supernatant taken for Western analysis along with the pellet.  
Only the supernatant was used for the subsequent preclear steps.  For each 1 ml of 
supernatant (adapted accordingly) 1μl of RNaseguard (Ambion), 10μl of DNAse 1 
and 100μl Protein A sepharose (PAS) (vol:vol PXL and PAS-rinsed 2x) was added.  
The cocktail was then incubated for 1 hour at 4ºC on a rotary wheel to eliminate any 
endogenous IgGs which may interfere with the antibody.  Samples were then 
centrifuged at 4000rpm for 2 minutes at 4ºC.  The sample was subsequently split into 
two aliquots of approximately 500μl and immunoprecipitation of proteins was then 
carried out.  One aliquot was incubated with the purified monoclonal antibody to 
murine DAZL (D) or with the antibody in the presence of the peptide (P+D), to 
which it was raised, along with PAS beads (Table 4.1).  The samples were then 
incubated at 4ºC overnight on a rotary wheel. 
 
Table 4.1: Immunoprecipitation of tissue and DAZL antibody 
 
 D P+D 
Anti DAZL antibody 20µl 20µl 
PAS 50% 50µl 50µl 
6μg/ul peptide - 10µl 
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Following overnight incubation the samples were centrifuged at 4000rpm at 4°C for 
1 minute and the supernatant removed.  The PAS beads were washed 3x in 500μl ice 
cold 1xPXL, and 1x in 500μl of PK (PXL + 500mM NaCl) with each sample being 
centrifuge at 4000rpm at 4°C for 1 minute between each of the washes.  The beads 
were then treated with 100μl final volume of PK + 2.5μl Proteinase K (enzyme) 
(Ambion), and incubated for 20 minutes at 37°C.   
 
4.2.4. RNA isolation 
After incubation of the beads with PK and Proteinase K, 100μl of RNA phenol was 
added to the mix in a fume hood before being vortexed thoroughly for 2 minutes, 
followed by centrifugation at 13000 rpm for 5 minutes at room temperature.  80μl of 
the aqueous phase (top layer) was then removed and stored on ice.  100μl of RNase 
free H2O was then added to the solution, before being vortexed and spun at 13000 
rpm for 5 minutes.  80μl aqueous phase of this second extraction was then removed 
and added to the previously collected 80μl.  This 160μl RNA sample was kept on ice 
and 10µl Linear acrylamide (Ambion), 160μl EtOH and 160μl isopopanol were 
added and left to precipitate at -20°C (dry ice) for 10-30 minutes.  The RNA samples 
were then centrifuged at 13000 rpm for 30 minutes, washed with 75% EtOH and 
centrifuged again at 13000 rpm for 20 minutes, before being dried and resuspended 
in RNase free dH2O (20μl).  The RNA then underwent DNase treatment (Ambion) 
by adding 2μl 10x buffer and 1µl of DNase and incubated at 37°C for 20 minutes.  
After treatment, 2μl of inactivating reagent (supplied) was added and the sample 
agitated for two minutes. 
 
RNA was quantified using the Nanodrop (Section 2.3.3) before being reverse-
transcribed using a sensiscript cDNA kit (Qiagen) (Section 2.3.4), followed by PCR 
to determine relative levels of transcripts present (Section 2.3.6).  PCR primers were 
designed against the 3’ end of the target gene and a mock reverse transcription 
reaction was carried out in all cases as a control for contamination with genomic 
DNA.  Gene-specific primers for MVH were used as a positive control reaction 
(Table 4.2). 
 114
Chapter 4                                                                              DAZL target identification 
 
Table 4.2: Primer Sequence for 3’ end of MVH 


































Figure 4.1: Schematic summary diagram of the UV CLIP method, demonstrating 1) UV cross-linking 
of protein (indicated by padlock): mRNA interactions within the oocyte 2) PAS beads used to 
pulldown mRNA linked to DAZL protein which in turn absorbed by the DAZL antibody which is 
attached to the PAS, 3) Dissociation of protein: RNA complex from the Antibody and PAS and 4) 
RNA extraction and identification of target mRNAs.  
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4.2.5. Protein detection 
Western blot analysis was performed on sample extracts and tissues (Section 2.6).  
After incubation of immunoblots with primary and secondary antibodies (see 
individual results for concentrations) the blots were scanned using the Licor.  
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4.3. Results 
4.3.1. Immunoprecipitation of DAZL/mRNA complexes 
To determine the putative targets to which DAZL protein binds within the ovary 
coimmunoprecipitation was performed.  The technique (Reynolds et al., 2005; 2007) 
used had not been previously applied to ovarian tissue therefore initial investigations 
replicated the same immunopulldown protocol that detected MVH and SYCP3 
within the testis (Reynolds et al., 2005; 2007).  To increase the probability of 
extraction of mRNAs bound to DAZL protein, and because DAZL protein is 
concentrated within the oocyte cytoplasm, oocyte preparations were initially used.  
The in vivo target, MVH was also selected for initial attempts to identify DAZL 
interactions within the ovary since this was achieved from the testes (Reynolds et al., 
2005) and oocytes express easily detectable levels of MVH (Chapter 3).  The original 
proposal was to link the findings from the extensive bioinformatic in silico trawl 
(Chapter 5) using the putative DAZL binding motif (Venables et al., 2001) in 
conjunction with UV cross-linking immunoprecipitation to identify in vivo targets 
within the ovary.  Optimising, repeating and applying this technique to oocytes could 
determine whether DAZL binds the same targets as in the testis or whether it 
functions through different mechanisms. 
 
4.3.2. MVH detection in testis extracts 
Control experiments were initially performed whereby endogenous DAZL protein 
was immunoprecipitated from mouse testis homogenate and any co-purified RNA 
isolated.  Within experiment control immunoprecipitations were also carried out 
using the anti-DAZL antibody in the presence of the peptide to which it was raised 
(negative control).  The results from the control pull down verify the results of 
Reynolds et al. (2005), whereby MVH transcripts were detectable after the 










Figure 4.2:  Photomicrograph of PCR products separated on agarose gel electrophoresis 
demonstrating UV CLIP protocol worked in the testis detecting MVH.  Band in lane 1) testis positive 
control for MVH mRNA expression 2) CLIP result showing MVH mRNA was pulled down with 
DAZL antibody 3) MVH absent when blocking peptide was used with the antibody 4) RT –ve and 5) 
H2O blank. 
 
4.3.3. Immunopulldown with oocyte and ovary preparation 
Despite numerous attempts (oocyte n=4; ovary n=4) this technique proved to be 
unsuccessful with the oocyte preparations even when using an abundant supply of 
DAZL expressing oocytes from eight x d10 ovary preparations.  The initial sample 
preparation of oocytes presented spurious RNA results, with a peak detected at the 
wrong wavelength suggestive of either DNA or reagent contamination or possibly no 
RNA.  In addition other potential problems include, the fact that the oocyte pools 
collected were from larger follicles and from the immunohistochemistry (Figure 4.3) 
oocytes from d21 follicles did not show abundant in DAZL protein expression.  
When analysing DAZL protein expression in d10 ovaries, it was obvious that a more 
homogeneous population of positively stained oocyte were present.  It may be that 
DAZL protein is too low in the ovary and this immunoprecipitation method cannot 
be applied in the same way as that which worked for the testis.  Furthermore it may 
be that the DAZL antibody is not working efficiently in the pulldown with ovarian 
tissue, in contrast to the testis, and that the sensitivity of the technique is not 
compatible when using ovarian tissue.   
 
4.3.4. Specificity of DAZL antibody 
To assess the specificity of DAZL protein expression the commercially available 
monoclonal antibody from Abcam (Cambridge, UK) clone 311/A (original 
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N.Groome Ab clone 311/A) was used.  Immunohistochemistry was performed on the 
testis of an adult male mouse and ovaries from d10 and d21 female mice (Figure 
4.3).  Immunohistochemisty confirmed that DAZL is expressed at the protein level in 
germ cells of the testis (Figure 4.3(a)), the small primordial follicles of the d21 
(Figure 4.3 (b)) ovary and more abundantly in the small primordial follicle of the day 
10 ovary (Figure 4.3 (c)).  DAZL protein expression was present but reduced in the 




Figure 4.3: Photomicrograph of immunohistochemistry for DAZL protein staining in (a) adult mouse 
testis (b) mouse d21 ovary and (c) d10 mouse ovary.  Scale bar represents 50µm. 
 
4.3.5. Western Blot problems and material limitations 
Following the unsuccessful immunopulldown using d21 oocytes and d10 ovaries a 
decision was made to look at protein expression using western blot analysis of the 
pull-down washes.  This was done to verify that the antibody was functioning in 
detecting the correct protein, and checking at each stage of the procedure that the 
PAS and antibody were working in the correct binding complex.  As no protein was 
detected the results are not presented.  
 
After discussions with Nicola Reynolds (HGU, Edinburgh) a further decision was 
made that in order to obtain optimal results with the immunopulldown from ovarian 
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tissue, there had to be an abundance of DAZL protein in the initial tissue sample, to 
ensure a detectable outcome was achieved.  Therefore, the DAZL protein from the 
ovaries must be detectable on a western.  A selection of ovarian samples were used 
and as a result of the limited protein extracted from the samples, detection of the 
oocyte protein was limited on western blots (Figure 4.4).  Furthermore, the protein 
bands detected on the Western blot (Figure 4.4) did not coincide with the published 
molecular weight of DAZL, where the size ranges from 33-35kDa while the band 
detected on the Western blot was approximately 50kDa (beta-tubulin was the correct 
size at 50kDa).  One possible suggestion was that the DAZL antibody was detecting 
the DAZL protein as a heterodimer on the Western blot, with a list of potential 




Figure 4.4: Western immunoblot of DAZL protein expression (red) and beta tubulin (green) as a 
loading control.  Faint positive band present in Lane (1) oocyte (6μg) whereas (2) Het d21 ovary 
(10ug), (3) 2 x d10 Het ovary (10μg) and (4) 2 x d10Wt ovary (10μg) all have a strong positive DAZL 
protein bands consistent with beta tubulin protein expression.  The red arrow indicates the size of the 
“DAZL” protein detected. 
 
Table 4.3: Proteins which interact and form heteodimers with DAZL. 
Protein Size (kDa) Reference 





Tsui et al., 2000 
Pumilio2 140 Fox et al., 2002 
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No other bands were detected on the Western blot.  Thus to determine whether the 
band detected was indeed DAZL ovaries from KO mice were used since DAZL 
protein should not be produced due to the transgenic modification.  Different DAZL 
genotypes, in conjunction with male and female tissue, were used with the 
hypothesis that the KO animals would provide a negative result.  The results show 
(Figure 4.5) that all genotypes exhibit the protein band at 50kDa and with two 
protein bands detected only in the adult testis, the lower one being of the correct size, 






Figure 4.5: Westen Blot analysis of DAZL protein expression from tissue from (1-3) 2 x d6 female 
ovary (4-6) 2 x d6 testes male with 1 and 4 Wt, 2 and 3 Het and 3 and 6 KO and 7 adult female KO 
ovary and 8 adult testis Wt.  Arrow indicates DAZL protein band in lane 8 in the mouse testis.   
 
Further to the investigation, a screen of male and female tissues was performed and 
once again all tissues (Figure 4.6) produced a positive band at the 50kDa size with 
only testes having a detectable band at 33kDa in lane 14. 
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Figure 4.6: DAZL protein expression in male and female organs.  Western blot image of (1-6) d6 
male and (7-12) d6 female; lanes 1+7 adrenal, 2+8 spleen, 3+9 heart, 4+10 kidney, 5+11 lung, 6+12 
liver, 13) adult Wt ovary and 14) adult Wt testis.  Red arrow indicates positive band in the testis and 
the possible faint band present in the heart (3 and 9) of the male and female (20μg protein). 
 
DAZL protein has been previously detected in human fetal ovary and testis by 
Western analysis (Anderson et al., 2007) and the 50kDa band was not observed.  
Therefore, a fetal human testis sample was used as a comparison to attempt to 
identify the DAZL protein in the mouse ovary (Figure 4.7). 
 
 
Figure 4.7: Western Blot analysis of DAZL protein expression in (1) male mouse liver; (2) heart; (3) 
ovary; (4) human fetal testis; (5) mouse testis Wt and (6) mouse testis KO (20μg protein).  
 
Interestingly, a positive band of the correct size was detected in the heart and liver 
for DAZL when the protein concentration was increased, with a single band present 
in the human fetal testis of the correct size with only a slight 50kDa band when 
compared to the mouse tissue.  A strong positive band is present in the Wt testis 
along with a band of the correct size, only the 50kDa bands are present in the KO. 
 
To further elucidate the detectable bands at 50kDa all tissue samples were incubated 
with either secondary antibody only or IgG control to ablate any none specific 
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primary antibody interactions.  The findings illustrate that in the absence of the 
DAZL antibody the positive protein bands of the correct size of 33 kDa are absent 
but the protein bands detected at the higher molecular weight 50kDa are still present 
(Figure 4.8).  These results suggest that the bands present at 50kDa are non-specific 




Figure 4.8: Western Blot analysis of DAZL antibody verification.  DAZL protein expression in the 
presence of (a) primary antibody, (b) no primary but secondary (c) no primary but IgG mouse instead 
and secondary.  1) kidney 2) liver 3) testis at 20μg protein.  Red arrows indicates protein bands at 50 
kDa and 33kDa  
 
To further elucidate the problems associated with the secondary antibody, different 
secondary antibodies were used to eliminate the chance that this result is only 
specific to the Odyssey goat anti-mouse secondary (Figure 4.9).  The other secondary 
antibodies used are listed below: 
 
 
• Rockland IRDye 800 Conjugated Affinity purified anti mouse IgG (H+L) 
(goat) (Figure 4.9 a, d) 
• Molecular Probes Alexa Flur 680 goat anti mouse IgG (Figure 4.9 c, e) 
• Odyssey goat anti mouse 680 (1:5,000) (Figure 4.9 c, f) 
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Figure 4.9: Western blot analysis of different Secondary antibodies (on previous page).  Panels (a), 
(b) and (c) incubated with primary DAZL and secondary antibodies.  (d), (e) and (f) incubation with 
secondary antibody only.  Protein from lane 1) liver 2) heart 3) d10 testis 4) adult testis (20μg 
protein).  Red arrow represents DAZL protein 33kDa. 
 
The results confirm that the observed bands at 50kDa band are a secondary antibody 
binding artefact, as they are still present in the absence of the primary antibody 
(Figures 4.8 and 4.9).  The presence of the DAZL antibody is required to detect 
DAZL protein bands of correct size.  After the detection of not only DAZL protein in 
the mouse and human testis, antibody specific proteins were detected in the liver and 
heart samples.  A further tissue screen was performed using increasing protein 
concentrations of 20µg, 40µg, 60µg (Figure 4.10).  Two protein bands were present 
in the testis sample, one at approximately 30kDa and the more prominent band at 
33kDa.  This secondary band which was present in the testis sample corresponded to 
the protein band detected in the different tissue samples, the liver, kidney and heart 
but not the brain.  Increasing the protein concentration of the input sample increased 
the intensity of the detectable protein.   
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Figure 4.10: Western Blot analysis of mouse tissue for DAZL protein (33 KDa). 1) positive control 
testis, 2-4) liver 20ng/40ng/60ng; 5-7) kidney 20ng/40ng/60ng; 8-10) heart 20ng/40ng/60ng and 11-
13) brain 20ng/40ng/60ng protein.  Top red arrow indicates DAZL band 33kDa, lower red arrow 
indicated protein band detected in all tissues apart from brain, approximately 30kDa. 
 
4.3.6. Immunohistochemistry analysis of DAZL protein expression 
To further investigate the findings of the positive DAZL protein band present in the 
liver, kidney and heart in the Western analysis, immunohistochemistry using Wt and 
KO mouse tissue was performed (Figure 4.11).  Interestingly very specific 
heapatocyte cells which surround the blood vessels within the liver showed positive 
DAZL protein in both the Wt and KO tissue samples.  There was brown staining 
detected within the heart and kidney samples but due to the nature of these tissues 
and despite the negative controls being clear these results may be non-specific.  All 
negative controls and IgG controls (not shown) were negative.  These results suggest 
that the protein band detected in the western analysis and immunohistochemistry is 
not DAZL as it is present in the KO tissue samples.  However it does suggest that the 








Figure 4.11: Immunohistochemistry of KO and Wt liver, heart and kidney. Brown positive specific 
staining located around the blood vessels of the liver, in the muscle fibres of the heart and within the 
tubules of the kidney.  Insets are negative antibody controls (Scale bar represents 50µm). 
 
4.3.7. DAZL mRNA expression tissue screen 
The next step was to determine if mRNA was present within the tissue of interest 
which had shown DAZL protein expression by both Western and 
immunohistochemistry.  Results from the RT-PCR demonstrated that the mRNA 
transcripts for DAZL were greatest in the testis and ovary (Figure 4.12, lane 1 and 2).  
There was evidence of mRNA DAZL transcripts present in the screen of different 
mouse tissue and although not detectable at the same intensity as the ovary and testis 
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this screen provides subsequent evidence that there may be a similar protein to 




Figure 4.12: PCR photomicrograph of tissues expressing DAZL mRNA transcripts from d10 animals 
1) testis 2) ovary 3) heart 4) liver 5) spleen 6) kidney 7) lung 8) adrenal and from d21 animals 9) liver 
10) spleen 11) kidney and 12) lung. 
 
These findings of “DAZL” expression at the mRNA level by PCR analysis in 
addition to the protein detection by Western blot and immunohistochemistry require 
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4.4. Discussion  
The major aim of these investigations was to develop and optimise the UV CLIP 
methodologies used to identify testis DAZL targets in vivo, and apply them to the 
ovary.  After extensive trials using DAZL expressing oocytes and extending this to 
d10 ovaries which have a higher intensity of DAZL protein present in the oocytes of 
the primordial and primary follicles, and using MVH as a potential target mRNA it 
became apparent that the application of this technique to the ovary was problematic.  
Abundant DAZL protein is available from the male germ cells within the testis, 
whereas DAZL protein was undetectable by Western blot from oocyte and ovary 
samples.  One of the possible limiting factors in the CLIP analysis of the ovary was 
the availability of DAZL protein as replicate results were obtained by performing a 
testis positive control pulldown to identify MVH.  Furthermore, the previously 
identified targets were originally detected from a comparative microarray which 
identified fold difference in transcript expression between Wt and KO testis 
(Reynolds et al., 2005; 2007).  Of a number of potential targets MVH was selected 
for further investigation and latterly SYCP3, both of which have now been confirmed 
to bind in vivo with testis DAZL.  In particular the putative MVH target detected 
within the testis preparation may not be a target of DAZL within the ovary as there 
are difference in meiotic activity between male and female germ cells.  Meiosis of 
the germ cells begins in the fetal ovary but in the adult testes and it is possible that 
targets will vary between genders.  Therefore using MVH may only be of valuable as 
ensuring that the validity of the CLIP technique in the testis and MVH may not be a 
DAZL target interacting in oocyte.   
 
The investigation using Western blots into DAZL protein expression within the 
mouse ovary after failure of the CLIP, suggested that, DAZL protein was 
undetectable by Western analysis in the samples used, despite being detected by 
immunohistochemistry.  The results from this also directed further investigation into 
a higher molecular weight protein band detected by the DAZL.  After systematic 
investigations using different tissues, protein concentrations and primary and 
secondary antibodies, this higher molecular weight protein was shown to be an 
artefact of the secondary antibody binding to the membrane.   
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Furthermore, the investigation into DAZL protein expression identified a subsequent 
protein, possibly DAZL, or similar homologue or isoform in other tissues as well as 
the testis.  This protein was of similar size at approximately 30kDa as DAZL 33kDa 
but detected in the heart, liver and kidney of d6 and d21 Wt male and female 
samples.  To verify this, the peptide sequence to which the monoclonal antibody was 
raised was used to perform a BLAST sequence match search and the outcome of this 
confirmed that the antibody epitope does not match the portions of the DAZL gene 
which are removed as a result of the mutation process.  This supports the results from 
the immunostaining where there is no evidence of DAZL protein in the KO ovary, 
but this is not surprising as there are no oocytes present.  These results are 
contradictory and although DAZL should definitely not be present in the KO or other 
somatic tissue, protein and mRNA specific for DAZL or similar a protein sequence 
were detected by Western blot and PCR from KO tissue.   
 
Supporting the localised expression of DAZL to the germ cells within the gonads, it 
has been previously shown (Cooke et al., 1996) by RT-PCR that the DAZL gene 
expression is solely confined to the gonads of adult mouse and transcripts are not 
detected in any other tissues.  Studies using Xenopus have additionally demonstrated 
that by Western analysis, protein is only detected in the testis and ovary (Mita and 
Yamashita, 2000).  In the Medaka fish oDAZL was not detected in somatic tissue 
(Xu et al., 2007) by Northern blot analysis.  A further report showed that murine 
DAZL was not been detected in the brain, lung, spleen or kidney (Maiwald et al., 
1996).  However, in the human DAZL transcripts have been detected in the amniotic 
fluid (Stefanidis et al., 2007), and in the CL, with the concentration decreasing with 
advancing luteal phase (Pan et al., 2002).   
 
From the evidence above and from the results from the current studies the detection 
of “DAZL” protein in the KO or other tissue is not supported.  One can suggest that 
the protein detected in these tissues is not DAZL but a protein with a similar 
sequence to which can be recognised by the DAZL antibody, possibly a different 
isoform.  The identification of any such protein requires thorough investigation. 
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The KO phenotype has very different consequences for the male and females as does 
the heterozygous phenotypes due to the comparative variations present in germ cell 
development.  In the KO, germ cells can complete mitosis, and embark on functional 
differentiation but thereafter, in both sexes progression through meiotic prophase 
requires the DAZL protein (Saunders et al., 2003).  As previously mentioned the KO 
males have failure of spermatogenesis as germ cells are unable to complete the first 
meiotic prophase in the initial wave of spermatogenesis and subsequently germ cells 
decrease in number due to a block at the A-aligned to A1 transition, although it has 
been demonstrated that mitotically active germ cells can be present up to and 
including day 19 post partum.  The Het males do have germ cells present and are 
fertile, yet spermatogenesis is severely compromised.  There is evidence that sperm 
are highly defective and that the number of germ cells are reduced (Ruggiu et al., 
1997).  In the female the KO ovary does not contain any germ cells after birth, with 
the heterozygous presenting with enhanced fertility producing larger litters.  This 
phenomenon is discussed later in Chapter 7.   
 
So not only the lack of DAZL gene expression leads to the phenotypic differences 
but the loss of or reduction in its translation of target mRNAs may contribute to the 
phenotypes observed in DAZL KO and Het mice (Reynolds et al., 2005).  It is also 
highly possible that as specific translational requirements change throughout germ 
cell development, the components and functions of the DAZL associated complexes 
may also alter (Reynolds et al., 2007).   
 
This study was unsuccessful in establishing oocyte in vivo targets due to the 
limitations presented with using oocytes and ovarian tissue as the source of DAZL 
expressing germ cells.  Therefore, the natural substrates of DAZL remain undefined 
within the ovary using the current CLIP technique (Reynolds et al., 2005; 2007) 
which was successful in detecting in vivo DAZL mRNA targets within the testis.  
The one major problem is the difference in germ cell distribution between the male 
and female, with oocytes being deficient in providing adequate DAZL protein to 
subsequently detect bound mRNAs.  As previously mentioned the entire mechanism 
of control may well be different between male and female germ cells.  Therefore a 
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reassessment of the approach to identify DAZL targets in vivo within the oocyte is 
required.  One suggestion is to use a collection of fetal ovaries to increase to 
concentration of DAZL protein for the immunopull down although these oocytes will 
still be in germ cell nests and not assembled as primordial follicle, so again function 
may be different.  In addition performing an age specific comparative microarray 
analysis on oocyte gene expression in an attempt to identify transcripts may show 
alterations in their transcription in comparison with the KO genotype and may 
provide some answers.  Another problem arises when trying to identify how the 
target translation affects fertility of the Het females, considering how the oocyte may 
be pre-programmed or how functional activity may be altered, this has been 
investigated further in Chapter 3 with regards to the oocyte and Chapter 7 with 
regards to the follicle. 
 
This study has been extremely helpful in illuminating problems with CLIP which 
arose as a result of using tissue with low abundance and expression of the target 
protein.  Despite the failure to identify murine female DAZL mRNA targets it has 
transpired that DAZL or similar protein(s) may be present specifically within the 
liver.  It is more likely that the antibody is detecting a related or similar protein and 
this requires extensive follow up investigations.  In conclusion, to address the 
problems in the female germline associated with DAZL, highly complex studies are 
now required to target different developmental periods and stages of oocyte 
maturation and follicle formation to identify true in vivo targets of the DAZL 
proteins in the ovary.   
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Chapter 5: In silico identification of DAZL targets  
5.1. Introduction 
The presence of the RNA binding domain within the DAZL protein suggested its 
involvement in RNA metabolism, however the mRNAs to which the DAZL protein 
binds and functions within the oocyte remain to be elucidated.  Diverse approaches 
have been adapted previously and utilised to identify the mRNA species that are 
specifically bound to this germ cell specific protein.  In Chapter 3 a direct approach 
was used to elucidate potential oocyte affected genes by the heterozygous genotype 
and the results suggested that the overall function of the oocyte within the somatic 
cell complex is altered.  In addition in Chapter 4 studies attempted to apply the 
successful techniques used to determine in vivo DAZL targets in the male and utilise 
them to identify targets within the oocyte.  However this method gave inconclusive 
results and requires further optimisation but it did identify potential problems with 
the specificity of the DAZL protein and mRNA.  What is known so far regarding 
potential DAZL targets fails to clearly define the importance, function and 
mechanisms involved with DAZL protein expression in the oocyte, and as previously 
mentioned all but two studies fail to show any in vivo interactions (Reynolds et al., 
2005; 2007).  In addition there are two unrelated published binding consensus 
sequences (Venables et al., 2001; Jiao et al., 2002) which have individually identified 
a range of target mRNAs that are bound at both the 5’ and the 3’ ends, suggesting 
that there may be multiple functions and mechanisms of action of this protein.   
 
This chapter focuses on using a further approach, not previously utilised, to 
undertake the arduous task of identifying oocyte specific targets.  The  consensus 
sequences T2(G/C)T3-10(G/C)T2, which represents U rich regions of mRNA 
interspersed with G and C (Venables et al., 2001) was used in conjunction with an 
extensive bioinformatics in silico trawl of the mouse genome to identify DAZL 
mRNA transcripts.  The outcome of this approach was a shortlist of oocyte specific 
putative DAZL target mRNAs.   
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5.2. Materials and methods 
As a strategy to identify putative DAZL targets the National Centre for 
Biotechnology Information (NCBI) public database was used in conjunction with the 
32 permutations of the Venables et al., (2001) consensus sequence for DAZL.   
 
5.2.1. Sequence alignment 
Established in 1988 as a national resource for molecular biology information, NCBI 
creates public databases, conducts research in computational biology, develops 
software tools for analyzing genome data, and disseminates biomedical information.  
These resources aid the better understanding of molecular processes which affect 
human health and disease.  The consensus sequences were used to perform an in 
silico Basic Local Alignment Search Tool (BLAST) search 
(http://www.ncbi.nlm.nih.gov/BLAST/) (Figure 5.1).  BLAST finds regions of local 
similarity between sequences.  The program compares nucleotide or protein 
sequences to sequence databases and calculates the statistical significance of 
matches.  
 
Figure 5.1: Screen shot of the BLAST webpage 
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The identification of targets using this approach will not only be useful in potentially 
providing novel targets but also exploits the potential of the bioinformatics tools in 
recognising gene targets.  The initial trawl required systematically selecting and 
identifying the permutations of the DAZL consensus sequence within specific mouse 
mRNAs.  Using the BLAST software and selecting the database called “refseq_rna” 
which represents the mRNA sequences from NCBI Reference Sequence Project, and 
limiting the entrez query to Mus musculus short sequences with near or exact 
matches were identified.  From these criteria a number of hits were produced, with 
information for the first 100 sequences and nucleotide alignments only for the first 
50 sequences.  It was therefore decided to set the limitation criterion to the first 50 
sequences which were aligned and select these for further investigation.  Once gene 
sequences were detected and checked to determine that the orientation of the putative 
binding domain was 5’ to 3’, the target sequences were matched and expanded if 
appropriate bases lay in an adjoining sequence.  A data spread sheet was developed 
using Microsoft Excel to record the results from the initial in silico trawl. 
 
5.2.2. Expressed sequence tags (ESTs) 
An EST is a short transcribed nucleotide sub sequence intended to identify 
transcripts of genes.  The use and identification of ESTs are instrumental to 
biological research and with approximately 37 million ESTs now available in public 
databases (e.g. GenBank 7/2006).  The production of an EST occurs by a one-shot 
sequencing of a cloned mRNA (sequencing several hundred base pairs from an end 
of a cDNA clone taken from a cDNA library).  The outcome of the cloning results in 
relatively low quality fragments whose length is limited by current technology to 
approximately 500 to 800 nucleotides.  The sequence of nucleotides is 
complementary to mRNA and hence represents a proportion of the expressed gene 
(http://www.cambridge.org/catalogue/catalogue.asp?isbn=9780511166563&ss=exc). 
 
Hits from the BLAST search were firstly individually compared against the mouse 
EST libraries using Unigene (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD 
=search DB=unigene) (Table 5.1).  If ESTs had been identified to either the oocytes 
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or the unfertilised ovum tissue groupings, they were selected and analysed in a 
further refined database.   
 
Table 5.1: Mouse EST libraries  
Lib ID Library Name Sequences 
Oocyte 
Lib.18552  Eppig Hampl Solter fully-grown mouse oocyte 18790 
Lib.16177  NIH_MGC_256 4487 
Lib.16178  NIH_MGC_257 4263 
Unfertilised Ovum 
Lib.10029  NIA Mouse Unfertilized Egg cDNA Library (Long) 13201 
Lib.14142  NIA Mouse Unfertilized Egg cDNA Library (Long 1) 6443 
Lib.1389  Mouse unfertilized egg cDNA 3098 
Not Shown: 1 library having fewer than 1000 sequences 
 
Once all genes had been subjected to an EST library search, the next stage was to use 
publications of oocyte expressed genes to confirm that ESTs were within the oocyte 
active genome.  The two papers selected were chosen due to the extensive published 
lists of oocyte genes: 
 
Stanton J. L., Green D. P. (2001) A set of 840 mouse oocyte genes with well-
matched human homologues. Mol Hum Reprod 7, 521-543 
 
Hamatani T., Falco G., Carter M. G., Akutsu H., Stagg C. A., Sharov A. A., 
Dudekula D. B., VanBuren V., Ko M. S. (2004) Age-associated alteration of gene 
expression patterns in mouse oocytes. Hum Mol Genet 13, 2263-2278. 
 
 
These publications provided further reference points to make a shortlist of potential 
candidate targets not only containing the consensus sequence, but being recognised 
in the EST library and in addition allow classification of the identified genes into 
functional categories.   
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Furthermore, a selection of these potential targets were analysed to confirm 
expression within Wt and Het oocytes by RT-PCR analysis (Section 2.3) and then 
subjected to semi-quantitative SYBR green analysis (Section 2.4) to determine 
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5.3. Results 
5.3.1. Shortlist of candidate putative targets 
After careful application of selection criteria, from the 30,000 genes present in the 
mouse genome, 30 were shortlisted as not only having the consensus sequence but 
also being expressed within the oocyte.  Further criteria for selection were limited to 
the length of detected transcript (>24 nucleotides long) or the number of repeated 
potential binding sequences.  It is important to note that as a direct result of the 
application regions which expanded beyond the sequence of selection criteria 
potential targets may have been missed or overlooked. 
 
The results from this extensive in silico are represented in Table 5.2.  Results were 
sorted into functional groups and the genes highlighted in green are those with 
transcripts longer than 24 nucleotides.  Increasing transcript length may increase the 
probability of these being true in vivo targets. 
 
Although variations in the consensus sequence were applied to the in silico trawl, the 
intention was to detect regions which expanded beyond the sequence limitation.  
Once the original selected genes had been subjected to an EST search there were still 
too many to analyse.  Using the two papers reduced the number of genes further, and 
aided the classification of the selected genes.  Potential targets included genes 
associated with the cell cycle, cytoskeleton, membrane receptors, signalling and 





Table 5.2: Shortlist of in silico detected DAZL oocyte target mRNAs 
Results from EST and Stanton and Green, (2001)  
Reference and Function  Gene Name Abbreviation   Sequence 
Cell cycle 
ref|NM_007570.2| Mus musculus B-cell translocation gene 2 Btg2   16-T3CT6GT5 
ref|NM_145436.2| Mus musculus cell division cycle 27  Cdc27   15-T4CT6CT3 
ref|NM_011495.2| Mus musculus polo-like kinase 4 (Drosophila)  Plk4   15-T2GT3GT5GT2 
Cytoskeleton  
ref|NM_007615.3|  Mus musculus catenin (associated protein), delta 1  Ctnnd1   26-T7GT3GT3GT4GT5 10-T3GT3CT2 
ref|NM_008943.2|  Mus musculus presenilin 1  Psen1   24-T4GT4CT3G 
Secretory pathways, exocytosis, endocytosis ect 
ref|NM_007479.3| Mus musculus ADP-ribosylation factor 4  Arf4   10-T2GT4GT2 
Membrane receptors, ion channels ect 
NM_007664.2|  Mus musculus cadherin 2  Cdh2   19-T4CT5GT3GT3C 
ref|NM_001080814.1| Mus musculus FAT tumor suppressor homolog 3  Fat3   10-T3CT3CT2 10-T2CT4CT2 
ref|XM_885736.2| Mus musculus fat tumor suppressor homolog  Fath   22-T2GT4GT7CT5G 
ref|NM_008943.2|  Mus musculus presenilin 1  Psen1   24-T4GT4CT3G 
ref|NM_009194.2|  Mus musculus solute carrier family 12, member 2  Slc12a2   20-T6CT5CT7 
Structural nuclear proteins  
NM_010880.3| Mus musculus nucleolin  Ncl   26-GT7GT6GT3GT4GT 
NM_183392.2| Mus musculus nucleoporin 54  Nup54     
Phosphatases 
  138 
 
NM_011200.1| Mus musculus protein tyrosine phosphatase 4a1 Ptp4a1   11-GT2GT6G 
Protein degradation  
ref|NM_011192.3| Mus musculus proteaseome (prosome, macropain) 28, 3   Psme3   16-T5GT6CT2C 
ref|NM_198091.2|  Mus musculus ubiquitin specific peptidase 2 Usp2   23-T6CT4GT7CT2C 
Signalling pathways         
ref|NM_172695.2|  Mus musculus phospholipase A2, activating protein Plaa   14-T4GT5CT3 
ref|NM_009535.2| 
Mus musculus Yamaguchi sarcoma viral (v-yes) 
oncogene homolog 1  Yes1   14-T3GT5CT4 
RNA transcription 
NM_010613.2|  Mus musculus KH-type splicing regulatory protein Khsrp   67-TCTCT7CT10CT5CT6CT6CT5CT18 
ref|NM_145457.3| 
Mus musculus polyadenylate binding protein-interacting 




In paper but not identified as EST  
ref|NM_009829.3|  Mus musculus cyclin D2 Ccnd2   34-T4GT4GT9GT13C 
ref|NM_011992.2|  Mus musculus reticulocalbin 2 Rcn2   19-T5GT8GT4 
 
Results from EST and Hamatani et al., (2004)  
Cell communication 
NM_007664.2|   Mus musculus cadherin 2 Cdh2   19-T4CT5GT3GT3C 
Ubiquuitine proteasome pathway  
ref|NM_016786.3|  Mus musculus huntingtin interacting protein 2  Hip2   42-T2CT7GT6GT7GT7GT7G 
ref|NM_009174.3| Mus musculus seven in absentia 2 Siah2   20-T5GT2GT5GT5 




Mitotic cell division, microtubule cytoskeleton, ATP-binding  
ref|NM_001081453.1| Mus musculus ninein, transcript variant 1 Nin   17-T5CT5CT4C 
Guanyl nucleotide binding, cell signaling  
ref|NM_001081105.1| Mus musculus ras homolog gene family, member H Rhoh   24-T4CT9CT9 
Chromosome organization and biogenesis, ATP-binding 
ref|NM_172937.3| 
Mus musculus SNF2 histone linker PHD RING helicase, 
transcript variant 2 Shprh   14-T3CT4CT2CT2 
Regulation of transcription  
ref|NM_001080132.1|  Mus musculus thymopoietin, transcript variant 2 Tmpo   14-T5GT3GT4 
 
Not positive for EST  
ref|NM_194268.2| Mus musculus one cut domain, family member 2  Onecut2   13-T4CT4GT3 
NM_177386.3| Mus musculus Scm-like with four mbt domains 2 Sfmbt2   52-GT6GT3GT6[GT4]4GT7GT3GT 
ref|NM_011462.2|  Mus musculus spindlin , transcript variant 1 Spin1  28-T2GT10CT14 
    
Similar between paper and positive EST Hit Paper   
ref|NM_007479.3| Mus musculus ADP-ribosylation factor 4 Arf4 Arf1 10-T2GT4GT2 
ref|NM_019835.2|  
Mus musculus UDP-Gal:betaGlcNAc beta 1,4-
galactosyltransferase, polypeptide 5  B4galt5 B4galt6 29-T2GT6CT2GTGT4GT2CT5G 
ref|NM_033370.3| Mus musculus coatomer protein complex, beta 1  Copb1 Copb2 11-T3CT3GT2C 
ref|NM_145457.3| 
Mus musculus polyadenylate binding protein-interacting 
protein 1 transcript variant 1 Paip1 Paip2 13-T2GT3GT3GT2 
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5.3.2. PCR analysis of selected targets 
From the shortlist of potential oocyte DAZL target mRNAs four genes were further 
selected for subsequent analysis comparing Wt and Het oocytes to determine if 
functional gene number is affecting target mRNAs.  The four genes selected for 
further analysis were Cdh2, Ctnnd1, Khsrp and Paip.  The justification for this gene 
selection relates to their potential function within the oocyte which may lead to the 
observed differenced noted between the Wt and Het litter sizes.  In particular 
Cadherins (Cdh2) and catenins (Ctnnd1) have been are associated with cellular 
communication, forming junctions between cells and are essential for cell 
proliferation all possible mechanisms which may be targeted and contribute to the 
differences between Wt and Het phenotype (Stockinger et al., 2001).  Furthermore 
Khsrp was selected due to the presence of an extensive DAZl binding region 
increasing the probability of it being a potential target and Paip which is a Poly A 
binding proteins, which in turn have been previously shown to be associated with 
DAZL proteins (Gray et al., 2000). All four selected genes were present in mRNA 
from d10 and d21 Wt and Het ovaries in addition to oocyte pools (Figure 5.2).  
However they were also present in the KO ovary, suggesting that although these 
genes have been shown to be expressed in the oocyte, they are not oocyte specific.   
 
 
Figure 5.2: PCR screen of selected target genes within the developing ovary d21 (1) Wt and (2) Het, 
d10 (3) Wt and (4) Het and oocyte pools (5) Wt and (6) Het and (7) d21 KO ovary was also used.  Rt-
ve (8) control and (9) water control. 
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Following the initial RT-PCR analysis these genes of interest were subjected to real- 
time quantitative PCR (Figure 5.4).  As a consequence of the low expression of Paip 
transcripts the results from the real time PCR could not be quantified as the detection 
range was beyond that of the threshold levels.  Wt and Het d21 oocyte pools were 
used to determine if the expression of two functional copies (Wt) compared to one 
functional copy (Het) had any effect in an attempt to identify oocyte DAZL targets.  
Results from the real-time quantitative PCR demonstrated that Cdh2 and Ctnnd1 
mRNA expression was not significantly different between the two genotypes.  Khsrp 
mRNA expression was significantly (P<0.05) up-regulated in the Het compared to 





















Figure 5.3: mRNA expression of Cdh2, Ctnnd1 and Khsrp putative DAZL targets.  No difference in 
expression was observed between the Wt and Het for Cdh2 and Ctnnd2, significant difference in 
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5.4. Discussion 
Identifying RNA targets of known RNA-binding proteins has proven more 
challenging than identifying proteins that bind to known RNAs and this is also true 
for identifying DAZL targets (Venables et al., 2001).  A complementary approach 
has been utilised within this chapter to identify RNA targets of mouse oocyte DAZL 
in order to gain insight into its mode(s) of action.  As repeatedly mentioned not only 
is DAZL essential for oogenesis, the phenomenon observed in the Hets also needs to 
be addressed, whereby fertility is augmented.  One hypothesis is that whichever 
RNAs are regulated by DAZL are in turn responsible or partly responsible for the 
increase in fertility observed in the Het mice in which only a single functional copy 
of DAZL is present. 
 
The main focus of this current chapter was to use an alternative Bioinformatics 
approach, which can be described as “the application of computational methods to 
biological problems”, with our biological problem being the identification of DAZL 
targets.  Furthermore, bioinformatics is a widely applied interdisciplinary research 
tool which uses the sequence, structure and functions of genes and genomes along 
with the corresponding products and uses the available technology for storage, 
retrieval, manipulation and distribution.  In the current investigations we have 
identified and employed the use of the pre-published consensus sequence (Venables 
et al., 2002) and NCBI software to identify in silico DAZL targets.  It is important to 
note that bioinformatic predictions are not formal proof of biological concepts or 
functions, and, although complimenting experimental biology they do not replace 
traditional experimental research methods for testing functional biological 
hypotheses (Kaminski, 2000; Goodman, 2002).  
 
From the bioinformatic methodologies used in this current chapter, the potential 
target Khsrp was identified as having an extensive length of DAZL consensus 
sequence, in addition to being identified in oocyte EST libraries and in the papers of 
interest.  Furthermore, Khsrp did show a significant increase in transcript expression 
in Het oocyte samples compared to that of the Wt.  Khsrp itself has KH domains 
which directly mediate RNA binding, mRNA decay and interactions with the 
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exosome and poly (A) ribonuclease (Gherzi et al., 2004), all function which are 
applicable to the oocyte.  It can now be proposed that in addition to the published 
targets and suggested functions DAZL may be involved in binding complexes with 
Khsrp and subsequently involved in mRNA decay.  With the unsuccessful attempt in 
apply the UV CLIP method (Chapter 4), we are unable to confirm in vivo interactions 
of selected mRNA targets and subsequent approaches may now need to be addressed. 
 
Two additional candidate target genes were selected and analysed using real-time 
PCR, cadherin-2 (Cdh2) and catenin-1 (Ctnnd1).  Both genes were identified to be 
expressing the consensus sequence but no significant difference in mRNA expression 
was identified between the two genotypes.  Cadherin-2 also known as N-cadherin is 
associated with catenins and involved in cell to cell communication.  Interestingly 
these complexes have many functions associated with cell adhesion and migration 
and blood vessel morphogenesis all of which may be applied to the oocyte and 
granulosa cells.  Furthermore, N-cadherin can be cleaved by presenilin-1 
(Marambaud et al., 2003) which also has the DAZL consensus sequence although 
this was not investigated further.  These two associated genes of interest cannot be 
totally ruled out as DAZL targets in spite of there being no alteration in expression 
between the Wt and Het, but once again any interactions have to be confirmed in 
vivo.  
 
One systematic problem with the application of bioinformatics in an attempt to 
identify individual candidate targets was a substantial number of genes exhibited the 
selected consensus sequence.  In addition, the selection criteria used may have 
limited and masked true oocyte DAZL targets or it is possibly that the specificity of 
the consensuses sequence used (Venables et al., 2001) is too ambiguous to be applied 
in this way.  Therefore, bioinformatics should not be used alone and should only be 
used to aid biological experimentation or at least provide guidance in the right 
direction.  It may be that the alternative sequence (Jiao et al., 2002) may provide 
additional DAZL targets, but once again until in vivo techniques have been 
established in the oocyte any potential targets cannot be confirmed.    
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To this end we have shown the promise of using an in silico bioinformatics approach 
to reveal potential mRNAs which may bind to DAZL as a result of the presence of 
consensus target sequence.  EST libraries in conjunction with published oocyte genes 
have been used to facilitate the further selection of potential targets.  Until now no 
direct targets have been determined in vivo for DAZL function within the oocyte.  It 
would now be ideal if the techniques applied in Chapter 4 could be utilised in 
conjunction with the results from this chapter to confirm the possible interactions 
between DAZL and these identified oocyte target genes. Many more DAZL mRNA 
target candidates could have been selected for further analysis, and these now require 
the application of functional methodologies that can be applied biologically to verify 
direct interactions and functional outcomes.  
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Chapter 6: Ovarian role of putative DAZL target 
PDCD4  
6.1. Introduction 
The methods used in Chapter 5, whereby the DAZL consensus sequence (Venables 
et al., 2001) was employed to identify DAZL targets within the mouse genome had 
been previously exploited to identify potential DAZL candidates within the human 
genome (Ismail, MSc 2007).  Once again a high number of potential targets were 
identified and by process of elimination by ovarian specificity and potential function, 
the candidate gene identified and selected for further investigation was programmed 
cell death factor 4 (PDCD4).  PDCD4 was not originally identified in the mouse 
bioinformatics trawl, but on investigation into the expression of the consensus 
sequence within the mouse gene homologue it was revealed that a DAZL binding 
motif was located at the 3’mRNA of this potential target (Figure 6.1).  Furthermore, 
with the understanding that DAZL affects litter size by a mechanism unknown, a 
potential function for PDCD4 in programmed cell death within the developing 
follicle resulting in an increase in ovulation and decrease in atresia in the Het females 
led to further investigation of this potential target. 
 
 
Figure 6.1: Human and mouse PDCD4 mRNA sequences exposing potential DAZL binding motifs 
present within the 3’ UTR. 
 
PDCD4 is also known as MA3 (Shibahara et al., 1995), TIS (Onishi et al., 1998) 
197/15a (Azzoni et al., 1998) H731 (Cmarik et al., 1999) and DUG (Goke et al., 
2002) and was originally isolated as a gene activated in cells during apoptosis and 
commonly up-regulated upon induction of cell death (Shibahara et al., 1995).  
Furthermore, PDCD4 has been identified as a translation factor which to bind to 
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eIF4A (Goke et al., 2002; Yang et al., 2003; 2004), inhibiting protein translation and 
expression is strongly associated with a decline in tumour progression.  Latterly, 
PDCD4 has been briefly reported to be expressed abundantly in oocytes and in 
embryos through the two-cell stage (Jurisicova et al., 1998), but how and when it 
functions within the steroidogenically active ovary is unknown.  In addition it has 
been reported that PDCD4 deficient mice which express many detrimental 
phenotypic characteristics (spontaneous lymphomas, significantly reduced life span, 
altered oncogenesis and inflammation) also develop multi-organ cysts which 
involved the ovary in 50% of animals (Hilliard et al., 2006).  Furthermore, PDCD4 
expression has been shown to be down-regulated in ovarian tumors (Bonome et al., 
2005).  Interestingly, unilateral ovarian hyperplasia and cystic tumour formation are 
also characteristic features of the DAZL KO ovary (McNeilly et al., SRF 2008) 
which might suggest that the lack of DAZL may be linked to a decrease in 
expression of PDCD4 controlled apoptotic control hence tumour growth.  Thus, 
PDCD4 may be involved as a positive regulator in programmed cell death within the 
ovary or indeed as a functional component of the transcription mechanism involving 
DAZL and eIF4A.  These potential connections were the major motivating factors 
for the studies in this chapter and in order to investigate the possibility that PDCD4 
plays an active role associated with DAZL and in particular regulating programmed 
cell death, it was necessary to expand and clarify the understanding on PDCD4 
expression and localisation within the ovary.  These parameters were therefore 
investigated first and related to potential function, again recognising that the 
functional copy number of DAZL in the Het phenotype may be having interacting 
effects.   
 
During these investigations of the potential role of PDCD4 as a DAZL target it 
became apparent that this cell death associated protein was abundantly expressed 
within the developing ovary, and of particular interest, was the difference in nuclear 
to cytoplasmic localisation within the corpus luteum.  Further to these findings, 
induced follicle atresia, natural apoptosis associated with pro-oestrous, and 
interruption to pregnancy through the use of luteolytic mediators bromocriptine and 
cloprostenol were also investigated to determine potential functional roles of PDCD4 
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within the ovary.  Having an understanding of the cellular and molecular 
mechanisms that activate and execute programmed cell death in the female germ line 
has implications for therapeutic management as does understanding the importance 
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6.2. Materials and Methods 
6.2.1. Identification of PDCD4  
In brief, by the same in silico approached used in Chapter 5 (Section 5.2) the human 
genome was subjected to a BLAST search (NB: the initial BLAST search was 
performed by Dr Wail Ismail with all subsequent analysis and investigations 
performed by myself) using the different permutations of the DAZL binding motif 
(Venables et al., 2001) to identify potential putative RNA targets to which DAZL 
may bind and regulate mRNA expression.  As mentioned a potential DAZL binding 
site is located in the murine PDCD4 sequence, however investigation of the patterns 
of expression and elucidation of potential function were required.  To verify PDCD4 
expression within Wt and Het oocytes (d21) and Wt and Het ovarian tissues (d21 and 
d10 mice) specific oligonucleotide primer sets were designed for mouse PDCD4 and 
used to detect reverse transcription products by conventional PCR (Section 2.3.4).  In 
addition real-time light cycler SYBR green PCR was performed to detect differences 
in PDCD4 transcript number between the two genotypes (Section 2.4).  The protein 
expression of PDCD4 was detected using immunohistochemistry, performed using 
the standard protocol (Section 2.8).   
 
6.2.2. Role of PDCD4 in ovarian apoptosis 
To investigate the potential roles of PDCD4 as a putative DAZL target the genes, in 
additions to its recognised pro-apoptotic function, studies were designed using mice 
to observe natural atresia in follicles and corpora lutea, induced follicle atresia, and 
disrupted CL function through induced luteolysis.   
 
6.2.2.1.Natural ovarian apoptosis 
Pro-oestrus animals were used to investigate natural atresia associated with corpus 
luteum degeneration during the oestrous cycle, whereby old luteinized corpora lutea 
undergoing functional regression should be present.  Cycling adult virgin mice were 
smeared daily (Judy McNeilly) to determine the stage of the oestrous cycle. The 
sample vaginal smears were analysed under a microscope to determine the cytology 
of the cells present, hence determine cycle stage.  Animals were selected depending 
on the stage of cycle for ovarian collection and further analysis. 
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6.2.2.2.Induced apoptosis: modulation by FSH withdrawal 
In order to investigate apoptosis within developing follicles a regime was designed 
whereby folliculogenesis was induced by the administration of recombinant human 
FSH (rech FSH) to pre-pubertal mice (d21) followed by FSH withdrawal.  The 
withdrawal of FSH from the system was achieved by neutralising the exogenous rech 
FSH by treatment with a rabbit anti-human FSH antibody (M91: 100μl ip) and 
endogenous FSH secretion was also inhibited by treatment with ovine follicular fluid 
(oFF; 100μl ip: Crawford et al., 2004) as a source of inhibin (Figure 6.2).  The 
antibody against FSH should immuno-neutralise the circulating recombinant FSH 
whereas the oFF inhibits secretion of any endogenous FSH present through a direct 
action on the pituitary (Brown et al., 2001).  This regime of FSH stimulation 
followed by acute withdrawal was hypothesised to induce follicle atresia.  Four 
animals were used in each treatment group. 
 
 
FSH               FSH FSH BrdU Cull
10iu                10iu 10iu 5mg/kg
FSH              FSH FSH Ab oFF BrdU Cull
10iu               10iu 10iu 5mg/kg  
Group 2
-withdrawal
Day 1 Day 2
Group 1
-stimulation





Figure 6.2: Schematic summary of FSH treatment regime applied to d21 pre-pubertal mice to induced 
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6.2.2.3.Chemically induced luteolysis 
Luteolysis is the natural structural and functional degradation of the CL.  However it 
can be chemically induced by direct and indirect methods.  Bromocriptine and 
cloprostenol were selected as luteolytic agents to investigate cell death within the CL 
and in understanding their disruptive mechanism to induce cell death it may aid the 
identification of potential roles of PDCD4 protein within the ovary.  Bromocriptine is 
a chemical dopamine agonist which inhibits prolactin synthesis and secretion by 
directly binding to dopamine D2 receptors on the pituitary lactotrophs (Vance et al., 
1984).  A decrease in prolactin results in a reduction of progesterone and hence 
induces luteolysis within the CL of the pregnant rodent (Zetser et al., 2001).  
Cloprostenol is a functional analogue of prostaglandin F2α having a specific 
luteolytic action at the ovarian level.  It causes functional and morphological 
regression of the CL in ungulates, marmosets and rodents (Nancarrow et al., 1982; 
Summers et al., 1985; Torjesen and Aakvaag, 1986) followed by a return to oestrous 
and normal ovulation.  The functional hypothalamic-pituitary-ovarian axis and the 
disruptions caused by bromocriptine and cloprostenol are summarised in Figure 6.3. 
 
Female mice caged with a stud male were checked daily for the appearance of 
vaginal plugs indicating mating and potential conception.  On the seventh day of 
gestation the females were injected intra peritoneal (ip) with bromocriptine (4mg/kg; 
120μg/30g mouse, Sigma) (2-bromo-α-ergocrytine.methanesulfonate salt B2134-
25MG 095K1528) or with cloprosetenol ((Estrumate synthetic Prostaglandin 
Schering-Plough Animal Health) dose 5μg/mouse)).  Sixteen hours after the 
luteolytic treatments, the animals were given injections of BrdU, (5mg/kg ip) and 
subsequently the mice were euthanized after an additional two hours.  Body weight 
was recorded, blood was collected by cardiac puncture and the ovaries were removed 
and weighed.  The number of visible corpora lutea were counted, the condition of the 
uterus noted and the number of implantation sites were recorded.  Ovaries were fixed 
in NBF (Section 2.7), for subsequent analysis and blood collected for LH and FSH 
radioimmunoassay (Section 2.9, performed by Judy McNeilly). 














































Figure 6.3: Summary of hypothalamic-pituitary-ovarian interaction during the luteal phase: actions of 
bromocriptine and cloprostenol on prolactin function and luteolysis. 
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6.2.3. Analysis 
To assess the degree of induced atresia, whether natural, by FSH withdrawal or by 
inducement of luteolysis, ovaries from the different treatment groups were sectioned 
and immunostained for markers of proliferation (PCNA or BrdU (Section 2.8)) and 
the apoptotic marker cleaved caspase 3, in addition to PDCD4, the protein of interest.  
Observations were made on the relationship between PDCD4 localisation and 
expression compared to that of cleaved caspase 3 expression.  Visual analysis of 
cleaved caspase 3 expression was performed from the ovaries which had been 
subjected to FSH stimulation/withdrawal.  In addition mRNA expression of PDCD4 
and cleaved caspase 3 was analysed using SYBR green RT-PCR (Section 2.4.2).  
The number of corpora luteum were recorded in the induced luteloysis groups in 
addition to the appearance of the nuclear compared to cytoplasmic localised 


















Chapter 6                                               Ovarian role of putative DAZL target PDCD4  
 154
6.3. Results 
6.3.1. PDCD4 as a potential DAZL target 
It is assumed that the functional copy number of DAZL would potentially determine 
the transcription levels of functional DAZL targets.  Therefore the expression of the 
recently identified putative target PDCD4 was firstly compared between the DAZL 
Wt and Het females.  PDCD4 mRNA expression levels were investigated in d21 
oocyte pools (localised DAZL expression) and d10 ovaries (uniform population of 
same stage oocytes) as previously used in Chapter 3.  The expression levels of 
PDCD4 were unchanged between the Wt and Het samples at both d21 (oocyte pools) 















Figure 6.4: Quantitative analysis of PDCD4 mRNA fold difference between Wt and Het in d21 
oocyte samples (n=5) and d10 ovaries (n=5).  Values are means ± SEM (Wt █ and Het █). 
 
6.3.2. Novel expression of PDCD4 in the mouse ovary  
Having confirmed that PDCD4 mRNA was present in the mouse ovary, and although 
no differences in mRNA expression were detected between the Wt and Het, we then 
established the pattern of PDCD4 protein expression within ovarian tissue using 
immunohistochemistry.  Initially d21 ovary, adult ovary with corpus luteum present, 
oviduct, DAZL KO d21 ovary and tumor samples from a DAZL KO ovary were 
analysed to enable a more informed interpretation of PDCD4 expression within the 
female reproductive tract.  Review of PDCD4 protein immunoexpression revealed 
positive cytoplasmic localisation within the oocytes of the d21 ovary, both in the 
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small primordial oocytes and oocytes within the larger pre/antral follicles (Figure 6.5 
A).  In addition PDCD4 was located to the granulosa cell cytoplasm, with light 
immunostaining present in the surrounding thecal layers (Figure 6.5 A).  PDCD4 
protein expression was additionally localised to the ovarian surface epithelium (OSE) 
surrounding the ovary where expression was strong (Figure 6.5 B) and to the 
steroidogenic cell of the corpus luteum (Figure 6.5 B).  Within the corpus luteum 
PDCD4 was expressed in both the cytoplasm and in the nucleus, which prompted 
further investigation (Section 6.3.4 and 6.3.5).  Furthermore, the oviduct epithelial 
cells intensely expressed PDCD4 protein (Figure 6.5 C) as did the OSE and cells 
within the KO ovary (Figure 6.5 D).  In the KO ovarian tumor and consistent with 
previous reports illuminating the decrease in PDCD4 expression associated with 
tumor progression, PDCD4 immunoexpression appeared reduced in the ovarian 
tumor sample (Figure 6.5 E).   
 
The observations of PDCD4 expression and the striking nuclear localization in cells 
within the CL compared to cytoplasmic expression in the granulosa cells of follicles 
suggested possible translocation of this protein with regards to its active function.  
These observations subsequently contributed to the series of investigations 
addressing natural and induced apoptotic functions within the ovary to identify 


















Figure 6.5: Immunoexpression of PCDC4 in representative sections of d21 ovary (A), adult ovary 
corpus luteum (B), oviduct (C), d21 DAZL KO ovary (D) and a tumor from a DAZL KO ovary.  
Scale bar represents 100µm. 
 
6.3.3. PDCD4 mRNA and protein expression during follicle apoptosis 
Evaluation of cell proliferation markers, PCNA and BrdU were investigated using 
immunohistochemistry after FSH stimulation or after FSH withdrawal of d21 
ovaries, to enable the detection of proliferating cells (Figure 6.6).  PCNA is a cell 
cycle protein which holds DNA polymerase delta to DNA with expression increasing 
during the G1-phase, peaking at the S-phase, and declining during the G2/M-phases 
of the cell cycle (Foley et al., 1993).  PCNA was detected within granulosa cells and 
stromal cells (Figure 6.6 A and B) of the two treatment groups.  As a result of the 
prolonged expression through the cell cycle no obvious differences were observed 
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between the two treatment groups, although cells did show different degrees of 
staining intensity which one would expect.  Furthermore, BrdU is present only the S 
phase of the cell cycle within which it is incorporated into newly synthesized DNA 
of replicating cells, substituting thymidine during replication.  In comparing the 
subsequent sections (Figure 6.6 C and 6.6 D), large atretic follicles have a substantial 
reduction in BrdU protein expression compared to the surrounding proliferating 
follicles.   
 
In comparison to these intrinsic proliferative markers, cleaved caspase 3 was used to 
identify apoptotic regions within the ovary and used as a comparative marker for the 
expression of the pro-apoptotic PDCD4.  An increase in cleaved caspase 3 
expression was notably observed after the FSH withdrawal treatment, clearly 
indicating follicle atresia (Figure 6.6 E).  Both an increase in pyknotic nuclei and an 
increase in cytoplasmic cell degradation was observed.  This increased cleaved 
caspase 3 expression was not observed in the FSH stimulation group (Figure 6.6 F).  
Interestingly even in the classified atretic follicles identified by the expression of 
cleaved caspase 3 and pyknotic nuclei, cell proliferation was also observed with 
reference to BrdU and PCNA positive immunoexpression, although expression of 
BrdU was reduced.  There was no identifiable difference in the localization or 
intensity of PDCD4 protein between the two FSH treatment groups.  If PDCD4 is 
acting as a pro-apoptotic factor in follicles one would presume either a decrease in 
expression at the onset of induced follicle atresia or a functional translocation to 
activate its activity within the apoptotic cell of the follicle. 
 
In order to further investigate the possibility that PDCD4 may play a role in ovarian 
apoptosis, ovaries from the d21 animals subjected to the FSH stimulation and 
withdrawal were additionally used to analyse cleaved caspase 3 and PDCD4 mRNA 
expression.  Interestingly the expression of cleaved caspase 3 was reduced after the 
FSH withdrawal treatment compared to FSH stimulation treatment, in contrast to the 
apparent increase in protein expression.  However, cleaved caspase 3 mRNA may 
have become degraded as a result of apoptosis despite protein remaining.  In support 
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of the absence of change in the expression of PDCD4 protein, no difference in 
PDCD4 mRNA expression was observed between the two treatment groups (Figure 
6.7), further suggesting that PDCD4 is not involved in induced follicle atresia 
regardless of its association as a pro-apoptotic factor. 
 
Figure 6.6: Immunoexpression of PCNA (A: FSH withdrawal and B: FSH stimulation), BrdU (C: 
FSH withdrawal and D: FSH stimulation), Cleaved caspase 3 (E: FSH withdrawal and F: FSH 
stimulation) and PCDC4 (G: FSH withdrawal and H: FSH stimulation).  Scale bar represents 100µm. 
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Figure 6.7: Quantitative analysis of cleaved caspase 3 and PDCD4 mRNA levels after FSH 
stimulated █ compared to FSH withdrawal █ treatment d21 ovaries (n=4).  Values are means ± SEM. 
 
6.3.4. PDCD4 protein expression during natural apoptosis 
In order to investigate a process of natural apoptosis within the ovary and in addition 
to the PDCD4 protein localisation identified within the CL, pro-estrous animals were 
screened again for the two proliferative markers PCNA and BrdU (Figure 6.8 A-D).  
Representative images from two different animals confirmed that there is extensive 
proliferation occurring in the pro-estrous ovary, with a reduced expression of PCNA 
within the corpora luteum and only a few BrdU positive cells.  Apoptotic follicles 
were observed within the pro-estrous ovaries, and as indicated by cleaved caspase 3 
protein expression, very few cells within the CL are apoptotic (Figure 6.8 E-F).  
Furthermore, the expression of PDCD4 notably changed within the CLs examined, 
ranging from light cytoplasmic expression with limited nuclear expression (Figure 
6.8 G) to more intensely expression and localised to the nucleus in the steroidogenic 
cells (Figure 6.8 H).  These differences observed in CL PDCD4 immunoexpression, 
visually correlated to the expression of cleaved caspase 3, whereby, when PDCD4 
was light with reduced nuclear expression a higher number of positive cleaved 
caspase 3 cells were present with the CL.  Conversely, when nuclear PDCD4 
expression was observed in the CL, little or no cleaved caspase 3 was identified. 





Figure 6.8: Representative photomicrographs depicting immunoexpression of proliferation markers 
PCNA (A and B), BrdU (C and D), apoptotic marker Cleaved caspase 3 (E and F) and protein under 
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6.3.5. PDCD4 protein expression in chemically induced luteolysis 
Exposure to bromocriptine and cloprostenol induced functional luteolysis and 
disruption of pregnancy compared to the non-treated pregnant controls.  Variation in 
the effects on the uterus, implantation sites and ovary were recorded (Table 6.1). 
 
Table 6.1: Ovarian and uterine observations of chemically induced luteolysis. 
Treatment Day of pregnancy Observation 
Bromocriptine 8 Uterus red and swollen 
 8 Very swollen 
 9 Swollen enlarged uterus 
 8 8 visible implantation sites 
   
Cloprostenol 6 10 visible implantation sites 
 6 6 visible implantation sites 
 7 11 visible implantation sites 
 8 White ovaries, implantations but not healthy 
 9 White ovaries, implantations but not healthy 
   
Control 8 11 visible implantation sites 
 7 9 visible implantation sites 
 8 12 visible implantation sites 
 
Changes in CLs were clearly visible in the different treatment groups when 
compared to the non-treated control, with the result that abnormally unorganized 
areas of cells were present.  The structural analysis of the CL suggest that upon 
chemically-induced luteolyis, CL degradation and structural regression is 
accompanied with an infiltration of epithelial type cells, which do not express 
PDCD4 protein (Figure 6.9 C, D and F).  The degree of abnormally organized cells 
and infiltration of epithelial type cells varied substantially.  It was clearly evident that 
the CL present in the non-treated pregnant controls (Figure 6.8 G and H) were more 
uniform in structure presenting with healthy round steroidogenic cells in contrast to 
the treated groups showing luteolyic changes in the CLs.  In addition the control 
animal showed a more overall cytoplasmic expression of PDCD4 in comparison to 
PDCD4 expression being nuclear and cytoplasmic in the treated animals.  
Furthermore, overall expression of PDCD4 was higher in the treated animals, thus 
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suggesting that the intensity and nuclear localization within the CL is linked to the 
morphological changes and structural regression as a result of disruption of prolactin 
function.  Although not shown there was very little cleaved caspase expression 
present in the CLs analysed from both the treatments inducing luteolysis, with the 
majoring of CLs remaining negative.  The highest proportion of caspase 3 expressing 
CL was from the bromocriptine treatment groups, suggesting that the actions of the 
two luteolytic factor are possibly inducing regression at a different rate.  Differences 
were also notable between the pregnant CLs and the pro-estrous CLs (Figure 6.9 A 
and B (pregnant) and G and H (pro-estrous)), with the pro-estrous CLs expressing a 
higher degree of nuclear expression compared to the mainly cytoplasmic expression 



























Figure 6.9: Representative photomicrographs depicting immunoexpression of PDCD4 in CLs of pro-
estrous animals (A and B), bromocriptine (C and D), cloprostenol (E and F) and the non-treated 
pregnant control (G and H).  Black arrows indicate representative areas with nuclear localization, red 
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The plasma levels of the gonadotrophins LH and FSH were measured after exposure 
to the luteolytic factor bromocriptine which disrupt prolactin secretion, and 
cloprostenol a PGF2α analogue which acts directly with the CL.  FSH levels were 
comparable to in all treatment groups.  However there was a reduction in LH after 
treatment with cloprostenol compared to LH levels observed in the control and 
bromocriptine animals, although due to the large variations observed in LH levels 













Figure 6.10: Changes in mean (±SEM) plasma concentrations of LH and FSH in non-treated pregnant 
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6.4. Discussion 
6.4.1. PDCD4 as a putative DAZL target 
This study is the first to identify PDCD4 not only as a potential DAZL mRNA target 
but additionally reports the temporal expression of PDCD4 within ovarian tissue.  
The initial identification of PDCD4 led to an extensive investigation in an attempt to 
elucidate probable PDCD4 functions within the ovary, with particular reference to 
the CL.  The identification of the DAZL consensus sequence within the mouse 
PDCD4 homologue suggests a potential role for this gene in DAZL-mediated 
regulation and control.  As previously investigated (Chapter 3 and 4), the functional 
copy number of DAZL is believed to be affecting the productivity of folliculogenesis 
and subsequently increasing the rate of ovulation and hence number of offspring in 
the Hets.  Comparison of PDCD4 mRNA between Wt and Het mice, no differences 
were detectable between PDCD4 mRNA levels in d21 oocytes or d10 ovaries were 
observed, suggesting the control mechanisms of the mRNA expression are not 
altered as a result of reduced functional copy of DAZL.  Although, it cannot be 
completely ruled out that PDCD4 is a functional target of DAZL until in vivo 
interactions are disproven.  This will require further optimisation of the 
immunoprecipitation technique (Chapter 4) for ovarian tissue in addition to 
investigating different approaches altogether to determine in vivo interactions. 
 
6.4.2. Potential ovarian function of PDCD4  
There are limited publications describing the expression of PDCD4 within the ovary.  
It has been detected within the oocyte and throughout blasotcyst development in the 
mouse, and the study states that its function is unknown although associated with 
apoptosis (Jurisicova et al., 1998).  Furthermore, from a microarray study comparing 
human ovarian tumours, PDCD4 mRNA expression was shown to be notably 
decreased.  Again elucidation of its function was not discussed (Bonome et al., 
2005).  However, this decrease in expression may be due to cellular transformation 
and progression of tumour growth rather than representative of a role for PDCD4 in 
ovarian function.  Therefore we report here for the first time the temporal expression 
of PDCD4 within the mouse ovary, in addition to suggesting potential involvement 
of this protein in functional luteolysis.  Evidence has been presented that PDCD4 is 
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detected at the mRNA and protein level in oocytes, which is supported by previous 
findings (Jurisicova et al., 1998), and additionally, protein has been localised to 
granulosa cells, the ovarian surface epithelium, oviduct epithelium and luteinised 
granulosa cells.  Due to this extensive expression of PDCD4 in the female 
reproductive tissue in addition to its host of roles in pro-apoptotic mechanisms 
(Shibahara et al., 1995), the likelihood of PDCD4 being a direct target of the oocyte 
specific DAZL remains low.  However PDCD4 may well play a significant role in 
the control and development of both the oocytes and surrounding ovarian structures.  
This chapter has highlighted that there are still many mechanisms within the ovary 
which remain unsolved and with regards to intra/extracellular control of CL during 
luteolysis the striking nuclear expression of PDCD4 cannot be overlooked.  To 
understand the possible ovarian function of PDCD4 an understanding in to its 
functional role elsewhere has been examined and discussed. 
 
6.4.3. Function of PDCD4 
PDCD4 was originally isolated in a search for genes that were activated as a result of 
apoptosis (Shibahara et al., 1995).  In addition work investigating species homology 
indicates that PDCD4 is highly conserved during evolution indicating its importance 
in biological function (Lankat-Buttgereit et al., 2004) and has been related to a 
variety of functions within different tissue and cell systems but how it actually works 
is still to be fully elucidated.  More recently, interests lies in the observation that 
PDCD4 has a tumor suppressor functioning by targeting and inhibiting translation 
and transformation.  It has been identified that translation initiation factor (eIF4A) is 
a major binding component of PDCD4 (Yang et al., 2003) and like the translation 
initiation factor 4G (eIF4G), PDCD4 can interact with the RNA helicase eIF4A via 
its component MA3 domains.  This competitive binding between PDCD4 and eIF4G 
results in an inhibition of translation by interfering with the assembly of the initiation 
complex consisting of the translation factors eIF4G, eIF4E and eIF4A (Goke et al., 
2002; Yang et al., 2003).  As a result, it seems that in the absence of PDCD4, eIF4A 
would be left unchecked to increase the amount of inefficiently translated mRNAs, 
thereby causing the cells to proliferate aberrantly leading to cancer (Jansen et al., 
2005).  It is important to note that this initiation complex has also been implicated in 
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the control of DAZL mediate transcription in Xenopus, whereby DAZL binds to Poly 
(A) binding proteins which are actively involved in the translation initiation complex 
(Gray et al., 2000; Collier et al., 2005). 
 
Studies performed in PDCD4 deficient mice support the role of PDCD4 as a 
suppressor of tumorgenesis in vivo and additionally indicate its involvement in 
inflammation initiation by selectively inhibiting protein translation in the immune 
system (Hilliard et al., 2006).  It has been shown in culture that the expression of 
PDCD4 is dramatically up-regulated in association with early event apoptosis as a 
result of serum starvation.  Furthermore, it has been suggested that PDCD4 may be 
involved in both the intrinsic and extrinsic pathways of apoptosis (Goke et al., 2002). 
 
Interestingly, unlike other documented translation factors that are constitutively 
expressed under physiological conditions, PDCD4 is normally expressed at low 
levels but is dramatically up-regulated under conditions that induce programmed cell 
death or transformation (Shibahara et al., 1995; Onishi et al., 1998; Goke et al., 
2002).  Therefore, the differences observed in PDCD4 immunoexpression at the time 
of functional luteolysis within the CL sequentially determine how much functional 
translation suppression is occurring regarding protein initiation and hence molecular 
function of PDCD4. 
 
In the present study PDCD4 was predominately localised to the cytoplasm of 
granulosa cells of both healthy and atretic follicles and oocytes, with the notable 
difference in cellular compartmentalisation observed in the CL, most probably as a 
result of stage of regression and luteinisation.  Thus, the differences observed further 
suggest that PDCD4 is an active molecular component within the CL, almost 
certainly associated with cell death.  In light of these findings and in support of the 
difference observed, PDCD4 has been reported to be localised to the cytoplasm 
(Yang et al., 2003) and to the nucleus (Schlichter et al., 2001a; b).  In a subsequent 
study PDCD4 protein was detected in the cytoplasm and/or in the nucleus, depending 
on the cells or their growth state (Yoshinaga et al., 1999).  Collectively these 
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observations suggest that in addition to the reported roles of PDCD4 in protein 
translation within the cytoplasm, PDCD4 may have an important functional role 
within the nucleus.  To clarify PDCD4 localisation, a further (Bohm et al., 2003) 
investigation revealed that PDCD4 can actually shuttle between the cytoplasm and 
nucleus, with nuclear location dominantly selected under normal growth conditions.  
In contrast to normal growth conditions, in serum depleted cells PDCD4 protein is 
located in the cytoplasm (Bohm et al., 2003).  These findings suggest that this 
transfer in localisation from the cytoplasm to the nucleus is responsible for active 
translation inhibition thereby initiating apoptosis.  In contradiction to this, it has been 
suggested that nuclear accumulation of PDCD4 occurs prior to apoptosis (Zhang et 
al., 2006).  More recently it has been identified that phosphorylation of PCDC4 by 
Akt is the cause of the nuclear translocation (Palamarchuk et al., 2005) and 
phosphorylation of PDCD4 in vitro and in vivo occurs in a P13K-dependent manner, 
causing nuclear translocation.  This action of phosphorlation inactivates PDCD4 in 
its function as an inhibitor of AP-1 mediated transcription.  Members of the TGFβ 
superfamily have also been implicated in PDCD4 regulation, with PDCD4 increasing 
after treatment of transfected PDCD4 Huh7 cells with transforming growth factor-β.  
This increase in PDCD4 not only coincided with the occurrence of apoptosis and 
caspase activation but was reversed by the transfection of Smad7 (a known 
antagonist of TGFβ1) suggesting that Smad7 protect cells from TGF β1 mediated 
apoptosis (Zhang et al., 2006).  Although somewhat under investigated, these studies 
suggest that PDCD4 may function in both the nucleus and the cytoplasm, with 
nuclear expression associated with normal growth and cytoplasmic expression 
associated with apoptosis.  Furthermore, translocation from the cytoplasm to the 
nucleus may be associated with inactivation of PDCD4 and initiation of eIF4G 
transcription. 
 
A coincidental common linkage has been formed between catenins and cadherins 
which have been identified both as putative DAZL targets as part of the 
bioinformatics trawl in Chapter 5, and to PDCD4.  It has been shown that 
knockdown of PDCD4 expression stimulates the translocation of β-catenin into the 
nuclei, which in turn activates β-cateninsol T cell factor (Tcf)-dependent 
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transcription, and AP-1 dependent transcription.  Thus, it has been suggested that 
PDCD4 regulates the expression of E-cadherin since both mRNA and protein levels 
of E-cadherin are decreased as a result of PDCD4 knock down.  Additionally E-
cadherin is a binding partner of β-catenin and therefore a decrease in E-cadherin 
expression resulted in an increase of cytoplasmic free β-catenin (Wang et al., 2007).  
Given that these two proteins, β-catenin and E-cadherin, are both potentially 
regulated by PDCD4 and catenin-1 and N-cadherin have been identified as putative 
targets of DAZL, communication between these groups of molecules may be linked 
and, although not by a directly functional interaction, may play important roles in 
translational control of interacting mechanisms. 
 
More recently novel findings have identified that suppression of PDCD4 expression 
is vital for the invasive activity of COX-2 mediated by PGE (2) and IL-8, and that 
PDCD4 increases TIMP-2 expression to inhibit breast cancer cell invasion (Nieves-
Alicea et al., 2008).  COX-2, TIMPs and PGE are all recognised as regulatory factors 
within the CL and most certainly play a dominant role in luteolysis (Bardin, 1970; 
Smith et al., 1999; Wiltbank and Ottobre, 2003).  It is well established that 
prostaglandins are involved in initiation of luteolysis in a number of species 
including rodents (Bardin, 1970; Smith et al., 1999; Wiltbank and Ottobre, 2003).  
With these data a plausible function for PDCD4 within the CL may be that increased 
expression associated with cytoplasmic localisation could increase TIMP 2 and 
hence aid structural regression of the CL.  This suggestion is supported by studies 
performed in rats where the expression of TIMP-2 mRNA in the regressing CL 
suggests an involvement in luteal demise (Simpson et al., 2001).   
 
The identification and molecular function of PDCD4 are recent discoveries and 
despite the documentation of potential roles the molecular function remains to be 
fully investigated, although some aspects of its function are beginning to emerge.  
The main functions remain to be associated with protein translation with PDCD4 and 
eIF4G having similar homolog thus being involved in translation suppression within 
the cytoplasmic compartment.  This localisation is enhanced as a direct result of 
serum starvation, inducing apoptosis, with nuclear representation associated with 
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normal growth.  All these documented mechanisms are transferable to the ovary, and 
in particular to the CL, where we observe an increase in cytoplasmic expression of 
PDCD4 as a result of removal of the luteolytic effects of prolactin.  This increase in 
PDCD4 cytoplasmic intensity is accompanied by an increase in nuclear expression 
and further augments the possibilities of multiple functions within different cellular 
compartments.  In addition to these findings it has also been shown that PDCD4 has 
intrinsic RNA binding properties although this has not been extensively investigated 
(Bohm et al., 2003).  We can suggest that cytoplasmic expression is aiding the pro-
apoptotic mechanisms of PDCD4 whereby protein translation is hindered allowing 
programmed cell death to occur.  Furthermore nuclear expression is exacerbating the 
signalling outcomes and could be contributing indirectly to the cell fate.  Even 
though this is the first study suggesting an active role of PDCD4 within the CL, the 
identity of RNA targets would additionally aid the clarification of the mechanistic 
properties of PDCD4.  In conclusion these speculative suggestions require functional 
confirmation, with the need to amalgamate all the potential associated systems to 
collate an overall theory of PDCD4 function and apply them to the ovarian 
requirements. 
 
6.4.4. PCNA v BrdU 
PCNA and BrdU were utilised in the current studies as markers of cell proliferation, 
and as comparative factors for PDCD4 immunoexpression.  In all studies, a large 
proportion of cells were actively labelled for PCNA compared to the BrdU.  It has 
been recognized that PCNA can be continuously expressed in cells that are not 
actively dividing possibly due to its long half-life (Morris and Mathews 1989; Scott 
et al., 1991).  PCNA has also been shown to be involved in DNA repair, which is not 
directly associated with proliferation (Celis and Madsen, 1986; Toschi and Bravo, 
1988; Shivji et al., 1992; Wood and Shivji, 1997), which could also have contributed 
to the fact that a high proportion of cells were PCNA labelled compared to BrdU. 
 
6.4.5. Apoptosis of the ovary 
In the ovary the critical decisions between cell survival and cell death involve 
extensive communication between groups of pro-apoptotic and pro-survival 
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molecules.  It is believed that this highly regulated coordination is entirely a quality 
control mechanism, supporting the viable oocyte with potential to ovulate and to 
eliminate those oocytes and follicles that become atretic.  It is well documented that 
programmed cell death plays an important role in the regulation of ovarian 
maintenance with controlled cell death present at numerous stages of oogenesis and 
folliculogenesis.  DAZL is undoubtedly essential for oocyte survival and by 
mechanisms not yet identified it may be contributing to the fate of the oocytes since, 
in the absence of DAZL, oocytes are lost after birth in mice.  DAZL therefore could 
possibly be linked to factors initiating cell survival, including possible interactions 
with PDCD4.  Thus we investigated the potential involvement of PDCD4 in ovarian 
apoptotic mechanisms, in both follicle atresia and luteolysis of the CL. 
 
Alternative treatment regimes were designed to initiate follicle atresia by FSH 
withdrawal and to initiate functional luteolysis by the administration of two known 
luteolytic agents, bromocriptine and cloprostenol.  FSH withdrawal undoubtedly 
induced follicle atresia in ovaries of d21 mice with extensive up-regulation of 
cleaved caspase 3 protein expression.  As a result of this onset of apoptosis, cleaved 
caspase 3 mRNA was reduced following FSH withdrawal suggesting functional 
transcription had ceased and cell death was occurring.  Even though PDCD4 has 
been targeted as a pro-apoptotic factor, induced upon apoptotic initiation, there was 
no difference in mRNA or protein expression in response to FSH withdrawal.  One 
suggestion is that although PDCD4 was present in the cytoplasm in the developing 
follicle it remains functionally quiescent at the onset of rapid withdrawal of FSH as 
alternative death mediated pathways are recruited.  Comparatively, follicle atresia is 
a quick and efficient process occurring rapidly within the ovary continuously 
whereas luteolysis is the gradual regression of the CL, which is both a functional and 
morphological process. 
 
From the visual analysis of pro-estrous ovaries and after luteolytic treatment, it can 
be concluded that CLs are present at different stages of progression and regression 
with luteolysis occurring at different rates.  PDCD4 phosphorylation (Palamarchuk et 
al., 2005) and hence translocation of functional protein to the nucleus may be 
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involved in the slow programmed cell death observed in the CL via shuttling 
between cytoplasm and nucleus.  PDCD4 protein expression was remarkably 
different between CLs in the same ovary possibly due to the stage of regression of 
each CL.  Not only did the intensity of cytoplasmic expression alter, nuclear 
expression was observed.  Taking in to account that both old CLs from previous 
cycles and new CLs from the current cycle are present in the pro-estrous ovaries and 
not supporting pregnancy with their progesterone secretion, nuclear localisation of 
PDCD4 was inversely correlated with the expression of cleaved caspase 3.  It 
became apparent that when PDCD4 was nuclear in the examined CL, cleaved 
caspase 3 expression was barely detectable.  However when there was an increase in 
cytoplasmic expression and reduced nuclear expression of PDCD4, suggesting an 
increase in translation inhibition, there was a marked expression of cleaved caspase 3 
cells within these regressing CLs.  These observations suggest that caspase 3 is 
functionally required for apoptosis to proceed normally during luteal regression but 
that enhancement of PDCD4 within the cytoplasm may aid the onset of cleaved 
caspase 3 expression with both contributing to luteolytic degradation (Carambula et 
al., 2002).  Extending this investigation into the inducement of functional and 
structural regression of the CL, by inducement of luteolysis, a similar pattern of 
PDCD4 and cleaved caspase 3 was observed.  Again it was notable that there was 
increased intensity of PDCD4 both nuclear and cytoplasmic staining upon 
inducement of luteolysis whether by bromocriptine or cloprostenol emphasising a 
potential functional role in programmed cell death within the CL.  As previously 
mentioned cleaved caspase 3 was only observed in CL in which there was a decrease 
in nuclear PDCD4 expression, and only in the CL from the bromocriptine and pro-
oestrous models.   
 
Finally, despite the original identification of PDCD4 mRNA as a potential target for 
DAZL mediated functions it has become evident that this novel transcription 
suppressor may be playing a significant role in luteolysis.  The abundant expression 
and localisation of PDCD4 in the CL may be key finding in regulating and 
facilitating events within the CL of the mature ovary.  One can now propose that 
there is a possible role for PDCD4 in programmed cell death associated with 
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structural CL regression.  The observed difference in PDCD4 localisation from high 
cytoplasmic expression and nuclear localisation may be associated with the caspase 
cascade induction.  In contrast, in follicles it has been shown that PDCD4 is probably 
not involved in cell death as no difference in protein or mRNA levels were detected 
as a result of natural or induced follicle atresia.  The mechanisms and control of 
PDCD4 now require further investigation to explore the possible mechanisms of this 
protein and to determine whether PDCD4 plays a substantial role in preventing and 
controlling cell proliferation by means of mediated control over programmed cell 
death.   
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Chapter 7: In vitro maturation of Wt and Het follicles  
7.1 Introduction 
Investigating the molecular mechanisms by which DAZL functions directly has been 
explored previously in Chapters 3 and 4, looking at identifying oocyte affected genes 
and potential mRNA targets.  Attempting to identify target mRNAs has led to a 
plethora of potential candidates including those identified in Chapter 5 (Venables et 
al., 2001; Jiao et al., 2002; Maegawa et al., 2002; Fox et al., 2005; Reynolds et al., 
2005: Reynolds et al., 2007) and with the mRNA binding properties of the DAZL 
protein (Cooke et al., 1996) it may, as previously suggested, have multiple targets 
with multiple functional effects.  It is now recognised (Cooke et al., 1996) that 
murine DAZL gene function is essential for germ cell development.  In addition 
there is now preliminary evidence (Chapter 3) that functional copy number does have 
an effect on additional oocyte gene regulation.  Surprisingly, the presence of only 
one functional copy of DAZL is somehow exerting an effect on the fecundity of the 
heterozygous females (McNeilly et al., 2000).  The present chapter now focuses on 
the indirect action that DAZL may be having on the ovarian follicle unit as a whole, 
investigating the bi-directional communication between the oocyte and somatic cells 
of the follicle which in turn may lead to identifying biochemical pathways involved 
in the increased follicle development and ovulation in the DAZL Het females. 
 
In addition to Het female mice producing significantly larger numbers of viable 
offspring compared to Wt, it has also been previously shown that Het females have 
increased plasma Inhibin B and reduced FSH levels (McNeilly et al., 2000).  
Furthermore, follicle growth has been reported to be significantly increased in the 
Het animals in culture when compared to the growth of the Wt follicles (McNeilly et 
al., SSR 2007).  This increase in growth occurred in in vitro cultures supplemented 
with FSH at concentrations of 1iu, 0.1iu and 0.01iu, indicative of an increase in 
sensitivity of the Het follicles to FSH in in vitro culture follicles (McNeilly et al., 
SSR 2007).  Initial stereological follicle count analysis indicated that at d21 the Het 
ovary contains a significantly larger proportion of large antral follicles compared to 
the Wt.  This proportional increase observed in the Hets can be reversed after 
Chapter 7                                                      In vitro maturation of Wt and Het follicles 
 175
administration of ovine follicular fluid (source of inhibin) to that of the Wt numbers.  
One proposed suggestion is that in addition to the Het ovary containing a greater 
number of advanced follicles compared to that of the Wt of the same age, atresia 
rates are reduced.  The combination of these two events in the Het females, advanced 
follicle stimulation with reduced atresia rates, would explain the increased litter 
sizes.  However, previous findings do not support the second part of this theory 
(Watson, PhD 2007), since atresia rates assessed by the presence of the apoptotic 
marker cleaved-caspase 3 and stereological analysis were not significantly different 
between the Het and Wt aged day 21. 
 
Since it is now recognised that bi-directional communication is vital to oocyte 
maturation and follicle development, it seems apparent that DAZL may be taking 
part in controlling various pathways involved in follicle selection, development and 
survival.  Follicle survival is an extremely inefficient process whereby the majority 
of ovarian follicles are actually lost either prior to birth or for those which do succeed 
into postnatal life, are mainly lost prior to ovulation, with only a few highly selected 
successful follicles making it to ovulation.  It remains unclear what is controlling this 
selection process but intense competition between female gametes or at least a 
rigorous selection process must be in place (Hartshorne, 1997).  This regulation of 
follicle survival may be one of the factors contributing to the difference observed 
between the DAZL phenotypes, whereby there is a reduction in follicle competition 
and reduced selection criteria in the Hets which may be controlled by local 
regulatory factors. 
 
The events associated with follicle growth are highly regulated and controlled by 
many local and systemic endocrine, molecular and cellular organisational factors.  
Many of these key mechanisms interact and are synchronised to achieve the ultimate 
goal of follicle maturation and consequently successful ovulation (Chapter 1).  
Growth of and hormone secretion by follicles from DAZL mice was assessed in 
culture in previous studies in our laboratory (McNeilly et al., SSR 2007; Watson, 
PhD 2007) but molecular factors have not been investigated.   
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The main aim of the studies in this chapter were to describe the molecular 
differences between Wt and Het follicles in culture by investigating the indirect 
actions DAZL gene expression on follicle growth, maintenance and differentiation 
from the FSH independent or responsive, to the FSH dependent stage.  
Understanding the endocrine control, follicle sensitivity to gonadotrophins and 
successive growth rates in addition to investigating mRNAs expressed in the follicle 
to assess maturation and responsiveness are fundamental to understand these 
underlying mechanisms.  To accomplish this, in vitro culture of individually isolated 
follicles in varying FSH treatments was performed closely mimicking in vivo follicle 
development.  The growth rates of the follicles were recorded over a six day period 
after which follicles were collected individually for comparative gene expression 
analysis.  To address the gonadotrophin independent to responsive stages of follicle 
growth, collections of classified (un-cultured) follicles were analysed for the same 
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7.2 Materials and Methods 
7.2.1 Follicle culture methods 
In vivo follicle culture systems are an essential valuable tool in the process of 
understanding the underlying mechanisms of the oocyte/follicle growth and 
differentiation.  As a guide it is estimated that only up to 12 follicles may be 
dissected and be appropriate for culture per mouse, six per ovary aged 21-25 days, 
but this number varied considerably depending on the individual mouse.  Individual 
follicles were dissected from Wt and Het DAZL mice and further selected for 
culture.  Isolation of individual follicles allows accurate observation of the growth 
and changes in gross morphology of follicles.  Although mechanical isolation of 
individual follicles is a laborious task it does ensure that individual follicles are at a 
similar stage of development.   
 
Follicle culture techniques were not established previously at the Queens Medical 
Research Institute.  Therefore initial training was undertaken with Dr Alison Murray 
within Dr Norah Spears’ Laboratory, George Square, University of Edinburgh 
(Spears et al., 1998).  The equipment and technique were subsequently set up and 
managed successfully by myself at the MRC HRSU, Edinburgh. 
 
7.2.2 Follicle Dissection 
All dissections were carried out under aseptic conditions in a laminar flow hood 
(Jencons).  With the microscope positioned far enough in the hood to protect the 
tissue and provided uninterrupted airflow.  For the in vitro primary follicles cultures, 
both animal and bench were sprayed with 70% ethanol and instruments used cleaned 
thoroughly in virkon (Antec International) and 70% ethanol prior to use to minimise 
the risk of contamination to the culture system.  The ovaries are removed from the 
mouse and placed into warmed L-15 medium (adjusted to 285 mOsm/kg using sterile 
water (Sigma) using an osmometer (Roebling) supplemented with 0.3% w/v BSA 
(Sigma Aldrich, Poole UK).  Under a microscope the ovaries are cleared of any 
surrounding fat and adhering tissue using insulin needles (Sharwood-Davies, UK cat 
no-1100601630).  Each ovary halved and each piece placed into a fresh dish of L-15, 
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keep in the incubator at 37°C, only half an ovary was dissected at a time for a 
maximum of 15 minutes.  
 
7.2.3 Follicle isolation 
Under a dissecting microscope (Zeiss KL1500 LCD) with a heated stage (Linkam 
Scientific Instruments) set at 37°C the Wt and Het ovaries were mechanically 
dissected using 27-gauge syringe needles and the appropriate sized follicles approx 
180-200μm in diameter were selected.  Any adhering stroma was removed from 
follicles.  After 15 mins of dissection follicles were transferred to a fresh dish of L-
15 medium.  The harvested preantral follicles were then evaluated, and those 
exhibiting an intact basement membrane, a high density of granulosa cell layers, 
centrally placed oocytes with some thecal attachment were selected for further 
culture.  Any follicles presenting with irregularities such as being non-spherical, 
having a non-central oocyte or having any darkening of granulosa cells as a result of 
atresia were avoided.   
 
7.2.4 Follicle culture 
Isolated Wt and Het follicles were cultured individually in a round bottom 96 well 
plate (non TC treated, Iwaki plates-cat no 3875-096; lids cat no 1803-096) 
equilibrated in an incubator (37°C 5% CO2) for 1-16h.  Each follicle was placed in 
30µl of culture medium in the bottom of the first row of wells and overlaid with 75µl 
silicone fluid (Dow-Corning cat no 630064v).   
 
Culture Media (1ml): 
935 ml Alpha-Mem (Gibco-22571)   
10 μl FSH (1 iu rhFSH; Purgon 50iu/0.5ml) 
50μl serum (5%) 
5μl ascorbic acid (Sigma) (made as 5mg/ml sodium ascorbate in alpha-mem) 
The medium was sterilised using small iwaki filter (13mm cat no 2032-014 for 
volumes under 10ml). 
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The follicles were cultured in four treatment groups (0.01iu; 0.1iu; 0.5iu and 1iu FSH 
(Puregon, Organon)) for a six day period after which follicles were individually 
collected for gene profiling analysis.  The follicles were moved to fresh medium 
daily and the diameter was measuring using an eye piece graticule and recorded.  If 
the follicle was not round the average was taken from perpendicular width and length 
measurements.  All manipulations of the follicles are carried out using finely drawn 
Pasture pipettes coated with 0.1% BSA (Sigma).  Follicles that did not survive the 
six day culture period, those with obvious darkening of the granulosa cell mass 
and/or signs of disintegration or that had spontaneously extruded their oocytes, were 
not included in the analysis.  These observations of follicle loss were likely due to 
manual damage caused during the isolation process.   
 
7.2.5 RNA extraction 
RNA was extracted from individual follicles using the Qiagen microRNAeasy 
protocol (Section 2.3).  The standard protocol was adapted to some extent as the 
volume of starting material was so small, and to increase the probability of the 
follicle being homogenised.  Hence, follicle samples were homogenised in a reduced 
volume of 100μl of RLT (normal volume 350μl) before being made up to the 
required 350μl.  The extracted RNA was then reverse transcribed to produce cDNA, 
which was subsequently used for expression analysis (Section 2.3.4). 
 
7.2.6 Gene expression 
Taqman gene expression assays were used to quantify mRNA expression levels of 
selected genes in individual follicles (Table 2.4).  Initial optimisation shows that 
when using limited material like individual follicle where typical mRNA yields were 
10ng/μl the gene expression was surprisingly still within the threshold limits of gene 
expression, 18s (<23) and Ct (<36) value (Section 2.4.2).  
 
7.2.7 Statistics  
Results for growth and atresia rates from were from at least five independent 
experimental culture runs, with the size of follicles in each group averaged, (1iu FSH 
Wt n=9, Het n=54; 0.5iu FSH Wt n=38, Het n=49; 0.1iu Wt n=20, Het n=49 and 
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0.01iu FSH Wt n=50; Het n=52).  Data from follicle growth were analysed using 
student’s t-test comparing Wt and Het on each day of growth.  χ2 was used to 
determine the atretic significance between Wt and Het follicles.  For taqman gene 
expression 10 representative follicle from each sample group were selected and each 
sample was repeated in triplicate and compared to 18s expression.  The results were 
analysed using one way ANOVA with Bonferroni’s multiple comparison test and 
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7.3 Results 
7.3.1 Follicle culture  
Follicles from treatment groups 0.1iu, 0.5iu and 1iu FSH had similar morphology at 
day six of culture (Figure 7.1).  These large follicles were spherical in shape, 
surrounded by an intact layer of theca cells with clear areas identifiable in the dense 
granulosa cells layers indicative of antral formation with the oocyte marginally 









Figure 7.1: Manually isolated mouse antral follicle approximately 400 µm in diameter growing in 
vitro in culture (1iu FSH after six days).  Scale bar represents 100 µm. 
 
7.3.2 Follicle growth 
Follicle growth is not only an indication of gonadotrophin responsiveness but cellular 
differentiation and overall follicle maturation.  When observing the four treatment 
groups there was no difference in final diameter between Wt and Het follicles at 1iu, 
0.5iu or 0.1iu (Figures 7.2).  At 0.5iu FSH Het follicle were significantly larger 
(P<0.01 day 1-2, P<0.05 day 3 and P<0.01 day 4) in size between day one and for, 
but there was no difference is final size at day six.  At 0.1iu FSH, Wt follicles were 
significantly larger (P<0.05 and P<0.01 consecutively) at day three and day five the 
Het (Figure 7.2).  However with 0.01iu FSH the Het follicles were significantly 
larger in diameter by day three (P<0.01, Figure 7.2) and remained significantly 
(P<0.01) larger over the remainder of the culture period.  Results from this study 
have provided evidence and support that follicle growth does significantly differ with 
Chapter 7                                                      In vitro maturation of Wt and Het follicles 
 182
the presence of one functional copy DAZL compared to two copies in the Wt 
response to low doses (0.01iu) of FSH.   
 
 





























































































Figure 7.2: Follicle growth over a six day culture of Wt v Het at 1iu, 0.5u, 0.1iu and 0.01iu FSH.  
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When comparing the Wt and Het over the range of FSH concentrations, final follicle 
sizes are comparable at 1iu, 0.5iu and 0.1iu for both Wt and Het (Figure 7.3).  It may 
be that the endogenous FSH supplied at these doses are surplus to follicle demand 
and the cultured follicles are exhibiting saturation as differences in growth rate are 
not significantly different.  The perturbed growth effect observed at 0.01iu suggests 
that FSH is playing an important role in maintenance of follicle growth and when in 


















































Figure 7.3: Follicle growth of Wt and Het follicles cultured in the presence of 1iu, 0.5iu, 0.1iu and 
0.01iu recombinant FSH.  Black arrows indicates cessation of follicles growth in 0.01iu FSH culture 
conditions (day 3 Wt and day 4 Het).  Values are means ±SEM. 
 
When directly comparing growth rates within a genotype at the lowest (0.01iu) FSH 
dose it can be observed that follicle growth ceases after three days in culture for Wt 
and four days for the Hets (Figure 7.3).  In addition this prolonged growth of the Het 
at 0.01iu FSH was accompanied by antral formation in a small proportion of Het 
follicles.  However this maturation stage was never observed within the Wt follicle 
cultured in 0.01iu conditions, suggesting there is insufficient FSH present to meet the 




Chapter 7                                                      In vitro maturation of Wt and Het follicles 
 184
7.3.3 Rate of follicle atresia 
In addition to monitoring daily follicle growth, the rates of follicle atresia were also 
observed (Figure 7.4).  The classification of follicle atresia in culture was defined as 
a shrinking and overall darkening of the granulosa cells surrounding the oocyte, and 
these follicles ceased to undergo further development.  There was a notable reduction 
in the total percentage of Het follicles undergoing atresia compared to Wt follicle at 
all concentrations of added FSH.  At 1iu FSH 20% of Wt follicle were classified as 
atretic compared to 4% of Het (P<0.05), at 0.5iu FSH 7% of Wt compared to 1% of 
Het (result not significant), at 0.1iu FSH 23% of Wt compared to 11% of Het 
(P<0.05) and finally 18% Wt compared to 2% of Het (P<0.01).   
 
 





















Figure 7.4: The percentage of atretic follicles at the end of six days in culture for Wt and Het follicles 
in 0.01iu, 0.1iu, 0.5iu and 1iu FSH.  (Values are overall % of total follicles cultured and monitored 
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7.3.4 Gene analysis of cultured follicles 
mRNA expression levels of selected gene were analysed and compared from 
individual follicles from culture 1iu, 0.5iu and 0.1iu FSH.  Growth by day six was 
perturbed in follicles from the 0.01iu treatment these were eliminated from the gene 
expression analysis.   
 
7.3.4.1.Gonadotrophin receptors and aromatase 
FSH receptor (FSHR) mRNA levels were investigated between the Wt and Het 
follicles, there being a significantly (P<0.05) up-regulation in the Het mice compared 
to the Wt at 1iu FSH (Figure 7.5).  This up-regulation was not observed at 0.1iu and 
0.5iu FSH culture conditions, although there was a reduction in FSHR mRNA in the 
Het compared to the Wt at 0.5iu FSH this result was not significant due to the high 




















Figure 7.5: Mean fold differences of FSHR for Wt and Het DAZL follicles cultures for six 
consecutive days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative 
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LHR mRNA expression levels were analysed and detected in all the three treatment 
groups (Figure 7.6).  The genotype of the DAZL mice did not have a significant 
effect of mRNA expression.  There was a reduction in LHR mRNA expression in 
both Wt and Het follicles at the 0.1iu FSH compared to the levels detected at 1iu and 



















Figure 7.6: Mean expression differences of LHR for Wt and Het DAZL follicles cultures for six 
consecutive days in 0.1iu, 0.5iu and 1iu concentrations of FSH.  (Values are the means ± SEM relative 
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Aromatase mRNA expression was comparable at 0.1iu and 1iu FSH culture 
conditions between the Wt and Het follicles (Figure 7.7).  However there was a 
significant (P<0.05) up-regulation in expression of aromatase mRNA at 0.5iu FSH in 



















Figure 7.7: Mean fold differences of Aromatase for Wt and Het DAZL follicles cultures for 6 
consecutive days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative 
to calibrator sample * p<0.05. Wt █ and Het █. 
 
7.3.4.2.TGF β superfamily  
Members of the TGFβ superfamily are widely expressed within the ovary and 
developing follicle and influence growth and function in a developmentally regulated 
manner.  These proteins have important roles in the control of folliculogenesis 
despite the majority of functional studies being mostly in vivo.  In the present study, 
Anti-Mullarian Hormone (AMH), Follistatin (FST), and inhibin and activin subunit 
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AMH is considered to have an essential role in folliculogenesis inhibiting the process 
of follicle recruitment and modifies the growth of preantral and antral follicles by 
diminishing the sensitivity of follicles for FSH stimulation.  It may be expected 
because of this that difference might occur between the Het and Wt.  However AMH 
mRNA expression showed no difference between genotypes at the different culture 
conditions (Figure 7.8).  There was a tendency for increased mRNA expression at 
0.1iu and 1iu in the Het follicles but due to sample variation these results were not 


















Figure 7.8: Mean fold differences of AMH for Wt and Het DAZL follicles cultures for 6 consecutive 
days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative to calibrator 
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FST mRNA expression was similar between genotypes at each FSH concentration 
(Figure 7.9).  mRNA expression was reduced when the culture FSH concentration 
was reduced to 0.01iu FSH.  Using comparative one way ANOVA this reduction in 
both Wt and Het is significantly different compared to mRNA expression at 1iu and 
0.5iu.  There is a significant increase (P<0.05) in FST mRNA expression in 
correlation with an increase in concentration of FSH in culture of both Wt and Het at 


















Figure 7.9: Mean fold differences of FST for Wt and Het DAZL follicles cultures for 6 consecutive 
days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative to calibrator 
sample.  Wt █ and Het █. 
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Expression of AR11a mRNA was just detectable for quantification but, with the 
results at the maximum limit for detection, the accuracy of the results may be 
jeopardised.  Although not significant there was a trend for a dose dependent 
increase in AR11a mRNA expression as a result of increased FSH concentrations in 



















Figure 7.10: Mean fold differences of AR11a for Wt and Het DAZL follicles cultures for 6 
consecutive days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative 
to calibrator sample. Wt █ and Het █. 
 
The changes in mRNA for inhibin α, inhibin βB, inhibin βA subunits were analysed.  
The expression of inhibin α mRNA did not differ between culture groups and was 
not different between genotypes (Figure 7.11).  























Figure 7.11: Mean fold differences of Inhibinα for Wt and Het DAZL follicles cultures for six 
consecutive days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative 
to calibrator sample. Wt █ and Het █. 
 
The level of mRNA of inhibin βB subunit was significantly reduced (P<0.01) in the 
Het follicles at 0.5iu FSH compared to that of the Wt (Figure 7.12).  For Wt follicles 
inhibin βB mRNA levels were significantly higher (P<0.05) at 0.5iu compared with 
both 1iu and 0.01iu FSH.  In contrast there were no differences between FSH 





















Figure 7.12: Mean fold differences of inhibin βB for Wt and Het DAZL follicles cultures for six 
consecutive days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative 
to calibrator sample ** p<0.01. Wt █ and Het █. 
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In contrast to βB subunit mRNA the inhibin βA subunit mRNA were significantly 
(P<0.05) increased in the Het follicles compared to the Wt at 0.5iu FSH (Figure 
7.13).  Furthermore, for Het follicles inhibin βA mRNA levels were significantly 
higher (P<0.05) at 0.5iu compared with both 1iu and 0.01iu of FSH.  In contrast 






















Figure 7.13: Mean fold differences of Inhibin βA for Wt and Het DAZL follicles cultures for six 
consecutive days in 1iu, 0.5iu and 0.1iu concentrations of FSH.  Values are the means ± SEM relative 
to calibrator sample * p<0.05.  Wt █ and Het █. 
 
7.3.5 Gene analysis of gonadotrophin independent stage 
7.3.5.1.Gonadotrophin receptors 
Real-time taqman PCR analysis was used to measure gene expression in follicles at 
the gonadotrophin independent stage of growth (≤180μm), prior to antral 
development.  These follicles were collected directly from the ovaries and were not 
cultured.  Cohorts of five follicles were classified into size groups from 60μm-
180μm (n=3 for each group).   
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There were no differences between FSHR and LHR mRNA expression between 
genotypes as the follicle size increased (Figure 7.14; 7.15).  
 



















Figure 7.14: Mean fold differences of FSHR for DAZL follicles at gonadotrophin independent stage 
from sizes 60µm to 180 µm.  Values are the means ± SEM relative to calibrator sample.  Wt █ and 
Het █. 
 


















Figure 7.15: Mean fold differences of LHR for DAZL follicles at gonadotrophin independent stage 
from sizes 60µm to 180 µm.  Values are the means ± SEM relative to calibrator sample.  Wt █ and 
Het █. 
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7.3.5.2.Inhibin subunits   
Analysis of mRNA levels for the inhibin subunits, inhibin α, inhibin βB and inhibin 
βA which form the basis of activin and inhibin molecules from sized follicles did not 
show any significant differences between genotypes at each follicle stage.  Inhibin 
βA mRNA expression appears decreased as follicles became more gonadotrophin 
responsive but these changes were not significant (Figures 7.16; 7.17; 7.18).  



















Figure 7.16: Mean fold differences of inhibin α for DAZL follicles at gonadotrophin independent 
stage from sizes 60µm to 180 µm.  Values are the means ± SEM relative to calibrator sample.  Wt █ 
and Het █. 
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Figure 7.17: Mean fold differences of inhibin βB for DAZL follicles at gonadotrophin independent 
stage from sizes 60µm to 180 µm.  Values are the means ± SEM relative to calibrator sample.  Wt █ 
and Het █. 
 



















Figure 7.18: Mean fold differences of inhibin βA for DAZL follicles at gonadotrophin independent 
stage from sizes 60µm to 180 µm.  Values are the means ± SEM relative to calibrator sample.  Wt █ 
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Table 7.1:  Summary of follicle gene expression differences between Wt and Het 
 
In vitro (<340 µm) 0.1iu FSH 0.5iu FSH 1iu FSH 
    
FSH receptor ND ND Het>Wt 
LH receptor ND ND ND 
Aromatase ND Wt<Het ND 
AMH ND ND ND 
FST 0.1iu<0.5iu & 1iu ND ND 
AR11a ND ND ND 
Inhibin βA ND Wt<Het ND 
Inhibin βB ND Wt>Het ND 
Inhibin α ND ND ND 
    






There was no significant difference between the Wt and Het genotypes at 
any stage of development in the gonadotrophin independent stage to the 
gonadotrophin responsive stage for the genes investigated. 
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7.4 Discussion 
The primary aim of this chapter was to investigate the indirect actions of functional 
DAZL gene expression.  To accomplish this, follicle growth was monitored first and, 
although it had been previously reported to be different between the Wt and Het 
follicles, verification of the results was required.  Secondly atresia rates of follicles in 
culture were monitored as these had not been previously investigated.  Finally, 
follicle gene expression was investigated to show any response differences as a result 
of the genotype and FSH stimulation.  Understanding the endocrine control, follicle 
sensitivity to gonadotrophins and successive growth rates in addition to investigating 
mRNAs expressed in follicles to assess maturation and responsiveness are 
fundamental in understanding the underlying mechanisms whereby DAZL 
heterozygous expression increases fertility. 
 
7.4.1 Follicle growth 
This study demonstrated and confirmed that in vitro Het follicles are more sensitive 
to low concentrations of FSH compared to Wt follicles.  Follicles selected for culture 
had established their growth phase having progressed in vivo from primordial to the 
early pre-antral stages, already appearing with thecal or stromal cells attached to the 
exterior of the follicle wall.  Follicles under the influence of 1iu, 0.5iu and 0.1iu FSH 
in culture all reached the same maximum size of approximately 430 µm after six 
days in culture, only slightly smaller than pre-ovulatory follicle found in vivo.  This 
maximum size of follicles is comparable to ranges (>500μm) previously reported for 
mouse follicles in culture (Hartshorne et al., 1994; Spears et al., 1998; Murray et al., 
2008).  It has been established that FSH is required for full follicle development in 
culture (Spears et al., 1998).  
 
At a high dose (1iu FSH) follicles from both genotypes grew substantially over the 
six day period at the same rate.  Reducing the FSH concentration to 0.5iu Het 
follicles grew at a significantly faster rate for the initial four days compared to the 
Wt, but by day five there was no differences and by the collection stage at day six 
follicles from both genotypes were equivalent in morphology and size.  These 
findings suggest that at a reduced concentration of FSH (as observed from 1iu to 
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0.5iu) Het follicles have accelerated growth in the initial stages.  It would therefore 
be reasonable to assume at 0.1iu this observed difference might be exaggerated and 
thus a larger difference between the growth rate of the Het and Wt follicles may 
occur.  However, although reaching comparable final size in actual fact Wt follicles 
were significantly larger than Het follicles on day three and day five of culture.  
These findings do not support the FSH sensitivity and threshold theory as previously 
observed, but the current studies used a different preparation of recombinant human 
FSH than the earlier studies in our laboratory, hence the concentration of FSH in 
culture was reduced further.  Under the influence of this reduced FSH (0.01iu) Wt 
follicle only grew for the initial three days to a size of approximately 250μm before 
ceasing to develop further.  In contrast, Het follicle grew for four days reaching a 
size of approximately 275μm reaching a maximum of 300μm by day six, thus clearly 
indicating that Het follicles are more sensitive to FSH than Wt at 0.01iu FSH.  
Although not completely comparable to previous findings (Elaine Watson, PhD 
2007), whereby significant difference in growth between the Het and Wt were 
observed at 1iu, these data still support a difference in follicle sensitivity.  
Furthermore on explanation for the differences observed are that the present study 
used FSH in a liquid preparation whereas the previous study (Elaine Watson, PhD 
2007) used a suspension, possibly altering the bioavailability of FSH to the growing 
follicle.  In addition, fetal calf serum was used in the present study compared to HPG 
mouse serum, although both have been shown to provide the correct supplementation 
for growth (Boland et al., 1993; Cortvrindt et al., 1996).  These results further 
confirm that FSH is essential for follicle growth and maturation in vitro and by 
reducing FSH the growth of follicle is compromised even without considering the 
genotype.  Although differences were observed in growth rates in the current studies 
these would need to be confirmed in vivo to have physiological relevance.   
 
FSH in the in vitro culture system stimulates glucose utilisation and oestradiol 
production and may also stimulate follicles to enlarge or granulosa cell density to 
increase (Nayudu and Osborn 1992; Boland et al, 1994; Hartshorne et al., 1994).  It 
is well established that in vivo FSH is essential for early antral formation and follicle 
growth and differentiation.  The cessation of follicle growth in addition to the lack of 
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antral formation in the Wt follicles at 0.01iu FSH confirms that FSH is indeed crucial 
for these processes.  Further supporting the importance of FSH are two transgenic 
models, the FSHβ deficient mouse and the FSHR KO which are both infertile, 
confirming that the function of FSH is vital for fertility and ovarian function (Kumar 
et al., 1997; Abel et al., 2000).  In comparison, it has also been recognised that 
excessive exposure to FSH could result in the down-regulation of the FSHR, leading 
to suboptimal follicular response (LaPolt et al., 1992), again supporting the theory 
that the FSH concentration is critical for normal development.  It is worth noting that 
follicles cultured in high dose 1iu FSH may be down-regulating the FSHR 
expression hence the increased in atresia rate compared to 0.5iu FSH.  
 
Despite follicle culture being an invaluable tool to aid biological research, it is not 
without its flaws.  There is evidence that the growth rates of the granulosa cell layers 
in in vitro cultures exceed the ability of the surrounding thecal layers to maintain 
adequate contacts between the thecal layer, basement membrane and granulosa cells, 
resulting in the occasional bursting or bulging of the follicle (Hartshorne, 1997).  
Bursting/bulging of follicles was observed in the present study, in relation to 
inadequate cellular growth but, in addition, mechanical manipulation may also 
contribute to these events.  Another common observation within in vitro follicle 
culture system is of slow and abnormal growth of follicles which results in the 
overgrowth of the surrounding theca (Nayudu and Osborn, 1992).  Again poor 
selection of follicles when preparing the cultures or failure to remove excess stromal 
tissue, may also add to this.   
 
It is important to note that ovarian follicles in static culture conditions exist in a very 
different environment in comparison to the dymanic situation in vivo.  It has been 
previously acknowledged that the growth rate of cultured follicles is accelerated in 
vitro compared to naturally occurring growth in vivo (Pedersen, 1970).  This 
expedited growth may be due to several factors, including the removal of the follicle 
from its ovarian niche where inhibitory influences produced by other growing 
follicles are absent, or as a direct result of the artificial culture conditions taking into 
account osmotic pressure changes and absence of intraovarian pressure (DiZerega et 
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al., 1983: Qvist et al., 1990: Nayudu and Osborn 1992).  Furthermore, the maximum 
size that follicles can achieve in vitro have physical constraints compared to that in 
vivo, the major factor being the absence of a rich blood supply to the theca.  This rich 
blood supply transports the systemic gonadotrophins, particularly just before 
ovulation (Zeleznik et al., 1981) and is involved in supplying localised steroid 
substrates, growth factors and structural support to the granulosa compartment 
(Skinner and Coffey, 1988).  In comparison the granulosa cell layer is avascular with 
the oocytes acquiring only limited oxygen via diffusion suggesting the interior of the 
follicle structure is quite hypoxic, even in vivo (Boland et al., 1994).  This hypoxic 
state may contribute to the ability of the follicular oocytes to survive in vitro as they 
are already adapted and tolerant to the gaseous conditions (Hartshorne, 1997).   
 
7.4.2 Follilce atresia 
Follicle atresia is a natural phenomenon occurring continuously within the ovary and 
it is not surprising that when removing follicles from their internal ovarian niche 
atresia rates differ.  One major contributing factor to follicle atresia is the 
competition for follicle dominance and response to FSH.  It has been established that 
there is a critical widow of sensitive whereby the follicle responds appropriately 
depending on its fate (McGee and Hsueh, 2000).  In addition to cultured follicles 
having accelerated growth (Pedersen, 1970), the proportion of follicles avoiding 
atresia in vitro appears to be greater than that in vivo although not studied extensively 
it may be due to factors including physiological concentrations of gonadotrophins 
and reduced competition due to individual isolation.   
 
For the first time this study has shown that atresia rates are significantly different 
between the Wt and Het cultured follicles.  The susceptibility of the Wt follicles to 
become atretic in culture suggests that the follicles are less tolerant to the culture 
conditions and are possibly less responsive to the protective roles of FSH.  The Wt 
follicles may also be more prone to atresia due to the altered expression of regulatory 
factors, including growth factors or intra-ovarian signals which may be below 
threshold levels.  The molecular control of this increased atresia rate by DAZL in Wt 
follicles may be contributing to the observed differences in litter sizes.  Furthermore, 
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from these studies it an be concluded the genotype but possibly not FSH 
concentration are having an effect on overall atresia rate further supporting the 
hypothesis that FSH works within a critical window of bioavailability to balance 
follicle selection, growth and atresia which may be altered between the Wt and Het.   
 
These experiments investigating the responses of individually cultured follicles from 
Wt and Het females to their FSH environment has shown that follicles are 
developmentally competent to undergo apoptosis-mediated cell death from the 
preantral/ early antral stage onward, at least in vitro, substantiating previous reports 
(McGee et al., 1997).  Furthermore, experiments using rat follicles cultured in the 
absence of hormones showed a 12-fold increase in the level of apoptotic DNA 
fragmentation (Chun et al., 1996).  This apoptotic event was prevented by treatment 
with FSH in a dose-dependent manner, these results supporting FSH as a major 
survival factor for early antral follicles.  However, in the current studies the decrease 
in FSH levels did not subsequently reduce atresia rates further as one may expect.  
Additionally, if all follicles are classified as dominant as a consequence of no intra-
ovarian competition, it is believed that the dominant follicle survives the declining 
plasma FSH due to their enhanced responsiveness to gonadotrophins relative to that 
of subordinate follicles (Ginther et al., 1996; 2001).  Therefore, the observed atresia 
rates in in vitro matured follicles are a true genotype phenomenon and not a result of 
declining culture FSH.  The Het follicles not only survive the decline in FSH from 
1iu to 0.01iu, they have increased responsiveness to FSH, and hence enhanced 
growth at low levels of FSH.  The reduction in follicular growth response at low dose 
FSH supported the previous findings that there is altered sensitivity within the Het 
compared to the Wt follicles.  Finally these results suggest that the cohort of follicles 
recruited at each oestrous cycle within the Het ovary have a higher proportion of 
dominance and greater capacity to avoid atresia compared to the Wt. 
 
As previously discussed (Chapter 3) there is evidence that oocyte genes may be 
targeted and affected as a result of active DAZL gene expression.  Additionally the 
results from the current study show that the growth rates of Wt and Het follicles are 
similar at high dose FSH (1iu-0.1iu) treatment groups.  Thus, an investigation into 
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local follicle gene expression was performed.  Furthermore regardless of DAZL 
being germ cell specific, the results from the other studies reported in this thesis 
suggest that DAZL gene functionality is having an effect on the whole follicle.   
 
7.4.3 Gene analysis of cultured follicles 
Follicle growth can be categorised into stage specific phases, the gonadotrophin 
independent, gonadotrophin responsive and the gonadotrophin dependent stages.  At 
each of these stages a range of factors regulate the growth and differentiation of the 
oocyte, granulosa and the thecal layers.  Many follicles will leave the gonadotrophin 
independent stage and become responsive, conversely many will not mature fully but 
instead will undergo atresia during this developmental process.  The criteria for 
follicles to achieve the position of dominance and become gonadotrophin dependent 
are mainly controlled by a tightly regulated feedback system.  The current study was 
used to investigate the expression of components of this important feedback 
regulatory system to determine, if any, constraints or enhancements are present 
between the Wt and Het follicles.   
 
7.4.3.1.Gonadotrophin receptors and aromatase 
As previously noted FSH and LH are fundamental for providing the correct 
conditions for follicle stimulation and ovulation.  Therefore analysis of the 
gonadotrophin receptor expression FSHR and LHR was investigated to determine 
whether the threshold sensitivity to gonadotrophins was a direct result of possible 
altered receptor expression and enhanced follicle maturity.   
 
The foremost function of FSH is to stimulate granulosa cell proliferation and is 
involved in the positive feedback expression and function of its own receptor.  It has 
been controversial whether or not FSH does actually regulate its own receptor, but 
early reports do state that up and down-regulation of the receptor can occur after 
FSH stimulation (Richards, 1980).  Members of the TGFβ family have also been 
implicated in controlling the expression of the FSHR gene and the formation of the 
receptors.  FSHR are exclusively expressed by granulosa cells from as early as the 
two-layer or primary stage of follicle development (Oktay et al., 1997) with oocytes 
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influenced and affected indirectly.  During antral formation FSH acts upon its 
receptor in the granulosa cell surface membrane to stimulate cell division and 
formation of glycosaminoglycans that are essential components of antral fluid 
(Hillier, 1991).  Therefore, the results from the mRNA analysis in the current study 
indicate that if FSH is up-regulating its own receptor at specific stages,  evidence 
from the Het follicles at 1iu FSH and not the Wt, further supports the hypothesis that 
Het follicles are more sensitive to FSH.  Furthermore, the increase of FSHR at 1iu in 
the Het may be a result of a greater number of granulosa cells expressing the FSHR 
at that stage in growth, or the number of granulosa cells is greater for the same give 
follicle size.  In addition these data suggests that DAZL may be playing a role in bi-
directional communication between its oocyte cytoplasmic location and subsequent 
function on FSHR on the granulosa cells.  Although detected, LHR mRNA 
expression was unchanged from the Wt and Het follicles suggesting that the follicles 
may be at the same stage of responsiveness as LHR increases on theca and on the 
outer layer of granulosa cells in preovulatory follicles prior to the LH surge.   
 
It is well established that aromatase is involved in oestrogen biosynthesis which 
plays an obligatory role in follicle dominance and endocrine control.  Our data shows 
that there is a significant increase in aromatase mRNA expression in the Het follicles 
compared to the Wt follicles at 0.5iu FSH supporting the role of aromatase in follicle 
dominance.  Furthermore, previous studies have shown that oestradiol production of 
cultured follicles at 1iu of FSH to not significantly differ between the Wt and Het 
suggesting equal dominance despite accelerated growth in the Het (Elaine Watson, 
PhD 2007).  However, the oestradiol production was not analysed from cultures at 
lower FSH stimulations, where differences in aromatase mRNA expression were 
observed in the present study.  This now requires further investigation to establish if 
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7.4.3.2.TGFβ superfamily 
Folliculogenesis requires the coordinated regulation of many genes, and members of 
the TGFβ family have been implicated in critical events associated with determining 
the fate of follicle survival.  This family of proteins are classified as multifunctional 
cytokines and control events such as cellular proliferation, differentiation and 
interactions with the extra cellular matrix.  The inhibins, activins and follistatins 
were first identified over 30 years ago in ovarian follicular fluid (deJong and Sharpe, 
1976) due to their ability to modulate FSH secretion.  It is now widely acknowledged 
that activin and inhibin play significant roles in follicle development (Knight and 
Glister, 2006).  It therefore seemed logical that activin and inhibin signalling 
molecules were assessed to establish whether there was any difference in 
responsiveness or particular feedback systems.  In in vitro situations inhibins and 
follistatin have been show to suppress FSH secretion, whereas the activins augment 
FSH secretion (Knight, 1996; Mather et al., 1997; de Kretser et al., 2000; Knight and 
Glister, 2001).  Comparatively and in response to the FSH secretion pattern it has 
been demonstrated in cattle that over the stage of follicle development the actions of 
activins decrease, whereas the actions of inhibins increase as does the actions of 
follistatin (Knight and Glister, 2001). 
 
FST is structurally unrelated to the inhibins despite having similar function in 
suppressing pituitary FSH (Ueno et al., 1987).  In addition FST binds to the activins 
and too lesser extent inhibins through the β subunit, naturalising their functional 
activity (Shimasaki et al., 1991), with the binding affinity of FST for activin similar 
to that of activin binding to its own receptors (Mathews, 1994).  FST mRNA was not 
found to change in the follicles, with very little variation between treatment groups 
and genotype.  There are reports using bovine follicles which show that 
intrafollicular concentrations of FST do not vary throughout growth, hence 
suggesting a developmental regulated bio-availability of activin A, due to the effects 
free activin A/inhibin (Knight and Glister, 2003) and a similar mechanism may be in 
place in the mouse. 
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As mentioned the functions of inhibin and activin change as follicle progression 
occurs.  Therefore the investigation in to their subunit expression was performed to 
attempt to elucidate if the function of these critical endocrine components were 
altered in Het compared to Wt follicles.  It has been previously shown that as 
follicles increase in size inhibin A increases whilst the inhibin B decreases (Knight 
and Glister, 2003).  Thus, the ratio of inhibin A: B rises and peaks at ovulation 
accompanied by no change in FST and an increase in activin A (Schwall et al., 1990; 
Yamoto et al., 1992; Roberts et al., 1993; Knight and Glister, 2003).  The inhibin α 
subunit is expressed throughout all follicle stages with expression increasing in the 
large antral follicles.  Furthermore, the inhibin βA subunit is expressed in the theca 
cells of the secondary to large antral follicles (Gougeon 1994; Hsueh et al., 1996; 
Bristol and Woodruff, 2004) and by the granulosa cells of primordial and primary 
follicles as is the inhibin βB subunit.  The roles of the inhibins and activins 
undoubtedly are crucial for correct follicle development (Knight and Glister, 2003; 
2006) and, therefore, it is not surprising that there was significant difference 
observed between the cultured Wt and Het follicles.  Findings from this study show 
that inhibin βB mRNA expression was reduced in the Het follicles compared to the 
Wt, suggesting an overall decrease in activin AB/B or inhibin B production which in 
turn can be interpreted as the Het follicles being more advanced, although 
comparable in size to the Wt.  Moreover, inhibin βA mRNA expression was 
increased in the Het follicle compared to the Wt directing inhibin/activin production 
towards activin A or inhibin A, which again supports the concept that Het follicles 
are at a more advanced stage of development.  There was no change between 
genotypes for the inhibin α subunit.    
 
It has been suggested that AMH has two main functions within the ovary firstly 
inhibiting initial follicle recruitment and secondly acting as an inhibitory growth 
factor during early stages of folliculogenesis by preventing the stimulatory effect of 
FSH on primordial follicle growth (Durlinger et al., 2002).  Due to the large variation 
in results it difficult to predict if AMH mRNA expression is having an effect as an 
indirect result of the genotype.  It could be proposed that if indeed it is acting as a 
primordial follicle inhibitor, it may be expected that there be a reduced function in 
Chapter 7                                                      In vitro maturation of Wt and Het follicles 
 206
the Het follicles allowing for increased recruitment.  To address this issue, earlier 
follicles would be required for analysis.  
 
7.4.4 Gene analysis of gonadotrophin independent stage 
The growing follicle undergoes considerable morphological changes which are 
associated with stage-specific roles of genes throughout folliculogenesis.  Events 
which occur are extensive and include: alterations in size due to proliferation, 
recruitment and differentiation of somatic cells, the accumulation of fluid within the 
antral cavity and alterations in oocyte size, associated with the maturing nucleus and 
cytoplamic components (Bownes and Gosden, 2005).   
 
Having identified potential factors including FSHR, LHR and the inhibin subunits, 
which may be involved in the phenotypic Het effect in the initial part of this study, it 
was important to analyse follicles from earlier stages of development to determine 
the stage at which control mechanisms may become altered.  The factors analysed 
are developmentally regulated and identifying when and where changes may occur is 
critical to the advancement of understanding of why DAZL functional copy number 
is having such a conspicuous effect on rate of preovulatory follicle development and 
ovulation in vivo.   
 
The assessment of the aforementioned mRNA expression in the cohorts of classified 
follicles remains inconclusive, most notably due to the large variations observed 
between samples.  In general it could be suggested that the effects of DAZL gene 
expression are only visible at the gonadotrophin dependent stage of development, yet 
it is dubious to make such a bold statement.  It is important to note that with all 
experiments the same concentration of RNA was used but the composition of RNA 
may be different due to the structure of the follicle with larger follicles containing 
more granulosa cells, thecal cells and a larger oocyte compare to smaller follicles, 
thus contributing to the large variations observed.  Further analysis is now required 
to assess the selected factors at these early gonadotrophin independent to 
gonadotrophin responsive stages.   
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7.4.5 Conclusion 
DAZL is undoubtedly essential for germ cell development with the functional 
consequences of the KO model being very distinctive with loss of all oocytes at birth 
(Ruggiu et al., 1996).  It is not uncommon for KO models of germ cell or, indeed, of 
ovary genes to be infertile, but it is scientifically intriguing why the heterozygous 
DAZL KO mice should have such a positive phenotype of increased ovulation and 
hence litter size.  We know that the oocytes of the DAZL KO are present prior to 
birth and at meiosis, malfunction of the germ cells takes place and oocyte ablation 
occurs (Ruggiu et al., 1996).  It could be suggested, although there is no evidence 
that this fetal effect would also affect the Hets at this same stage, thus, resulting in a 
programming event making the Het follicles more responsive for selected ovulation 
and hence have increased sensitivity to FSH.  Additionally, results from this study 
show that the mechanisms of atresia associated with follicle survival are also altered 
in the Hets compared to Wt. 
 
FSH concentration understandably affects growth potential with threshold limits 
being the desired mechanism for selected receptor expression regulation and 
subsequent gonadotrophin function.  There is a vast amount of evidence to suggest 
that inhibins, activins and follistatin function as intra-ovarian regulatory molecules 
involved in many processes including somatic cell proliferation, steroidogenesis, 
oocyte maturation and CL formation (Knight and Glister, 2006).  If these regulatory 
molecules are altered as an indirect result of DAZL function within the ovary it may 
explain or partially explain the Het phenotype.  These regulatory pathways at each 
stage of development now require a more comprehensive study to fully explain the 
difference observed between the phenotypes.  If particular systems have an increase 
in sensitivity, or communication is enhanced, this may be having the observable 
effects detected in this study relating to increase fertility.  Growth factors that 
augment FSH responsiveness would promote further follicle development, whereas 
ones that attenuate FSH responsiveness might induce atresia, this may be the 
situation that is occurring in the DAZL Het, whereby a growth factor is enhancing 
follicle growth and reducing atresia.   
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Furthermore, no histological analysis was performed on cultured follicles, therefore 
further investigating the differences in oocyte size/quality, prevalence of apoptosis, 
granulosa cell number and ability for cumulus expansion and overall maturation of 
the oocyte may highlight differenced in the morphological development of the Hets 
follicles in addition to the molecular control. 
 
Endocrine and locally produced factors are essential requirements for successful 
follicular growth and maturation, the process which is highly regulated and 
demanding.  It can now be added that components of this controlled developmental 
process are altered in the Hets allowing increased follicle advancement and affecting 
sensitivity to FSH and inadvertently may be subsequently affecting the ease of 
fertilisation.  These altered systems may result from fetal life development during 
meiosis of the primordial germ cells or it may be that DAZL is functionally active 
within the adult ovary through a mechanism yet to be discovered.  The RNA binding 
properties of DAZL are inconclusive with many potential targets (Venables et al. 
2001; Jiao et al. 2002; Maegawa et al. 2002; Fox et al. 2005; Reynolds et al. 2005; 
Reynolds et al., 2007) including those identified in Chapter 5, none of which would 
so far explain the hypothesis partially proven in this thesis, that ovarian sensitivity is 
altered.  An understanding of how the increased responsiveness of heterozygous 
follicle is accomplished, and how the differences in signalling are achieved under the 
coordinated response in terms of ordered follicular development to ovulatory status, 
or to selectively reduce follicle atresia remains a major goal.  Understanding the 
underlying phenomenon that increase litter sizes remains elusive although progress 
has now been made in directing the control to the gonadotrophin dependent stage of 
development involving bi-directional communication between the oocyte and 








Chapter 8: Final discussion 
The studies in this thesis stem from an interest in ovarian failure and the mechanisms 
by which it can arise.  A large proportion of human female reproductive disorders are 
caused by unknown factors with only a minority being identified to be caused by 
genetic mutations.  Therefore, genes which cause ovarian failure in mice are 
potential candidates for ovarian failure in humans, and there are now many 
transgenic murine ovarian pathologies which closely resembling conditions observed 
in humans.  Consequently, the aims of this thesis were to establish the direct and 
indirect actions of the oocyte specific gene DAZL on the molecular mechanisms 
associated with ovarian regulation and control.  Moreover, interest was directed at 
the effects of function copy number of DAZL on fertility, whereby the Het females 
have significantly larger litter sizes than their DAZL Wt counterparts.  To address 
the phenotypic differences directly, identifying how the molecular function of DAZL 
affects oocyte gene expression was investigated (Chapter 3).  In addition a novel 
approach of identifying in silico targets of DAZL was employed, exploiting one of 
the putative DAZL consensus sequences previously identified to be essential for 
DAZL RNA binding (Chapter 4) (Venables et al., 2001).  The RNA binding 
properties of DAZL were additionally investigated by attempting to identify in vivo 
targets within the ovary by immunprecipitation (Chapter 5) (Reynolds et al., 2005; 
2007).  Results from the in silico trawl (Chapter 4) provided a plethora of potential 
targets with one candidate, PDCD4, selected for further analysis (Chapter 6).  
Consequently, from investigating plausible actions of PDCD4 within the ovary and 
as a DAZL mRNA target, a novel mechanism of programmed cell death was 
identified in the mouse CL (Chapter 6).  In addition to the direct methods explored, 
DAZL gene function was investigated indirectly by means of in vitro follicle culture.  
It had been previously shown (Elaine Watson, PhD 2007) that, in vitro, follicles from 
DAZL Het mice showed a greater sensitivity to FSH, accelerating in growth and 
reaching significantly larger sizes than their Wt counterparts.  To address these 
preliminary results further, additional in vitro studies were performed to investigate 
the role of DAZL on FSH sensitivity and determine if any molecular control of 




follicle development, and potential bi-directional control of follicle maturation, were 
significantly altered by investigating gene regulation (Chapter 7).   
 
Evidence from the studies performed on oocyte gene assessment concluded that 
DAZL is probably having a regulatory effect on several known oocyte-expressed 
genes that may be essential components for oocyte development.  The reduction in 
mRNA of 10 candidate oocyte genes in d21 oocyte pools, accompanying the 
decreased functional DAZL copy number in Hets, suggests that the function of 
DAZL protein may be limiting the direct translation of these identified genes, 
although reduced DAZL protein formation resulting in translation efficiency has not 
been investigated.  Of selected interest were Oosp1 and H1foo as the mRNA 
expression of these two oocyte factors were also significantly down-regulated in Het 
ovaries at d10.  Furthermore, using d21 ovaries subsequent analysis of follicles 
which had been pooled regarding their size and potential developmental stage, 
showed that the expression levels of these two oocyte specific genes remained 
different between Het and Wt.  However, in contrast to d10, mRNA expression was 
up-regulated in the Het compared to the Wt but only in follicles of 180μm but not in 
smaller follicles.  Interestingly, Oosp1 has an unknown function (Yan et al., 2001; 
Choi et al., 2007), but has been demonstrated to be expressed in follicles beyond the 
primordial stage whereas, H1foo has been implicated in earlier selection processes 
from primordial to primary stage of development (Tanaka et al., 2005).  In addition 
Nobox, Figla and ZP3, all associated with early primordial follicle formation and 
oocyte development, were down-regulated in the Het compared to the Wt follicles in 
the d21 oocyte pools (Liang et al., 1997; Soyal et al., 2000; Suzumori et al., 2002).  
The down-regulation in expression of both ZP3 and Figla mRNA is consistent with 
the role of Figla as the transcriptional regulator of ZP3 (Liang et al., 1997; Soyal et 
al., 2000).  Intriguingly, both ZP3 and Cd9, a further candidate down-regulated in the 
Het oocytes are both associated with fertilisation capacity (Le Naour et al., 2000).  
However, the reduction in expression does not appear to have any detrimental effects 
on the fertilisation capacity of oocytes in Het mice in vivo.  Moreover, DAZL 
affected the transcription of Zar1, Stella and H1foo, three critical early 
embryogenesis genes (Wu et al., 2003; Payer et al., 2003; Tanaka et al., 2005).  




Collectively these findings suggest a possible developmental role for DAZL either 
directly or indirectly regulating a subset of genes preferentially expressed in 
postnatal oocytes, some of which have been shown to play essential roles in 
oogenesis.  Furthermore, these findings also suggest that DAZL may be not only 
functioning near the top of a signalling cascade regulating genes necessary for oocyte 
and early follicle development but possibly plays a further role in early embryo 
development.  It can be concluded that DAZL could have either pre-programmed the 
oocyte with subsequent regulatory effects on growth and sensitivity or is functionally 
active at different stages of oocyte development.  But how these factors may be 
directly or indirectly associated with DAZL function remain to be fully elucidated. 
 
Previous attempts to identify DAZL RNA binding targets remained inconclusive, 
with very little evidence to suggest a direct action within the ovary in addition to 
limited literature on the effects of DAZL mutation of female fertility.  The studies in 
this thesis were the first to attempt to isolate endogenous DAZL protein: RNA 
complexes directly using mouse oocytes and ovary preparations rather than 
reconstituting those interactions using recombinant proteins or RNA libraries.  To 
address the binding specificity of DAZL in vivo and to investigate direct interactions 
further, the previously used CLIP technique was employed.  This technique has 
already been used to identify in vivo interaction of DAZL within the testis (Reynolds 
et al., 2005, 2007).  We present evidence which supports previously published data 
that DAZL protein binds to and regulates the translation of MVH within this testis, 
an important factor in spermatogenesis and oogenesis.  However the CLIP was 
problematic when transferred to the oocyte, at least with the numbers of oocytes used 
in the present studies.  In light of these studies it became apparent that the abundance 
of DAZL protein within the ovary was such that is was undetectable by Western Blot 
analysis, and subsequently the CLIP technique as it stands in unsuitable for the use in 
oocytes.  Collectively, the results highlight the difficulties present when working 
with limited material such as the oocyte and until such a time that the sensitivity of 
the CLIP technique can be optimised and applied to oocytes these studies to identify 
in vivo DAZL target remain inconclusive.  Interestingly these studies did highlight 
the possibility of a similar DAZL protein being detected within different tissues used 




as controls during these studies, including the liver, kidney and heart all of which 
now require further investigation before conclusions can be drawn.   
 
To further explore DAZL mRNA targets within oocytes in an attempt to further 
identify if transcription regulation is altered between the Wt and Het, a published 
consensus sequence (Venables et al., 2001) was used to perform an in silico trawl of 
the mouse genome.  The results of this analysis showed that this consensus sequence 
was highly expressed in many sequences which question the feasibility of it being the 
only requirement for DAZL binding and subsequent function.  The abundance of 
potential targets additionally highlighted that bioinformatics can only be used as a 
biological aid and not as a tool for definite answers.  Potential targets were identified 
and selected based on oocyte-expressed genes with suspected functional involvement 
in apoptosis, cell proliferation or steroidogeneis.  However, until such time that direct 
in vivo interactions between oocyte DAZL and target mechanisms these results 
remain unexplored. 
 
In light of the in silico trawl one potential candidate, PDCD4, was selected for 
further investigation and now an unforeseen role for this protein within the ovary has 
emerged.  We have now determined that PDCD4 may play a fundamental role in 
regulating programmed cell death within the CL during functional and structural 
luteolysis.  In support of a pro-apoptotic function of PDCD4 in the ovary (Shibahara 
et al., 1995), in addition to the evidence of protein localisation and translocation from 
the cytoplasm to the nucleus, a similar pattern of protein expression was observed at 
luteolysis as previously shown in other cell types undergoing programmed cell death 
(Schlichter et al., 2001a, b; Bohm et al., 2003; Yang et al., 2003).  Through a series 
of experiments examining induced follicle atresia by FSH withdrawal, induced 
luteinisation using therapeutic agents of cloprostenol and bromocriptine, and a 
natural model of luteolysis the pro-estrous mouse, it can be concluded that the 
localisation of PDCD4 is associated with CL remodelling and becomes nuclear on 
induced luteolysis in conjunction with an increased abundance in cytoplasmic 
expression.  
 




Adopting an indirect approach to identify molecular alterations of DAZL function on 
the follicle unit, which may explain the phenomenon of increased Het litter size, 
provided evidence that bi-directional control of the granulosa cells may be a further 
target of DAZL action.  Culture systems have provided a wealth of information in 
association with intra-ovarian, intra-follicular and cross talk communication between 
follicle in recent years (Spears et al., 1996, 2002; Baker et al., 2001).  There was 
support from previous studies that demonstrated that the Het follicles are more 
sensitive to FSH in vitro (Elaine Watson, PhD 2007).  It has now been demonstrated 
that molecular control of Het follicles is altered compared to the Wt, most notably 
with reference to the FSHR up-regulation at high FSH culture concentrations, thus, 
further supporting the proposed hypothesis that the threshold sensitivity of the Het 
follicles is comparatively altered.  The up-regulation of aromatase mRNA in Het 
follicles suggests advancement in follicle development although there was no 
difference in LHR mRNA expression.  Furthermore, we demonstrated that the 
relationship between the inhibin βB and inhibin βA subunit expression was altered, 
suggests that there are fundamental differences in the production of activin and 
inhibin, with preference for inhibin A production at reduced FSH levels in the Het 
but inhibin B in the Wt.  These findings are suggestive of the advanced stage of 
follicle development after culture.  However, previous results from plasma from d21 
mice show that Hets have an increase in inhibin B plasma levels compared to Wt 
(McNeilly et al., 2000), but these result represent the production from the entire 
ovary and the two cannot be directly related.  These findings emphasise the potential 
specific role for inhibin subunits in follicle progression and FSH sensitivity.  In 
conclusion, these indirect investigations into the molecular control of follicle 
development mediated by DAZL functional expression not only suggest that FSH 
may be playing a modulating role, possibly by regulating its own receptor, but that 
other regulatory factors are involved.  Recruiting members of the TGFβ superfamily 
into the regulatory control of DAZL follicle development suggests that advanced Het 
follicles transfer their preference to inhibin A, which has been additionally related to 
advancement of follicle growth (Knight and Glister, 2003).  Furthermore this may be 
directly related to the increased sensitivity of these Het follicles to FSH and hence 
decreased levels of follicle atresia.  Bearing in mind that the pressure of the ovarian 




environment is removed, follicle regulation may be subjected to adaptive modulation 
in vitro, and in vivo analysis is now required to address the physiological relevance 
of these molecular findings.   
 
The assessment of molecular control in the current thesis has been principally 
directed at the gonadotrophin-dependent stage of follicular development where FSH 
and LH-signalling pathways play obligatory roles.  In vivo the increase in plasma 
FSH during luteo-follicular transition is the basis for follicle selection, with the most 
sensitive follicle responding first to threshold concentration.  Only FSH has been 
subjected to scrutiny on the sensitivity in the current studies.  As previously 
mentioned, in the gonadotrophin-dependent phase of follicular development, LH also 
appears to act within a critical minimal threshold and ceiling level for the normal 
functions of the follicle unit (Palermo, 2007).  LH has not been investigated and the 
roles of LH between Wt and Het follicle development may additionally provide 
evidence into the developmental differences which are beginning to emerge.   
 
Although not studied in depth, there appears to be no difference in oocyte exhaustion 
and premature ovarian failure in vivo between the Wt and Het (unpublished, Judy 
McNeilly) suggesting that follicle atresia is also reduced in the cohort of recruited 
follicles, leading to the overall increased litter sizes.  Therefore the results detailed in 
this thesis showing that Het follicles are less susceptible to atresia in vitro regardless 
of the FSH concentration, supporting that of the physiological observation.  
Furthermore, it could be argued that the observed increase in Het litter size could 
additionally occur as a result of increased survival of embryos rather than an increase 
in ovulation rate and a decrease in atresia rate.  However, during preliminary studies 
investigating the Het phenotype, the number of implantation sites and CL present 
were directly correlated to the number of embryos present in both Wt and Het ruling 
out the aforementioned possibility of increased embryo survival (unpublished, Judy 
McNeilly).   
 
The last decade has witnessed considerable advances in both our understanding of 
follicular development and atresia, and the tools available to further manipulate and 




investigate these processes are becoming greatly exploited with particular reference 
to transgenic murine models.  In addition follicle culture is now a widely used 
technique which allows one to manipulate the expression of genes of interest and 
monitor local regulatory events at different stages of development and in a more 
physiological environment.  Together these permit increasingly comprehensive 
studies and both have been employed and exploited in the current studies.  Acquiring 
an improved understanding of intra-ovarian interaction between follicles of the 
DAZL transgenic model may help to determine how this genotype recruits follicles 
for initial development and subsequent ovulation, under reduced FSH thresholds and 
altered molecular control.  Moreover, understanding this may subsequently be a 
useful application for oocyte selection and further aiding reproductive technologies 
in human fertility, possibly using DAZL as a biomarker for oocyte selection with 
reduced DAZL being potentially better for survival. 
 
The many regulatory components related to the processes of folliculogenesis present 
persisting challenges and when one pathway is thought to be complete another 
emerges.  The importance and timing of follicle development and control are 
sensitive issues and clearly malfunction results in death.  An accurate balance 
between survival and atresia remains fundamental to healthy viable oocytes with 
survival factors promoting follicle growth and protecting cells from apoptosis.  
Absence of survival factor contributes to activation of the endogenous apoptotic 
pathways leading to follicle atresia.  A generalisation regarding DAZL is that in the 
complete absence, germ cell apoptosis occurs, but Het expression increases survival 
over and above that of the Wt.  Actions are beginning to emerge that DAZL function 
may be perturbing the system aiding selection criteria and fundamentally altering the 
sensitivity of the FSH control system. 
 
Finally, from the studies performed in this thesis it is possible that DAZL is 
regulating follicle selection and subsequent growth directly via oocyte associated 
mechanisms as demonstrated by oocyte gene expression differences.  These in turn 
may be indirectly playing critical roles in the intra-ovarian bi-directional 
communication, regulating FSH sensitivity and having an effect on oocyte 




maturation and granulosa cell proliferation and differentiation including members of 
the TGFβ family.  Furthermore, understanding how DAZL regulates target mRNAs 
in its direct function as an RNA binding protein will provide further information 
about how target gene function relates to the mRNA difference observed within this 
comparative study at the oocyte, follicle and endocrine level.  
 
Direct and indirect mechanisms of investigation have certainly highlighted that there 
are alterations in the control systems between the Wt and Het DAZL phenotypes.  
The possible roles for DAZL in fetal life, predetermining the molecular requirement 
of subsequent development and in post-translational programming of oogenesis, 
folliculogenesis at the time of gonadotrophin responsiveness, steroidogenesis, and 
overall sensitivity of the HPG axis have been accentuated.  Understanding the 
possibility that DAZL may be involved in multiple developmental functions 
regulating events associated with different targets and transcription mechanism has 
implications for therapeutic management.  Together, the studies in this thesis support 
the hypothesis that DAZL is essential and critical for germ cell function with the 
suggestion that the oocyte subsequently alters the sensitivity of follicles to 
component parts of the HPG.  Long term studies are now need to be designed to 
observe regulation differences between the DAZL Het and Wt from fetal life until 
cessation of fertility, to understand the developmental competence of follicle growth, 
the endocrinology, and steroidogenic capacity.  Ultimately, the better the 
understanding of the transcriptional control in oogenesis and subsequent 
folliculogenesis within the DAZL mouse model, the more rational our approach will 
be to modulate and assess human fertility problems.   
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Appendix Table: Oligonucleotide primer sequences used for PCR (A) and Real-Time PCR (B). 
A: PCR     
Primer Forward Sequence Reverse Sequence 
Atm gCTCTCCCATATCCTgTCTgTC gCTgCCCTTACTCAACTCTTC 
BMP15 CAATgACACCgATgACAgA gAgCAATgATCCAgTgATCC 
BMP6 TTCTTCAAggTgAgCgAggT TAgTTggCAgCgTAgCCTTT 
Cd9 CggTCAAAggAggTAgCAAg TCACCAAgAggAACCCgAAg 
CDC2 TgAAAgCgAggAAgAAggAg CCCTggAggATTTggTgTAAg 
CDC25c CCTCTgACTTCTCCTCTgTg gACTCTTCCTCCTCCATCTg 
c-kit ATCCCgACTTTgTCAgATgg AAggCCAACCAggAAAgTT 
Cx37 TCAAAggCACCTCAgAgAC AATAggggAggCTCgAAAg 
Cyclin B1 CCTCACAAAgCACATgACTg TCgACAACTTCCgTTAgCC 
DAZAP1 gAAATATCgACCCgAAgCC gTCCACTgATTgTTCgTCC 
DAZAP2 TCCTCAgACCTTACATCTTCC CATCATACCCTCCTTCCACC 
Dazl TCCAAATgCTgAgACTTACATg gTCTgTCTgCTTCggTCCAC 
Dmc1 CCAgATgTTgTCACgACTCC ACCAATTCCCCACCTACTCC 
DNMT1 TTACgACgAAgCCAAggAC ACAgACCTCACAgACACCAC 
DNMT2 gggACAggAAACATCAACAAg ggTggCAAATCAggAAgAg 
DNMT3l ggACCTCAgAgAggATCAATg AgAACCAgAACCgCTTTCC 
Figla ACAgAgCAggAAgCCCAgTA ACTCgCACAgCTggTAggTT 
Fragilis CTTCTCAAgCCTTCATCACC TTCCgATCCCTAgACTTCAC 
Gapdh ACCACAgTCCATgCCATCAC TCCACCACCCTCTTgCTgTA 
GDF9 ATCTgATAggCgAggTgAgAC CACAAggTCACACATACAgg 
Gpiap1 AAgATggAAggAgTggAgTg CAgAAgAgCCAATCAAAgCC 
H1foo  TggAgAAAgggCAgAAgAgg TTTTggCgAgggAAgCAAC 
mEomes gCAgggCAATAAgATgTACg CTgAgTCTTggAAggTTCA 
Msh4 gAgCTgCATCCAgTTTTCC TTgCCATTCCTATCTCgCC 




Msh5 CAAACAggATgAggCTATgAC AAgggAATAATggAggAgAgg 
MSY2 CATCAACAggAATgACACCAAg TACgTCgATTAggggCATAgC 
MVH AggAggTgAAAgCAgTgATAg  ATgAgCCAAAATAggCAAgAg 
Nobox CTgCTgCACTggAgACAgAg CTTCAgCgATTCTgCCTTTC 
Nr6a1 TgTTTgCTCTgCTTTgCC ATCACCTCCATCCCTTCATC 
Oas1d AACTCCTTCCTgACACCACC CCTCAATgAACACTACCTgTCC 
Oct 4 AgCACgAgTggAAAgCAACTC CAgATggTggTCTggCTgAAC 
Oosp1 TgTgAAgCAgAAAgTAgAggAg ggAgAAATggAAAACCgAgAAg 
PABPC1 gAgACCAgCTTCCTCACAgg ACCTTgCACATgAACAgCAg 
PABPC2 AAATgAACgggATgCTTCTg CTTTCgATTTCCCACCTTCA 
Pdcd4 gCTAgAATCAATgCAAAAgCC TCCACCTCTTCCACATCATAC  
Pkd2l2 gCTATCCCgACTTTTACTTCC ACCCAAAAACCAgAATCCC 
Plat gCTgAgTgCATCAACTggAA gCCACggTAAgTCACACCTT 
Pumillio2 gCAgCAACCAAgCACTAAC AACTgCCAACTgATgAgCC 
Smac/Diablo gCCTCAgTCTCTCAgTAACg TgCCACACCTCATCTTCCTC 
Stella ATACagAcgTCCTACAACCAg CATCTgAATggCTCACTgTC 
Sycp3 CCgCTgAgCAAACATCTAAAg gCATATTCTgTACTTCACCTCC 
wee1 CCTCAATCCCAAATgCTgTC TgCCACTgCTCTCCATTTC 
Zarl gCCgAgTgTgTgAgAAATC AAgggAAgAggTgAAgAggg 
Zp1 AggATTgCCACggATAAgAC TTgAAAggACACCCATATgAC 
Zp2 CATACCCAgACCAATCCTACC CAgTTCATATTCACAgCCATCC 
Zp3 ACTCCTCCCCCTCTCACTTC AATCACAgATgTCAgCATCAC 
B: Real Time PCR   
Primer Forward Sequence Reverse Sequence 
Dazl gAAggCAAAATCAtgCCAAACAC CTTCTgCACATCCACgTCATTA 
Gapdh gACATCAagAaggTggTgAagC gTCCACCACCCTgTTgCTgTAg 
MVH CCACCggCAATTTTgACTTTTg AAAgCTgCAgTCTTCCCAgAC 
Pum2 gCAgCAACCAAgCACTAAC AACTgCCAACTgATgAgCC 
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